Pyridazine(thio)amides as fungicidal compounds.

Novel pyridazine(thio)amide compounds provide effective and selective control of phytopathogenic fungi, addressing the limitations of existing crop protection agents by ensuring low toxicity and preventing resistance.

JP7578593B2Active Publication Date: 2024-11-06BAYER AG +1

Patent Information

Application Number
JP2021530265
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2018-11-28
Filing Date
2019-11-27
Publication Date
2024-11-06
Estimated Expiration
2039-11-27

AI Technical Summary

Technical Problem

Existing crop protection agents face challenges in providing broad-spectrum efficacy against phytopathogenic microorganisms like fungi with low toxicity, high selectivity, and low application rates, while also preventing resistance development.

Method used

Development of novel pyridazine(thio)amide compounds and compositions for use in controlling phytopathogenic fungi, including specific formulations and production methods.

Benefits of technology

The pyridazine(thio)amide compounds offer effective pest control with low toxicity and high selectivity, reducing the risk of resistance development.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007578593000001
    Figure 0007578593000001
  • Figure 0007578593000002
    Figure 0007578593000002
  • Figure 0007578593000003
    Figure 0007578593000003
Patent Text Reader

Abstract

The present invention relates to pyridazine (thio)amide compounds, processes and intermediates for their preparation and their use for controlling plant pathogenic microorganisms, such as plant pathogenic fungi.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical Field]

[0001] The present invention relates to pyridazine (thio)amide compounds and their use for controlling plant pathogenic microorganisms, such as plant pathogenic fungi. The present invention also relates to processes and intermediates for producing these compounds. [Background technology]

[0002] A large number of crop protection agents have been developed to combat or prevent the damage caused by microorganisms.However, there remains a need to develop new compounds that can be used at low toxicity, high selectivity or low application rate, but still enable effective pest control, in order to provide compounds that are effective against a wide range of plant pathogenic microorganisms such as fungi.It may also be desirable to have new compounds that can prevent resistance development.

[0003] In at least some of these aspects, the present invention provides novel compounds and compositions for controlling plant pathogenic microorganisms, such as fungi, that offer advantages over known compounds. Summary of the Invention

[0004] The present invention relates to a compound of formula (I):

[0005] [ka]

[0006] In the compound of the formula, T, n, m, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 and Q are as described herein, as well as salts, N-oxides and solvates thereof.

[0007] The present invention relates to compositions comprising at least one compound of formula (I) as defined herein and at least one agriculturally suitable adjuvant.

[0008] The present invention relates to a method for controlling plant pathogenic fungi, said method comprising the step of applying at least one compound of formula (I) as defined herein or a composition as defined herein to plants, plant parts, seeds, fruits or the soil in which said plants grow.

[0009] The present invention also relates to processes and intermediates for preparing compounds of formula (I). definition

[0010] As used herein, the term "halogen" refers to a fluorine, chlorine, bromine, or iodine atom.

[0011] As used herein, the term "methylidene" refers to a CH2 group connected to a carbon atom by a double bond.

[0012] As used herein, the term "halomethylidene" refers to a CX2 group connected to a carbon atom by a double bond, where X is a halogen.

[0013] As used herein, the term "oxo" refers to an oxygen atom attached to a carbon or sulfur atom by a double bond.

[0014] As used herein, the term "C1-C6-alkyl" refers to a saturated branched or straight hydrocarbon chain having 1, 2, 3, 4, 5 or 6 carbon atoms. Examples of C1-C6-alkyl include, but are not limited to, methyl, ethyl, propyl (n-propyl), 1-methylethyl (isopropyl), butyl (n-butyl), 1-methylpropyl (sec-butyl), 2-methylpropyl (isobutyl), 1,1-dimethylethyl (tert-butyl), pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl, and 1-ethyl-2-methylpropyl. In particular, the hydrocarbon chain has 1, 2, 3 or 4 carbon atoms ("C1-C4-alkyl"), for example methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, isobutyl or tert-butyl.

[0015] As used herein, the term "C2-C6-alkenyl" refers to an unsaturated branched or straight hydrocarbon chain having 2, 3, 4, 5, or 6 carbon atoms and comprising at least one double bond. Examples of C2-C6-alkenyl include ethenyl (or "vinyl"), prop-2-en-1-yl (or "allyl"), prop-1-en-1-yl, but-3-enyl, but-2-enyl, but-1-enyl, pent-4-enyl, pent-3-enyl, pent-2-enyl, pent-1-enyl, hex-5-enyl, hex-4-enyl, hex-3-enyl, hex-2-enyl, hex-1-enyl, prop-1-en-2-yl (or aryl). or "isopropenyl"), 2-methylprop-2-enyl, 1-methylprop-2-enyl, 2-methylprop-1-enyl, 1-methylprop-1-enyl, 3-methylbut-3-enyl, 2-methylbut-3-enyl, 1-methylbut-3-enyl, 3-methylbut-2-enyl, 2-methylbut-2-enyl, 1-methylbut-2-enyl, 3-methylbut-1-enyl, 2-methylbut-1-enyl, 1-methylbut-1-enyl, 1,1-Dimethylprop-2-enyl, 1-ethylprop-1-enyl, 1-propyl vinyl, 1-isopropyl vinyl, 4-methylpent-4-enyl, 3-methylpent-4-enyl, 2-methylpent-4-enyl, 1-methylpent-4-enyl, 4-methylpent-3-enyl, 3-methylpent-3-enyl, 2-methylpent-3-enyl, 1-methylpent-3-enyl, 4-methylpent-2-enyl, 3-methylpent-2-enyl, 2-methylpent-2-enyl, 1-methylpent-2-enyl, 4-methylpent-1-enyl, 3-methylpent-1-enyl, 2-methylpent-1-enyl, 1-methylpent-1-enyl, 3-ethylbut-3-enyl, 2-ethylbut-3-enyl, 1-ethylbut-3- Examples of the aryl group include, but are not limited to, butenyl, 3-ethylbut-2-enyl, 2-ethylbut-2-enyl, 1-ethylbut-2-enyl, 3-ethylbut-1-enyl, 2-ethylbut-1-enyl, 1-ethylbut-1-enyl, 2-propylprop-2-enyl, 1-propylprop-2-enyl, 2-isopropylprop-2-enyl, 1-isopropylprop-2-enyl, 2-propylprop-1-enyl, 1-propylprop-1-enyl, 2-isopropylprop-1-enyl, 1-isopropylprop-1-enyl, 3,3-dimethylprop-1-enyl, 1-(1,1-dimethylethyl)ethenyl, buta-1,3-dienyl, penta-1,4-dienyl, hexa-1,5-dienyl, or methylhexadienyl groups.

[0016] As used herein, the term "C2-C6-alkynyl" refers to a branched or straight hydrocarbon chain having 2, 3, 4, 5 or 6 carbon atoms and comprising at least one triple bond. Examples of C2-C6-alkynyl include ethynyl, prop-1-ynyl, prop-2-ynyl (or "propargyl"), but-1-ynyl, but-2-ynyl, but-3-ynyl, pent-1-ynyl, pent-2-ynyl, pent-3-ynyl, pent-4-ynyl, hex-1-ynyl, hex-2-ynyl, hex-3-ynyl, hex-4-ynyl, hex-5-ynyl, 1-methylprop-2-ynyl, 2-methylbut-3-ynyl, 1-methylbut-3-ynyl, 1-methylbut-2-ynyl, 3-methylbut-1-ynyl, 1-ethylprop-2-ynyl, 3-methylpent-4-ynyl, 2-methylpent-1-ynyl, 2-methylpent-2-ynyl, 2-methylpent-3-ynyl, 2-methylpent-3-ynyl, 2-methylpent-2 ...4-ynyl, 2-methylpent-4-ynyl, 2-methylpent-4-ynyl, 2-methylpent-4-ynyl, 2-methylpent-4-ynyl, 2-methylpent-4-ynyl, 2-methylpent- Examples of methylpent-1-ynyl include, but are not limited to, pent-4-ynyl, 1-methyl-pent-4-ynyl, 2-methylpent-3-ynyl, 1-methylpent-3-ynyl, 4-methylpent-2-ynyl, 1-methyl-pent-2-ynyl, 4-methylpent-1-ynyl, 3-methylpent-1-ynyl, 2-ethylbut-3-ynyl, 1-ethylbut-3-ynyl, 1-ethylbut-2-ynyl, 1-propylprop-2-ynyl, 1-isopropylprop-2-ynyl, 2,2-dimethylbut-3-ynyl, 1,1-dimethylbut-3-ynyl, 1,1-dimethylbut-2-ynyl or 3,3-dimethylbut-1-ynyl groups.

[0017] As used herein, the term "C1-C6-haloalkyl" refers to a C1-C6-alkyl group as defined above in which one or more hydrogen atoms are replaced by one or more halogen atoms, which may be the same or different.

[0018] As used herein, the term "C2-C6-haloalkenyl" refers to a C2-C6-alkenyl group as defined above in which one or more hydrogen atoms are replaced by one or more halogen atoms, which may be the same or different.

[0019] As used herein, the term "C2-C6-haloalkynyl" refers to a C2-C6-alkynyl group as defined above in which one or more hydrogen atoms are replaced by one or more halogen atoms, which may be the same or different.

[0020] As used herein, the term "C1-C6-alkoxy" refers to a group of the formula (C1-C6-alkyl)-O-, where the term "C1-C6-alkyl" is as defined herein. Examples of C1-C6-alkoxy include methoxy, ethoxy, n-propoxy, 1-methylethoxy, n-butoxy, 1-methylpropoxy, 2-methylpropoxy, 1,1-dimethylethoxy, n-pentoxy, 1-methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 2,2-dimethylpropoxy, 1-ethylpropoxy, 1,1-dimethylpropoxy, 1,2-dimethylpropoxy, n-hexyloxy, 1-methylpentoxy, 2-methylpentoxy. Examples of alkyl ethers include, but are not limited to, 3-methylpentoxy, 4-methylpentoxy, 1,1-dimethylbutoxy, 1,2-dimethylbutoxy, 1,3-dimethylbutoxy, 2,2-dimethylbutoxy, 2,3-dimethylbutoxy, 3,3-dimethylbutoxy, 1-ethylbutoxy, 2-ethylbutoxy, 1,1,2-trimethylpropoxy, 1,2,2-trimethylpropoxy, 1-ethyl-1-methylpropoxy, and 1-ethyl-2-methylpropoxy.

[0021] As used herein, the term "C1-C6-haloalkoxy" refers to a C1-C6-alkoxy group as defined above, in which one or more hydrogen atoms are replaced by one or more halogen atoms, which may be the same or different. Examples of C1-C6-haloalkoxy include, but are not limited to, chloromethoxy, bromomethoxy, dichloromethoxy, trichloromethoxy, fluoromethoxy, difluoromethoxy, trifluoromethoxy, chlorofluoromethoxy, dichlorofluoromethoxy, chlorodifluoromethoxy, 1-chloroethoxy, 1-bromoethoxy, 1-fluoroethoxy, 2-fluoroethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2-dichloro-2-fluoroethoxy, 2,2,2-trichloroethoxy, pentafluoroethoxy, and 1,1,1-trifluoroprop-2-oxy.

[0022] As used herein, the term "C1-C6-haloalkoxy" refers to a C1-C6-alkoxy group as defined above in which one or more hydrogen atoms are replaced by one or more halogen atoms, which may be the same or different.

[0023] As used herein, the term "C1-C6-hydroxyalkyl" refers to a C1-C6-alkyl group as defined above, in which at least one hydrogen atom is replaced by a hydroxyl group. Examples of C1-C6-hydroxyalkyl include, but are not limited to, hydroxymethyl, 1-hydroxyethyl, 2-hydroxyethyl, 1,2-dihydroxyethyl, 3-hydroxypropyl, 2-hydroxypropyl, 1-hydroxypropyl, 1-hydroxypropan-2-yl, 2-hydroxypropan-2-yl, 2,3-dihydroxypropyl, and 1,3-dihydroxypropan-2-yl.

[0024] As used herein, the term "C1-C6-alkylsulfanyl" represents a saturated straight or branched chain group of formula (C1-C6-alkyl)-S-, where the term "C1-C6-alkyl" is as defined herein. Examples of C1-C6-alkylsulfanyl include, but are not limited to, methylsulfanyl, ethylsulfanyl, propylsulfanyl, isopropylsulfanyl, butylsulfanyl, sec-butylsulfanyl, isobutylsulfanyl, tert-butylsulfanyl, pentylsulfanyl, isopentylsulfanyl, and hexylsulfanyl groups.

[0025] As used herein, the term "C1-C6-haloalkylsulfanyl" refers to C1-C6-alkylsulfanyl as defined above in which one or more hydrogen atoms are replaced by one or more halogen atoms, which may be the same or different.

[0026] As used herein, the term "C1-C6-alkylsulfinyl" refers to a saturated straight or branched chain group of the formula (C1-C6-alkyl)-S(=O)-, where the term "C1-C6-alkyl" is as defined herein. Examples of C1-C6-alkylsulfinyl include saturated straight or branched chain alkylsulfinyl radicals having 1 to 8, preferably 1 to 6, more preferably 1 to 4 carbon atoms, such as (but not limited to) methylsulfinyl, ethylsulfinyl, propylsulfinyl, 1-methylethylsulfinyl, butylsulfinyl, 1-methylpropylsulfinyl, 2-methylpropylsulfinyl, 1,1-dimethylethylsulfinyl, pentylsulfinyl, 1-methylbutylsulfinyl, 2-methylbutylsulfinyl, 3-methylbutylsulfinyl, 2,2-dimethylpropylsulfinyl, 1-ethylpropylsulfinyl, 1,1-dimethylpropylsulfinyl, 1,2-dimethylpropylsulfinyl, hexyl ... C1-C6-alkylsulfinyl such as silsulfinyl, 1-methylpentylsulfinyl, 2-methylpentylsulfinyl, 3-methylpentylsulfinyl, 4-methylpentylsulfinyl, 1,1-dimethylbutylsulfinyl, 1,2-dimethylbutylsulfinyl, 1,3-dimethylbutylsulfinyl, 2,2-dimethylbutylsulfinyl, 2,3-dimethylbutylsulfinyl, 3,3-dimethylbutylsulfinyl, 1-ethylbutylsulfinyl, 2-ethylbutylsulfinyl, 1,1,2-trimethylpropylsulfinyl, 1,2,2-trimethylpropylsulfinyl, 1-ethyl-1-methylpropylsulfinyl and 1-ethyl-2-methylpropylsulfinyl.

[0027] As used herein, the term "C1-C6-haloalkylsulfinyl" refers to a C1-C6-alkylsulfinyl as defined above in which one or more hydrogen atoms are replaced by one or more halogen atoms, which may be the same or different.

[0028] As used herein, the term "C1-C6-alkylsulfonyl" represents a saturated straight or branched chain group of formula (C1-C6-alkyl)-S(=O)2-, where the term "C1-C6-alkyl" is as defined herein. Examples of C1-C6-alkylsulfonyl include methylsulfonyl, ethylsulfonyl, propylsulfonyl, 1-methylethylsulfonyl, butylsulfonyl, 1-methylpropylsulfonyl, 2-methylpropylsulfonyl, 1,1-dimethylethylsulfonyl, pentylsulfonyl, 1-methylbutylsulfonyl, 2-methylbutylsulfonyl, 3-methylbutylsulfonyl, 2,2-dimethylpropylsulfonyl, 1-ethylpropylsulfonyl, 1,1-dimethylpropylsulfonyl, 1,2-dimethylpropylsulfonyl, hexylsulfonyl, 1-methylpentylsulfonyl, 2-methylpentyl ...,1-dimethylpropylsulfonyl, 1,2-dimethylpropylsulfonyl, hexylsulfonyl, 1-methylpentylsulfonyl, 2-methylpentylsulfonyl, 1,1-dimethylethylsulfonyl, pentylsulfonyl, 1,1-dimethylpropylsulfonyl, 1,2-dimethylpropylsulfonyl, hexyls Examples of alkyl groups include, but are not limited to, butylsulfonyl, 3-methylpentylsulfonyl, 4-methylpentylsulfonyl, 1,1-dimethylbutylsulfonyl, 1,2-dimethylbutylsulfonyl, 1,3-dimethylbutylsulfonyl, 2,2-dimethylbutylsulfonyl, 2,3-dimethylbutylsulfonyl, 3,3-dimethylbutylsulfonyl, 1-ethylbutylsulfonyl, 2-ethylbutylsulfonyl, 1,1,2-trimethylpropylsulfonyl, 1,2,2-trimethylpropylsulfonyl, 1-ethyl-1-methylpropylsulfonyl and 1-ethyl-2-methylpropylsulfonyl.

[0029] As used herein, the term "C1-C6-haloalkylsulfonyl" refers to C1-C6-alkylsulfonyl as defined above in which one or more hydrogen atoms are replaced by one or more halogen atoms, which may be the same or different.

[0030] As used herein, the term "C1-C6-alkylcarbonyl" represents a saturated straight or branched chain group of formula (C1-C6-alkyl)-C(=O)-, where the term "C1-C6-alkyl" is as defined herein.

[0031] As used herein, the term "C1-C6-haloalkylcarbonyl" refers to a C1-C6-alkylcarbonyl as defined above in which one or more hydrogen atoms are replaced by one or more halogen atoms, which may be the same or different.

[0032] As used herein, the term "C1-C6-alkoxycarbonyl" represents a saturated straight or branched chain group of formula (C1-C6-alkoxy)-C(=O)-, where the term "C1-C6-alkoxy" is as defined herein.

[0033] As used herein, the term "C1-C6-haloalkoxycarbonyl" refers to a C1-C6-alkoxycarbonyl as defined above in which one or more hydrogen atoms are replaced by one or more halogen atoms, which may be the same or different.

[0034] As used herein, the term "C1-C6-dialkylamino" refers to an amino radical having two independently selected C1-C6-alkyl groups, as defined herein. Examples of C1-C6-dialkylamino include, but are not limited to, N,N-dimethylamino, N,N-diethylamino, N,N-diisopropylamino, N-ethyl-N-methylamino, N-methyl-Nn-propylamino, N-isopropyl-Nn-propylamino, and N-tert-butyl-N-methylamino.

[0035] As used herein, the term "C3-C 12 "-Carbocycle" refers to a non-aromatic saturated or unsaturated hydrocarbon ring system in which all of the ring members, varying from 3 to 12, are carbon atoms. The ring system may be monocyclic or polycyclic (fused, spiro or bridged). Non-aromatic C3-C 12 -Carbocyclic rings include C3-C 12 -cycloalkyl (monocyclic or bicyclic), C3-C 12-cycloalkenyl (monocyclic or bicyclic), bicyclic systems comprising an aryl (e.g., phenyl) fused to a monocyclic C3-C8-cycloalkyl (e.g., tetrahydronaphthalenyl, indanyl), bicyclic systems comprising an aryl (e.g., phenyl) fused to a monocyclic C3-C8-cycloalkenyl (e.g., indenyl, dihydronaphthalenyl), and tricyclic systems comprising a cyclopropyl linked by one carbon atom to a bicyclic system comprising an aryl (e.g., phenyl) fused to a monocyclic C3-C8-cycloalkyl or monocyclic C3-C8-cycloalkenyl. 12 The carbocycle can be attached to the parent molecular moiety through any carbon atom.

[0036] As used herein, the term "C3-C 12 "-cycloalkyl" represents a saturated monovalent monocyclic or bicyclic hydrocarbon ring containing 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12 carbon atoms. Examples of monocyclic C3-C8-cycloalkyl include, but are not limited to, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, or cyclooctyl. Bicyclic C6-C8 12 Examples of -cycloalkyl include, but are not limited to, bicyclo[3.1.1]heptane, bicyclo[2.2.1]heptane, bicyclo[2.2.2]octane, bicyclo[3.2.2]nonane, bicyclo[3.3.1]nonane, bicyclo[4.2.0]octyl, octahydropentalenyl, and bicyclo[4.2.1]nonane.

[0037] As used herein, the term "C3-C 12 "-Cycloalkenyl" represents an unsaturated monovalent monocyclic or bicyclic hydrocarbon ring containing 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12 carbon atoms. Examples of monocyclic C3-C8-cycloalkenyl include, but are not limited to, cyclobutenyl, cyclopentenyl, cyclohexenyl, cycloheptenyl, and cyclooctenyl groups. Bicyclic C6-C8 12Examples of -cycloalkenyl include, but are not limited to, bicyclo[2.2.1]hept-2-enyl or bicyclo[2.2.2]oct-2-enyl.

[0038] As used herein, the term "C6-C 14 "Carbocycle" or "aryl" refers to an aromatic hydrocarbon ring system in which all of the ring members, varying from 6 to 14, preferably 6 to 10, are carbon atoms. The ring system may be monocyclic or fused polycyclic (e.g., bicyclic or tricyclic). Examples of aryl include, but are not limited to, phenyl, azulenyl, and naphthyl. An aryl can be attached to the parent molecular moiety through any carbon atom. When the aryl group is substituted with one or more substituents, it is further understood that the substituents may be at any position on the aryl ring. Specifically, for an aryl that is a phenyl group, the substituents may occupy one or both ortho positions, one or both meta positions, or para positions, or any combination of these positions.

[0039] As used herein, the term "non-aromatic 3- to 14-membered heterocycle" refers to a saturated or unsaturated non-aromatic ring system comprising 1 to 4 heteroatoms independently selected from the group consisting of oxygen, nitrogen, and sulfur. When a ring system contains more than one oxygen atom, the oxygen atoms are not immediately adjacent. Non-aromatic heterocycles include, but are not limited to, 3- to 7-membered monocyclic non-aromatic heterocycles and 6- to 14-membered polycyclic (e.g., bicyclic or tricyclic) non-aromatic heterocycles. A non-aromatic 3- to 14-membered heterocycle can be connected to the parent molecular moiety through any carbon atom or nitrogen atom contained within the heterocycle.

[0040] As used herein, the term "non-aromatic 3- to 7-membered monocyclic heterocycle" refers to a 3-, 4-, 5-, 6-, or 7-membered monocyclic ring system that contains 1, 2, or 3 heteroatoms independently selected from the group consisting of oxygen, nitrogen, and sulfur, and the ring system is saturated or unsaturated, but is not aromatic. For example, the heterocycle may contain 1 to 3 nitrogen atoms, or 1 or 2 oxygen atoms, or 1 or 2 sulfur atoms, or 1 to 3 nitrogen atoms and 1 oxygen atom, or 1 to 3 nitrogen atoms and 1 sulfur atom. It may contain three nitrogen atoms and a sulfur atom, or one sulfur atom and one oxygen atom. Examples of saturated non-aromatic heterocycles include three-membered rings such as oxiranyl and aziridinyl, four-membered rings such as azetidinyl, oxetanyl and thietanyl, tetrahydrofuranyl, 1,3-dioxolanyl, tetrahydrothienyl, pyrrolidinyl, pyrazolidinyl, imidazolidinyl, triazolidinyl, isoxazolidinyl, oxazolidinyl, and oxadiazolidinyl. five-membered rings such as piperidinyl, hexahydropyridazinyl, hexahydropyrimidinyl, piperazinyl, triazinanyl, hexahydrotriazinyl, tetrahydropyranyl, dioxanyl, tetrahydrothiopyranyl, dithianyl, morpholinyl, 1,2-oxazinanyl, oxathianyl, thiomorpholinyl, and the like; six-membered rings such as oxepanyl, azepanyl, 1,4-diazepanyl, and the like; Examples of unsaturated non-aromatic heterocycles include, but are not limited to, 5-membered rings such as dihydrofuranyl, 1,3-dioxolyl, dihydrothienyl, pyrrolinyl, dihydroimidazolyl, dihydropyrazolyl, isoxazolinyl, dihydrooxazolyl, dihydrothiazolyl, and the like, or 6-membered rings such as pyranyl, thiopyranyl, thiazinyl, and thiadiazinyl.

[0041] As used herein, the term "non-aromatic 6- to 14-membered polycyclic heterocycle" refers to a 6-, 7-, 8-, 9-, 10-, 11-, 12-, 13-, or 14-membered polycyclic (e.g., bicyclic or tricyclic) ring system containing 1, 2, or 3 heteroatoms independently selected from the group consisting of oxygen, nitrogen, and sulfur, and wherein the ring system is saturated or unsaturated, but not aromatic. A non-aromatic bicyclic heterocycle may consist of a monocyclic C3-C8-cycloalkyl, a monocyclic C3-C8-cycloalkenyl, or a monocyclic heteroaryl as defined herein fused to a monocyclic non-aromatic heterocycle, or may be fused to an aryl (e.g., phenyl), a monocyclic C3-C8-cycloalkenyl, or a monocyclic non-aromatic heterocycle. The non-aromatic tricyclic heterocycle may consist of a monocyclic cycloalkyl fused to either a monocyclic C3-C8-cycloalkenyl or a monocyclic non-aromatic heterocycle. When two monocyclic heterocycles (aromatic or non-aromatic) containing a nitrogen atom are fused, the nitrogen atom may be a bridgehead (e.g., 4,5,6,7-tetrahydropyrazolo[1,5-a]pyridinyl, 5,6,7,8-tetrahydro[1,2,4]triazolo[1,5-a]pyridinyl, 5,6,7,8-tetrahydroimidazo[1,2-a]pyridinyl). The non-aromatic tricyclic heterocycle may consist of a monocyclic cycloalkyl connected to a non-aromatic bicyclic heterocycle by one common atom.

[0042] As used herein, the term "aromatic 5- to 14-membered heterocycle" or "heteroaryl" refers to an aromatic ring system comprising 1 to 4 heteroatoms independently selected from the group consisting of oxygen, nitrogen, and sulfur. When a ring system contains more than one oxygen atom, the oxygen atoms are not immediately adjacent. Aromatic heterocycles include aromatic 5- or 6-membered monocyclic heterocycles and 6- to 14-membered polycyclic (e.g., bicyclic or tricyclic) aromatic heterocycles. A 5- to 14-membered aromatic heterocycle can be connected to the parent molecular moiety through any carbon atom or nitrogen atom contained within the heterocycle.

[0043] As used herein, the term "aromatic 5- or 6-membered monocyclic heterocycle" or "monocyclic heteroaryl" refers to a 5- or 6-membered monocyclic ring system containing 1, 2, 3, or 4 heteroatoms independently selected from the group consisting of oxygen, nitrogen, and sulfur. Examples of 5-membered monocyclic heteroaryls include, but are not limited to, furyl (furanyl), thienyl, pyrrolyl, pyrazolyl, imidazolyl, triazolyl, tetrazolyl, isoxazolyl, oxazolyl, oxadiazolyl, oxatriazolyl, isothiazolyl, thiazolyl, thiadiazolyl, and thiatriazolyl. Examples of 6-membered monocyclic heteroaryls include, but are not limited to, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, and tetrazinyl.

[0044] As used herein, the term "6- to 14-membered polycyclic aromatic heterocycle" or "polycyclic heteroaryl" refers to a 6-, 7-, 8-, 9-, 10-, 11-, 12-, 13-, or 14-membered polycyclic (e.g., bicyclic or tricyclic) ring system containing one, two, or three heteroatoms independently selected from the group consisting of oxygen, nitrogen, and sulfur. An aromatic bicyclic heterocycle may consist of a monocyclic heteroaryl, as defined herein, fused to an aryl (e.g., phenyl) or monocyclic heteroaryl. Examples of bicyclic aromatic heterocycles include, but are not limited to, 9-membered rings such as indolyl, indolizinyl, isoindolyl, benzimadozolyl, imidazopyridinyl, indazolyl, benzotriazolyl, purinyl, benzofuranyl, benzothiophenyl, benzothiazolyl, benzoxazolyl, and benzisoxazolyl, or 10-membered rings such as quinolinyl, isoquinolinyl, cinnolinyl, quinazolinyl, quinoxalinyl, phthalazinyl, naphthyridinyl, pteridinal, and benzodioxinyl. In 9- or 10-membered aromatic bicyclic heterocycles comprising two fused 5- or 6-membered monocyclic heteroaromatic rings, the nitrogen atom may be a bridgehead (e.g., imidazo[1,2-a]pyridinyl, 1,2,4]triazolo[4.3-a]pyridinyl, imidazo[1,2-a]pyridinyl, imidazo[2,1-b]oxazolyl, furo[2,3-d]isoxazolyl). Examples of tricyclic heteroaromatic rings include, but are not limited to, carbazolyl, acridinyl, and phenazinyl.

[0045] As used herein, the term “non-aromatic C-C 12 -carbocyclyloxy", "C3-C8-cycloalkyloxy", "aromatic C6-C 14 -carbocyclyloxy," "aromatic 5- to 14-membered heterocyclyloxy," and "non-aromatic 3- to 14-membered heterocyclyloxy" refer to a group of formula -OR, where R is each a non-aromatic C3-C6 heterocyclyloxy as defined herein. 12 -Carbocyclyl, C3-C8-cycloalkyl, aromatic C6-C 14-carbocyclyl, aromatic 5- to 14-membered heterocyclyl or non-aromatic 3- to 14-membered heterocyclyl group.

[0046] As used herein, when a group is said to be "substituted," the group may be substituted with one or more substituents. The phrase "one or more substituents" refers to a number of substituents ranging from 1 to the maximum number of possible substituents based on the number of available bonding sites, provided that stability and chemical feasibility conditions are met.

[0047] As used herein, the term "leaving group" shall be understood to mean a group that is displaced from a compound in a substitution or elimination reaction, such as, for example, a halogen atom, a trifluoromethanesulfonate ("triflate") group, alkoxy, methanesulfonate, p-toluenesulfonate, etc.

[0048] Variables Q, T, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , n, and m, the term "as described herein" encompasses broad definitions of the variables, as well as preferred, more preferred, and even more preferred definitions, if any. DETAILED DESCRIPTION OF THE INVENTION

[0049] Compounds of formula (I) The present invention relates to a compound of formula (I):

[0050] [ka]

[0051] In the compound of formula T is O or S; n is 0 or 1; m is 0 or 1; provided that when n is 1, then m is 1; R 1 is hydrogen, hydroxyl, cyano, C1-C6-alkyl, C1-C6-alkoxy, C1-C6-alkoxy-C1-C6-alkyl, -C(=O)R a1 , -C(=O)(OR a1 ), -S(=O)R a1 , -S(=O)2R a1 , -C(=O)N(R a2 )2 and S(=O)2N(R a2 )2, and R a1 is selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, and C2-C6-alkenyl; R a2 is selected from the group consisting of hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl and C2-C6-alkenyl; R 2 and R 3 are independently selected from the group consisting of hydrogen, halogen, cyano, hydroxyl, carboxyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-alkoxycarbonyl and C3-C8-cycloalkyl, or R 2 and R 3 together with the carbon atoms to which they are attached form a C3-C8-cycloalkyl or non-aromatic 3- to 7-membered monocyclic heterocycle; R 4 and R 5 are independently selected from the group consisting of hydrogen, halogen, cyano, hydroxyl, carboxyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-alkoxycarbonyl and C3-C8-cycloalkyl, or R 4 and R 5 together with the carbon atoms to which they are attached form a C3-C8-cycloalkyl or non-aromatic 3- to 7-membered monocyclic heterocycle; R 2 and R 4together with the carbon atoms to which they are attached form a C3-C8-cycloalkyl or non-aromatic 3- to 7-membered monocyclic heterocycle, and R 3 and R 5 are independently hydrogen or halogen; or R 2 and R 4 form a covalent bond, and R 3 and R 5 are independently hydrogen or C1-C6-alkyl; R 6 is a non-aromatic C3-C 12 -carbocyclic, aromatic C6-C 14 -Carbocycle, non-aromatic 3- to 14-membered heterocycle, aromatic 5- to 14-membered heterocycle, non-aromatic C3 to C 12 -Carbocyclyloxy, aromatic C6-C 14 -Carbocyclyloxy, aromatic 5- to 14-membered heterocyclyloxy, non-aromatic 3- to 14-membered heterocyclyloxy, non-aromatic C3-C 12 -C1-C3-alkoxy substituted by a carbocyclic ring, aromatic C6-C 14 -C1-C3-alkoxy substituted by a carbocycle, C1-C3-alkoxy substituted by a non-aromatic 3- to 14-membered heterocycle, C1-C3-alkoxy substituted by an aromatic 5- to 14-membered heterocycle, non-aromatic C3-C 12 -C1-C3-haloalkoxy substituted with a carbocyclic ring, aromatic C6-C 14 - selected from the group consisting of C1-C3-haloalkoxy substituted by a carbocycle, C1-C3-haloalkoxy substituted by a non-aromatic 3- to 14-membered heterocycle, and C1-C3-haloalkoxy substituted by an aromatic 5- to 14-membered heterocycle, and 6 Substituent, or R 6 The cyclic portion of the substituent may be one or more R 6S and optionally substituted by R 6Sis halogen, cyano, isocyano, nitro, hydroxyl, mercapto, pentafluorosulfanyl, oxo, methylidene, halomethylidene, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C1-C6-alkynyl sulfanyl, C1-C6-haloalkylsulfanyl, C3-C8-cycloalkylsulfanyl, C1-C6-alkylsulfinyl, C1-C6-haloalkylsulfinyl, C3-C8-cycloalkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-haloalkylsulfonyl, C3-C8-cycloalkylsulfonyl, C3-C8-cycloalkyl, C3-C8-cycloalkyloxy, C3-C8-cycloalkenyl, aromatic C6-C 14 -Carbocycle, aromatic 5- or 6-membered monocyclic heterocycle, non-aromatic 3- to 7-membered monocyclic heterocycle, -N(R c )2, -C(=O)R d , -C(=O)(OR d ), -C(=O)N(R d )2, -S(=O)2N(R d )2, -O-Si(C1-C6-alkyl)3 and -Si(C1-C6-alkyl)3, or two R 6S The substituents, together with the carbon atom to which they are attached, may form a C3-C8-cycloalkyl; R c are independently selected from the group consisting of hydrogen, C1-C6-alkyl and C3-C8-cycloalkyl, R d are independently selected from the group consisting of hydrogen, C1-C6-alkyl and C1-C6-haloalkyl, aliphatic R 6S , R c and R dThe substituents may be substituted with one or more substituents independently selected from the group consisting of cyano, hydroxyl, C1-C6-alkoxy, C1-C6-haloalkoxy, -O-Si(C1-C6-alkyl)3, -Si(C1-C6-alkyl)3, C3-C8-cycloalkyl, C3-C8-halocycloalkyl and non-aromatic 3- to 7-membered monocyclic heterocycle; cyclic R 6S Or R 6S and cyclic moieties of cyclic R c The substituents may be substituted with one or more substituents independently selected from the group consisting of halogen, cyano, nitro, hydroxyl, formyl, carboxyl, oxo, methylidene, halomethylidene, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkoxycarbonyl, C1-C6-haloalkoxycarbonyl, C2-C6-alkenyl, C3-C8-cycloalkyl and C3-C8-halocycloalkyl, and / or a cyclic R 6S Substituent or R 6S the cyclic moiety may be substituted by two substituents which, together with the carbon atom to which they are attached, form a C3-C8-cycloalkyl; R 7is hydrogen, halogen, cyano, isocyano, hydroxyl, mercapto, nitro, amino, formyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C1-C6-alkylcarbonyl, C1-C6-haloalkylcarbonyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C 2-C6-alkynyloxy, C2-C6-haloalkynyloxy, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C3-C8-cycloalkylsulfanyl, C1-C6-alkylsulfinyl, C1-C6-haloalkylsulfinyl, C3-C8-cycloalkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-haloalkylsulfonyl, C3-C8-cycloalkylsulfonyl, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, aromatic C6-C 14 -Carbocycle, aromatic 5- or 6-membered monocyclic heterocycle, non-aromatic 3- to 7-membered monocyclic heterocycle, C3-C8-cycloalkyloxy, aromatic C6-C 14 -carbocyclyloxy, aromatic 5- or 6-membered monocyclic heterocyclyloxy, non-aromatic 3- to 7-membered monocyclic heterocyclyloxy, -O-Si(C1-C6-alkyl)3, -Si(C1-C6-alkyl)3, -N(R e )2, -C(=NR f )R f , -NR g C(=O)R g , -C(=O)(OR g ), -C(=O)N(R g )2, -S(=O)2N(R g )2 and -S(=O)(=NR g )R g is selected from the group consisting of R eis hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, aromatic C6-C 14 - independently selected from the group consisting of carbocycle, aromatic 5- or 6-membered monocyclic heterocycle, and non-aromatic 3- to 7-membered monocyclic heterocycle; R f are independently selected from the group consisting of hydroxyl, amino, cyano, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-alkylamino and di(C1-C6-alkyl)amino; R g are independently selected from the group consisting of hydrogen, C1-C6-alkyl, C1-C6-haloalkyl and C3-C8-cycloalkyl, aliphatic R 7 , R e , R f and R g The substituents may be one or more R 7Sa may be substituted by a substituent, cyclic R 7 Substituent or R 7 The cyclic portion of the substituent, cyclic R e and cyclic R g The substituents may be one or more R 7Sc may be substituted by a substituent, R 7Sa is cyano, hydroxyl, carboxyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C1-C6-alkoxycarbonyl, -O-Si(C1-C6-alkyl)3, -Si(C1-C6-alkyl)3, aromatic C6-C 14 - selected from the group consisting of carbocycles and non-aromatic 3- to 7-membered monocyclic heterocycles; R 7Scis selected from the group consisting of halogen, cyano, nitro, hydroxyl, formyl, oxo, methylidene, halomethylidene, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, -O-Si(C1-C6-alkyl)3 and non-aromatic 3- to 7-membered monocyclic heterocycle, or two R 7Sc the substituents together with the carbon atoms to which they are attached form a C3-C8-cycloalkyl; R 8 is hydrogen, halogen, cyano, isocyano, amino, nitro, hydroxyl, mercapto, carboxyl, C1-C6-alkoxycarbonyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C2-C6-alkenyl Oxy, C2-C6-haloalkenyloxy, C2-C6-alkynyloxy, C2-C6-haloalkynyloxy, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C1-C6-alkylsulfinyl, C1-C6-haloalkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-haloalkylsulfonyl, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, aromatic C6-C 14 -Carbocycle, non-aromatic 3- to 14-membered heterocycle, aromatic 5- to 14-membered heterocycle, C3-C8-cycloalkyloxy, aromatic C6-C 14 -Carbocyclyloxy, non-aromatic 3- to 14-membered heterocyclyloxy, aromatic 5- to 14-membered heterocyclyloxy, -O-Si(C1-C6-alkyl)3, -Si(C1-C6-alkyl)3, -N(R h )2, -SR i , -S(=O)R i and -S(=O)2R i is selected from the group consisting of R his hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, aromatic C6-C 14 - independently selected from the group consisting of carbocycle, aromatic 5- to 14-membered heterocycle, and non-aromatic 3- to 7-membered monocyclic heterocycle; R i is C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, aromatic C6-C 14 - selected from the group consisting of carbocycles, aromatic 5- to 14-membered heterocycles and non-aromatic 3- to 7-membered monocyclic heterocycles; aliphatic R 8 , R h and R i The substituents may be one or more R 8Sa may be substituted by a substituent, cyclic R 8 Substituent or R 8 The cyclic portion of the substituent, cyclic R h and cyclic R i The substituents may be one or more R 8Sc may be substituted by a substituent, R 8Sais cyano, amino, nitro, hydroxyl, formyl, carboxyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkoxy-C1-C6-alkoxy, C1-C6-alkoxycarbonyl, C1-C6-haloalkoxycarbonyl, C1-C6-alkylcarbonyl, C1-C6-haloalkylcarbonyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C1-C6-alkylsulfinyl, C1-C6-haloalkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-haloalkylsulfonyl, -O-Si(C1-C6-alkyl)3, -Si(C1-C6-alkyl)3, non-aromatic 3- to 7-membered monocyclic heterocycle and -N(R a’ )2, and R a’ is independently selected from the group consisting of hydrogen, formyl, C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl and C1-C6-alkylcarbonyl, and the non-aromatic 3- to 7-membered monocyclic heterocycle R 8Sa is optionally substituted by one or more C1-C6-alkyl substituents, which may be the same or different, R 8Sc is selected from the group consisting of halogen, cyano, amino, nitro, hydroxyl, formyl, carboxyl, oxo, methylidene, halomethylidene, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkoxycarbonyl, C1-C6-haloalkoxycarbonyl, C2-C6-alkenyl, C1-C6-alkylsulfanyl, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, -O-Si(C1-C6-alkyl)3 and non-aromatic 3- to 7-membered monocyclic heterocycles optionally substituted by one or more C1-C6-alkyl substituents which may be the same or different, or two R 8Scthe substituents, together with the carbon atoms to which they are attached, form a C3-C8-cycloalkyl or a non-aromatic 3- to 7-membered monocyclic heterocycle, which is optionally substituted with one or more C1-C6-alkyl substituents, which may be the same or different; Q is an aromatic C6-C 14 -Carbocyclic, non-aromatic C3~C 12 - selected from the group consisting of carbocycle, non-aromatic 3- to 14-membered heterocycle, and aromatic 5- to 14-membered heterocycle, wherein either the carbocycle or heterocycle group is selected from the group consisting of one or more Q S may be substituted by a substituent, Q S is halogen, cyano, isocyano, nitro, hydroxyl, mercapto, formyl, carboxyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkylcarbonyl, C1-C6-haloalkylcarbonyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkoxy-C1-C6-alkyl, C1-C6-alkoxycarbonyl, C1-C6-haloalkoxycarbonyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C2-C6-alkenyl Alkenyloxy, C2-C6-haloalkenyloxy, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C1-C6-alkylsulfinyl, C1-C6-haloalkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-haloalkylsulfonyl, C3-C8-cycloalkyl, C3-C8-cycloalkyloxy, C3-C6-cycloalkenyl, non-aromatic 3- to 7-membered monocyclic heterocycle, aromatic 5- to 14-membered heterocycle, -O-Si(C1-C6-alkyl)3, -Si(C1-C6-alkyl)3, -OC(=O)R j , -NR j C(=O)R j , -C(=O)N(R j )2, -C(=S)R j , -C(=S)N(R j )2, -C(=NR j )R j and -C(=NORj )R j and -N(R k )2, R j are independently selected from the group consisting of hydrogen, C1-C6-alkyl, C1-C6-haloalkyl and C1-C6-alkoxy; R k are independently selected from the group consisting of hydrogen, hydroxyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-haloalkenyl and C3-C8-cycloalkyl; Aliphatic Q S , R j and R k The substituents may be substituted with one or more substituents independently selected from the group consisting of cyano, amino, nitro, hydroxyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkoxycarbonyl, C1-C6-haloalkoxycarbonyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, -Si(C1-C6-alkyl)3 and non-aromatic 3- to 7-membered monocyclic heterocycles; cyclic Q S Substituent or Q S The cyclic moiety of the substituent and the cyclic R k The substituents may be one or more R independently selected from the group consisting of halogen, cyano, amino, nitro, hydroxyl, formyl, carboxyl, oxo, methylidene, halomethylidene, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkoxycarbonyl, C1-C6-haloalkoxycarbonyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C2-C6-alkenyl and non-aromatic 3- to 7-membered monocyclic heterocycle. Qs may be substituted by a substituent, and the cyclic R Qs A substituent may be optionally substituted with two substituents which, together with the carbon atoms to which they are attached, form a C3-C8-cycloalkyl; However, the compound of formula (I) (a) 3-(1H-benzotriazol-1-yloxy)-N-(4-tert-butylphenyl)-6-chloropyridazine-4-carboxamide ([561297-99-2]); (b) 3-(cyclopentyloxy)-6-(4-fluorophenoxy)-N-{[(3R)-1-isopropylpiperidin-3-yl]methyl}pyridazine-4-carboxamide ([1336909-91-1]); (c) 6-(4-fluorophenoxy)-N-{[(3R)-1-isopropylpiperidin-3-yl]methyl}-3-(tetrahydro-2H-pyran-4-yloxy)pyridazine-4-carboxamide ([1336909-90-0]); (d) 6-chloro-N-{[(3R)-1-isopropylpiperidin-3-yl]methyl}-3-(tetrahydro-2H-pyran-4-yloxy)pyridazine-4-carboxamide ([1336910-48-5]); (e) 6-chloro-3-(cyclopentyloxy)-N-{[(3R)-1-isopropylpiperidin-3-yl]methyl}pyridazine-4-carboxamide ([1336910-49-6]); (f) 3-(1H-benzotriazol-1-yloxy)-6-chloro-N-(cyclohexylmethyl)pyridazine-4-carboxamide ([1202404-84-9]) No.

[0052] Compound (a) ([561297-99-2]) is disclosed in US Patent Application Publication No. 2009 / 0143355 as an intermediate in the preparation of substituted arylamine derivatives useful in the treatment of cancer.

[0053] Compounds (b) and (c) ([1336909-91-1] and [1336909-90-0]) are disclosed in WO 2011 / 117254 as potential modulators of the ghrelin receptor useful for the treatment of diabetes and obesity. Compounds (d) and (e) ([1336910-48-5] and [1336910-49-6]) are disclosed in WO 2011 / 117254 as intermediates in the preparation of potential modulators of the ghrelin receptor.

[0054] Compound (f) is disclosed in US Patent Application Publication No. 2011 / 0108767 as a component of compositions that may be used in the manufacture of light-emitting devices.

[0055] The above disclosed embodiment is referred to herein as "Embodiment 1."

[0056] Compounds resulting from combinations that violate the laws of nature and that would therefore be excluded by a person skilled in the art based on their technical knowledge are not encompassed herein, for example, ring structures having three or more adjacent oxygen atoms are excluded.

[0057] The compounds of formula (I) can suitably exist in their three forms, as salts, N-oxides or solvates (eg hydrates).

[0058] Depending on the nature of the substituents, the compound of formula (I) may exist in various stereoisomeric forms. These stereoisomers are, for example, enantiomers, diastereomers, atropisomers or geometric isomers. Therefore, the present invention encompasses both pure stereoisomers and any mixtures of these isomers. If a compound can exist in two or more tautomeric forms in equilibrium, a reference to a compound by one tautomer shall be deemed to include all tautomers.

[0059] Any compound of the present invention may exist in one or more geometric isomers depending on the number of double bonds in the compound. Geometric isomers due to the nature of the substituents around the double bond or ring may exist in cis (=Z-) or trans (=E-) form. Therefore, the present invention equally relates to all geometric isomers and all possible mixtures in all proportions.

[0060] Depending on the nature of the substituents, the compounds of formula (I) may exist in the form of the free compounds and / or of their salts, such as pesticide active salts.

[0061] Pesticide-active salts include acid addition salts of inorganic and organic acids and salts of common bases. Examples of inorganic acids are hydrohalic acids such as hydrofluoric acid, hydrochloric acid, hydrobromic acid, and hydrogen iodide, sulfuric acid, phosphoric acid, and nitric acid, as well as acid salts such as sodium bisulfate and potassium bisulfate. Useful organic acids include, for example, formic acid, carbonic acid, and alkanoic acids such as acetic acid, trifluoroacetic acid, trichloroacetic acid, and propionic acid, as well as glycolic acid, thiocyanic acid, lactic acid, succinic acid, citric acid, benzoic acid, cinnamic acid, oxalic acid, saturated or monounsaturated or diunsaturated fatty acids having 6 to 20 carbon atoms, alkyl sulfate monoesters, alkyl sulfonic acids (sulfonic acids having a linear or branched alkyl radical having 1 to 20 carbon atoms), aryl sulfonic acids, or aryl disulfonic acids (sulfonic acids having one or two sulfuric acid groups). and arylphosphonic acids (aromatic radicals such as phenyl and naphthyl having one or two phosphonic acid groups), alkylphosphonic acids (phosphonic acids having straight or branched chain alkyl radicals having 1 to 20 carbon atoms), arylphosphonic acids or aryldiphosphonic acids (aromatic radicals such as phenyl and naphthyl having one or two phosphonic acid groups), wherein the alkyl and aryl radicals may have further substituents, such as p-toluenesulfonic acid, salicylic acid, p-aminosalicylic acid, 2-phenoxybenzoic acid, 2-acetobenzoic acid, etc.

[0062] Solvates of the compounds of the invention or their salts are stoichiometric compositions of the compound and a solvent.

[0063] The compounds of the present invention may exist in multiple crystalline and / or amorphous forms. Crystalline forms include unsolvated crystalline forms, solvates and hydrates.

[0064] “Aliphatic R 6S , R c and R d As used herein, the phrase "a substituent may be substituted with one or more substituents" refers to an aliphatic R 6S The substituents represent C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C1-C6-alkylsulfinyl, C1-C6-haloalkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-haloalkylsulfonyl and the C1-C6-alkyl part of -Si(C1-C6-alkyl)3 and -O-Si(C1-C6-alkyl)3.

[0065] “Aliphatic R 6S , R c and R d As used herein, the phrase "a substituent may be substituted with one or more substituents" refers to an aliphatic R c The substituent represents a C1-C6 alkyl.

[0066] “Aliphatic R 6S , R c and R d As used herein, the phrase "a substituent may be substituted with one or more substituents" refers to an aliphatic R d The substituents represent C1-C6-alkyl and C1-C6-haloalkyl.

[0067] “Aliphatic R 7 , R e , R f and R gThe substituents are one or more R 7Sa As used herein, the phrase "optionally substituted by a substituent" refers to an aliphatic R 7 The substituents are C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C1-C6-alkylcarbonyl, C1-C6-haloalkylcarbonyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkoxycarbonyl, C1-C6-haloalkoxycarbonyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C2-C6-alkenyloxy, C2 ∼C6-haloalkenyloxy, C2-C6-alkynyloxy, C2-C6-haloalkynyloxy, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C1-C6-alkylsulfinyl, C1-C6-haloalkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-haloalkylsulfonyl and the C1-C6-alkyl portion of -Si(C1-C6-alkyl)3 and -O-Si(C1-C6-alkyl)3.

[0068] “Aliphatic R 7 , R e , R f and R g The substituents are one or more R 7Sa As used herein, the phrase "optionally substituted by a substituent" refers to an aliphatic R e The substituents represent C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl and C2-C6-haloalkynyl.

[0069] “Aliphatic R 7 , R e , R f and R g The substituents are one or more R 7Sa As used herein, the phrase "optionally substituted by a substituent" refers to an aliphatic R fThe substituents represent C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy and the C1-C6-alkyl portion of C1-C6-alkylamino and di(C1-C6-alkyl)amino.

[0070] “Aliphatic R 7 , R e , R f and R g The substituents are one or more R 7Sa As used herein, the phrase "optionally substituted by a substituent" refers to an aliphatic R g The substituents represent C1-C6-alkyl and C1-C6-haloalkyl.

[0071] “Aliphatic R 8 , R h and R i The substituents are one or more R 8Sa As used herein, the phrase "optionally substituted by a substituent" refers to an aliphatic R 8 The substituents are C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C2-C6-alkynyloxy, C2-C6 -haloalkynyloxy, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C1-C6-alkylsulfinyl, C1-C6-haloalkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-haloalkylsulfonyl and the C1-C6-alkyl portion of -Si(C1-C6-alkyl)3 and -O-Si(C1-C6-alkyl)3.

[0072] “Aliphatic R 8 , R h and R i The substituents are one or more R 8Sa As used herein, the phrase "optionally substituted by a substituent" refers to an aliphatic R hThe substituents represent C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl and C2-C6-haloalkynyl.

[0073] “Aliphatic R 8 , R h and R i The substituents are one or more R 8Sa As used herein, the phrase "optionally substituted by a substituent" refers to an aliphatic R i The substituents represent C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl and C2-C6-haloalkynyl.

[0074] "Aliphatic Q S , R j and R k As used herein, the phrase "a substituent may be substituted with one or more substituents" refers to an aliphatic Q group. S The substituents are C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkylcarbonyl, C1-C6-haloalkylcarbonyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkoxy-C1-C6-alkyl, C1-C6-alkoxycarbonyl, C1-C6-haloalkoxycarbonyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-halo ... nyl, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C1-C6-alkylsulfinyl, C1-C6-haloalkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-haloalkylsulfonyl and the C1-C6-alkyl portion of -Si(C1-C6-alkyl)3 and -O-Si(C1-C6-alkyl)3.

[0075] "Aliphatic Q S , R j and R kAs used herein, the phrase "a substituent may be substituted with one or more substituents" refers to an aliphatic R j The substituents represent C1-C6-alkyl, C1-C6-haloalkyl and C1-C6-alkoxy.

[0076] "Aliphatic Q S , R j and R k As used herein, the phrase "a substituent may be substituted with one or more substituents" refers to an aliphatic R k The substituents represent C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C2-C6-alkenyl and C2-C6-haloalkenyl.

[0077] "Cyclic R 6 Substituent or R 6 The cyclic portion of the substituent may be one or more R 6S As used herein, the phrase "optionally substituted by a substituent" refers to a cyclic R 6 The substituents are non-aromatic C3-C 12 -Carbocyclic, aromatic C6~C 14 -represents a carbocycle, a non-aromatic 3- to 14-membered heterocycle, and an aromatic 5- to 14-membered heterocycle.

[0078] "Cyclic R 6 Substituent or R 6 The cyclic portion of the substituent may be one or more R 6S As used herein, the phrase "optionally substituted by a substituent" refers to R 6 The cyclic portion of the substituent is a non-aromatic C3-C 12 -Carbocyclyloxy non-aromatic C3-C 12 -Carbocyclic, aromatic C6~C 14 -Carbocyclyloxy aromatic C6-C 14 -Carbocycle, aromatic 5- to 14-membered heterocyclyloxy aromatic 5- to 14-membered heterocycle, non-aromatic 3- to 14-membered heterocyclyloxy non-aromatic 3- to 14-membered heterocycle, non-aromatic C3-C 12 -Non-aromatic C3-C C-alkoxy substituted with carbocyclic rings12 -Carbocyclic, aromatic C6~C 14 -Aromatic C6-C of C1-C3-alkoxy substituted with carbocyclic ring 14 -Carbocycle, non-aromatic 3- to 14-membered C1-C3-alkoxy heterocycle substituted with non-aromatic 3- to 14-membered heterocycle, aromatic 5- to 14-membered C1-C3-alkoxy heterocycle substituted with aromatic 5- to 14-membered heterocycle, non-aromatic C3-C 12 -Non-aromatic C3-C haloalkoxy substituted with a carbocyclic ring 12 -Carbocyclic, aromatic C6~C 14 -Aromatic C6-C of C1-C3-haloalkoxy substituted with a carbocyclic ring 14 -represents a carbocycle, a non-aromatic 3- to 14-membered heterocycle of C1-C3-haloalkoxy substituted with a non-aromatic 3- to 14-membered heterocycle, and an aromatic 5- to 14-membered heterocycle of C1-C3-haloalkoxy substituted with an aromatic 5- to 14-membered heterocycle.

[0079] “Cyclic R 6S Substituents and R c As used herein, the phrase "a substituent may be optionally substituted with one or more substituents" refers to a cyclic R 6S The substituents are C3-C8-cycloalkyl, C3-C8-cycloalkenyl, aromatic C6-C 14 -represents a carbocycle, an aromatic 5- or 6-membered monocyclic heterocycle, and a non-aromatic 3- to 7-membered monocyclic heterocycle.

[0080] “Cyclic R 6S Substituent or R 6S The cyclic moiety of the substituent and the cyclic R c As used herein, the phrase "a substituent may be optionally substituted with one or more substituents" refers to R 6S The cyclic part of the substituent represents C3-C8-cycloalkyl, such as C3-C8-cycloalkyloxy, C3-C8-cycloalkylsulfanyl, C3-C8-cycloalkylsulfinyl, and C3-C8-cycloalkylsulfonyl.

[0081] cyclic R 6SSubstituent or R 6S The cyclic moiety of the substituent and the cyclic R c As used herein, the phrase "a substituent may be optionally substituted with one or more substituents" refers to a cyclic R c The substituent represents a C3-C8-cycloalkyl.

[0082] “Cyclic R 7 , R e and R g The substituents may be one or more R 7Sc As used herein, the phrase "optionally substituted by a substituent" refers to a cyclic R 7 The substituents are C3-C8-cycloalkyl, C3-C6-cycloalkenyl, aromatic C6-C 14 -represents a carbocycle, an aromatic 5- or 6-membered monocyclic heterocycle, and a non-aromatic 3- to 7-membered monocyclic heterocycle.

[0083] “Cyclic R 7 Substituent or R 7 The cyclic portion of the substituent, cyclic R e and cyclic R g The substituents may be one or more R 7Sc As used herein, the phrase "optionally substituted by a substituent" refers to R 7 The cyclic portion of the substituent is C3-C8-cycloalkyl, aromatic C6-C ... 14 -Carbocyclyloxy aromatic C6-C 14 -represents a carbocycle, an aromatic 5- or 6-membered monocyclic heterocycle in an aromatic 5- or 6-membered monocyclic heterocyclyloxy, and a non-aromatic 3- to 7-membered monocyclic heterocycle in a non-aromatic 3- to 7-membered monocyclic heterocyclyloxy.

[0084] “Cyclic R 7 , R e and R g The substituents may be one or more R 7Sc As used herein, the phrase "optionally substituted by a substituent" refers to a cyclic Re The substituents are C3-C8-cycloalkyl, C3-C8-halocycloalkyl, aromatic C6-C 14 -represents a carbocycle, an aromatic 5- or 6-membered monocyclic heterocycle, and a non-aromatic 3- to 7-membered monocyclic heterocycle.

[0085] "Cyclic R 7 , R e and R g The substituents may be one or more R 7Sc As used herein, the phrase "optionally substituted by a substituent" refers to a cyclic R g The substituent represents a C3-C8-cycloalkyl.

[0086] "Cyclic R 8 , R h and R i The substituents may be one or more R 8Sc As used herein, the phrase "optionally substituted by a substituent" refers to a cyclic R 8 The substituents are C3-C8-cycloalkyl, C3-C6-cycloalkenyl, aromatic C6-C 14 -represents a carbocycle, a non-aromatic 3- to 14-membered heterocycle, and an aromatic 5- to 14-membered heterocycle.

[0087] "Cyclic R 8 Substituent or R 8 The cyclic portion of the substituent, cyclic R h and cyclic R i The substituents may be one or more R 8Sc As used herein, the phrase "optionally substituted by a substituent" refers to R 8 The cyclic portion of the substituent is C3-C8-cycloalkyl in C3-C8-cycloalkyloxy, aromatic C6-C 14 -Carbocyclyloxy aromatic C6-C 14 - represents a carbocycle, a non-aromatic 3- to 14-membered heterocycle of a non-aromatic 3- to 14-membered heterocyclyloxy, and an aromatic 5- to 14-membered heterocycle of an aromatic 5- to 14-membered heterocyclyloxy.

[0088] "Cyclic R 8 Substituent or R 8The cyclic portion of the substituent, cyclic R h and cyclic R i The substituents may be one or more R 8Sc As used herein, the phrase "optionally substituted by a substituent" refers to a cyclic R h The substituents are C3-C8-cycloalkyl, C3-C8-halocycloalkyl, aromatic C6-C 14 -represents a carbocycle, an aromatic 5- to 14-membered heterocycle, and a non-aromatic 3- to 7-membered monocyclic heterocycle.

[0089] “Cyclic R 8 , R h and R i The substituents may be one or more R 8Sc As used herein, the phrase "optionally substituted by a substituent" refers to a cyclic R i The substituents are C3-C8-cycloalkyl, C3-C8-halocycloalkyl, aromatic C6-C 14 -represents a carbocycle, an aromatic 5- to 14-membered heterocycle, and a non-aromatic 3- to 7-membered monocyclic heterocycle.

[0090] “Cyclic Q S Substituent or Q S The cyclic moiety of the substituent and the cyclic R k The substituents may be one or more R Qs As used herein, the phrase "optionally substituted by a substituent" refers to a cyclic Q S The substituents represent C3-C8-cycloalkyl, C3-C6-cycloalkenyl, non-aromatic 3- to 7-membered monocyclic heterocycle and aromatic 5- to 14-membered heterocycle.

[0091] “Cyclic Q S Substituent or Q S The cyclic moiety of the substituent and the cyclic R k The substituents may be one or more R Qs As used herein, the expression "optionally substituted by a substituent" refers to Q S The cyclic part of the substituent represents the C3-C8-cycloalkyl of the C3-C8-cycloalkyloxy.

[0092] “Cyclic QS and R k The substituents may be one or more R Qs As used herein, the phrase "optionally substituted by a substituent" refers to a cyclic R k The substituent represents a C3-C8-cycloalkyl.

[0093] R 2 and R 4 taken together to form a covalent bond, the following group: -CR 3 =CR 5 -Get.

[0094] In the above formula (I), n is 0 or 1, and m is 0 or 1, with the proviso that when n is 1, m is 1. Thus, the present invention relates to compounds where n is 1 and m is 1, or n is 0 and m is 1, or n is 0 and m is 0.

[0095] In some embodiments, in the above formula (I), R 1 is hydrogen, hydroxyl, cyano, C1-C6-alkyl, C1-C6-alkoxy, C1-C6-alkoxy-C1-C6-alkyl and -C(=O)(OR a1 ), and R a1 is C1-C6-alkyl or C2-C6-alkenyl.

[0096] In the above formula (I), R 1 is preferably hydrogen, hydroxyl and —C(═O)(OR a1 ), and R a1 is C1-C6-alkyl or C2-C6-alkenyl, more preferably R 1 is hydrogen.

[0097] Appropriate R 1 Non-limiting examples of "R 1 R disclosed in the " column 1 groups.

[0098] In the above formula (I), R 2 and R 3 is, when present (i.e., n=1), preferably independently selected from the group consisting of hydrogen, cyano, C1-C6-alkyl (e.g., methyl) and C1-C6-alkoxycarbonyl (e.g., methoxycarbonyl), or R 2 and R 3 together with the carbon atom to which they are attached form a C3-C8-cycloalkyl (e.g., cyclopropyl). More preferably, R 2 and R 3 are, if present, both hydrogen or R 2 and R 3 together with the carbon atom to which they are attached form a C3-C8-cycloalkyl (eg cyclopropyl).

[0099] In the above formula (I), R 4 and R 5 is, when present (i.e., m=1), preferably independently selected from the group consisting of hydrogen, halogen, hydroxyl, and C1-C6-alkyl (e.g., methyl), or R 4 and R 5 together with the carbon atom to which they are attached form a C3-C8-cycloalkyl (e.g., cyclopropyl) or a non-aromatic 3- to 7-membered monocyclic heterocycle (e.g., a non-aromatic 3- to 7-membered saturated monocyclic heterocycle, e.g., oxetanyl). More preferably, R 4 and R 5 are, when present, independently selected from the group consisting of hydrogen, halogen (e.g., fluorine) and C1-C6-alkyl (e.g., methyl), or R 4 and R 5 together with the carbon atom to which they are attached form a C3-C8-cycloalkyl (eg cyclopropyl).

[0100] In the above formula (I), R 2 and R 4 together with the carbon atom to which they are attached form a C3-C8-cycloalkyl, R2 and R 4 preferably forms a cyclopropyl, R 3 and R 5 is independently hydrogen or halogen (e.g., fluorine).

[0101] In the above formula (I), R 6 is preferably a non-aromatic C3-C 12 -Carbocyclic, aromatic C6~C 14 -Carbocycle, non-aromatic 3- to 14-membered heterocycle, aromatic 5- to 14-membered heterocycle, aromatic C6 to C 14 -Carbocyclyloxy, aromatic C6-C 14 -C1-C3-alkoxy and aromatic C6-C substituted by carbocyclic rings 14 -C1-C3-haloalkoxy substituted by a carbocyclic ring.

[0102] R 6 Non-aromatic C3-C 12 - if R is a carbocyclic ring 6 is preferably C7 to C 12 Polycyclic systems, more preferably C7-C comprising aryl fused with C3-C8-cycloalkyl. 12 Bicyclic systems, C7-C comprising aryl fused with C3-C8-cycloalkenyl 12 Bicyclic systems or bicyclic systems comprising aryl fused with either C3-C8-cycloalkyl or C3-C8-cycloalkenyl and C9-C comprising cyclopropyl linked by one common atom 12 It is a tricyclic system.

[0103] Preferred C3-C8-cycloalkyl and C7-C comprising aryl fused 12 Bicyclic systems include indanyl, 1,2,3,4-tetrahydronaphthalenyl and bicyclo[4.2.0]octa-1(6),2,4-trienyl.

[0104] Preferred C3-C8-cycloalkenyl and C7-C comprising aryl fused 12Bicyclic systems include indenyl and 1,2-dihydronaphthalenyl.

[0105] A bicyclic system comprising an aryl fused to either a preferred C3-C8-cycloalkyl or a C3-C8-cycloalkenyl and a C9-C6-cyclopropyl fused to a cyclopropyl fused to a C3-C8-cycloalkenyl, ... 12 Tricyclic systems include spiro[cyclopropane-1,2'-indan]-1-yl and spiro[cyclopropane-1,2'-tetralin]-1-yl.

[0106] R 6 Non-aromatic C3-C 12 - if R is a carbocyclic ring 6 is more preferably indanyl, 1,2,3,4-tetrahydronaphthalenyl or spiro[cyclopropane-1,2′-indan]-1-yl, and even more preferably R 6 is indan-1-yl, indan-2-yl, 1,2,3,4-tetrahydronaphthalen-1-yl, 1,2,3,4-tetrahydronaphthalen-2-yl, 1,2,3,4-tetrahydronaphthalen-6-yl or spiro[cyclopropane-1,2'-indan]-1-yl.

[0107] R 6 is aromatic C6~C 14 - if R is a carbocyclic ring 6 is preferably phenyl or naphthyl, more preferably phenyl, naphth-1-yl or naphth-2-yl.

[0108] R 6 When R is a non-aromatic 3- to 14-membered heterocycle, 6 is typically a non-aromatic 6- to 14-membered polycyclic heterocycle, and R 6is preferably a non-aromatic bicyclic heterocycle comprising a 4- to 6-membered monocyclic non-aromatic heterocycle fused with an aryl, a non-aromatic bicyclic heterocycle comprising a 5- or 6-membered monocyclic heteroaryl fused with a monocyclic C3-C8-cycloalkyl, a non-aromatic bicyclic heterocycle comprising a 5- or 6-membered monocyclic heteroaryl fused with a 3- to 7-membered monocyclic non-aromatic heterocycle, a non-aromatic tricyclic heterocycle comprising a cyclopropyl linked by one common atom to a non-aromatic bicyclic heterocycle, said heterocycle comprising a 4- to 6-membered monocyclic non-aromatic heterocycle fused with an aryl (e.g., phenyl), or a non-aromatic tricyclic heterocycle comprising a cyclopropyl linked by one common atom to a non-aromatic bicyclic heterocycle comprising a 5- or 6-membered monocyclic heteroaryl fused with a monocyclic C3-C8-cycloalkyl.

[0109] Preferred non-aromatic bicyclic heterocycles comprising a 4- to 6-membered monocyclic non-aromatic heterocycle fused to an aryl include 2,3-dihydrobenzofuranyl, 2,3-dihydrobenzothiophenyl, indolinyl, 1,3-benzodioxolyl, 1,2,3,4-tetrahydroquinolinyl, chromanyl, isochromanyl, thiochromanyl, and 2,3-dihydro-1,4-benzodioxinyl.

[0110] Preferred non-aromatic bicyclic heterocycles comprising a 5- or 6-membered monocyclic heteroaryl fused to a monocyclic C3-C8-cycloalkyl include tetrahydrobenzothiophenyl, 6,7-dihydro-5H-cyclopenta[b]pyridinyl, 5,6,7,8-tetrahydroquinolinyl, 4,5,6,7-tetrahydrobenzothiophenyl, 4,5,6,7-tetrahydrobenzofuranyl, 4,5,6,7-tetrahydro-1,3-benzoxyl, 4,5,6,7-tetrahydro-1,3-benzothiazolyl, 4,5,6,7-tetrahydro-1H-benzimidazolyl, 4,5,6,7-tetrahydroindazolyl, 4,5,6,7-tetrahydro-2H-isoindolyl, 4,5,6,7-tetrahydro-2-benzothiophenyl, 5,6-dihydro-4H-cyclopenta[b]thiophenyl and 5,6-dihydro-4H-cyclopenta[d]thiazolyl.

[0111] Preferred non-aromatic bicyclic heterocycles comprising a 5- or 6-membered monocyclic heteroaryl fused to a 3- to 7-membered monocyclic non-aromatic heterocycle include 4,5,6,7-tetrahydropyrazolo[1,5-a]pyridinyl, 5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridinyl, 5,6,7,8-tetrahydroimidazo[1,2-a]pyridinyl, and 6,7-dihydro-5H-thieno[3,2-b]pyranyl.

[0112] Preferred examples of non-aromatic bicyclic heterocycles comprising a 4- to 6-membered monocyclic non-aromatic heterocycle fused with an aryl and a non-aromatic tricyclic heterocycle comprising a cyclopropyl bonded by one common atom include spiro[chroman-3,1'-cyclopropane]-yl.

[0113] Preferred non-aromatic bicyclic heterocycles comprising a 5- or 6-membered monocyclic heteroaryl fused to a monocyclic C3-C8-cycloalkyl and a non-aromatic tricyclic heterocycle comprising a cyclopropyl linked by one common atom include spiro[7,8-dihydro-5H-quinolin-6,1'-cyclopropan]-yl.

[0114] R 6 When R is a non-aromatic 3- to 14-membered heterocycle, 6 is more preferably a 4- to 6-membered monocyclic non-aromatic heterocycle fused with phenyl (preferably selected from the group consisting of 2,3-dihydrobenzofuranyl, indolinyl, 1,3-benzodioxolyl, chromanyl, isochromanyl, thiochromanyl and 2,3-dihydro-1,4-benzodioxinyl) or a 5- or 6-membered monocyclic heteroaryl fused with monocyclic C3-C8-cycloalkyl (preferably 5,6,7,8-tetrahydroquinolinyl or 4,5,6,7-tetrahydrobenzothiophenyl).

[0115] R 6 When R is a non-aromatic 3- to 14-membered heterocycle, 6 is even more preferably 2,3-dihydrobenzofuran-3-yl, 2,3-dihydrobenzofuran-5-yl, 2,3-dihydrobenzofuran-7-yl, indolin-3-yl, 1,3-benzodioxol-5-yl, chroman-4-yl, isochroman-4-yl, thiochroman-4-yl, 2,3-dihydro-1,4-benzodioxin-5-yl, 2,3-dihydro-1,4-benzodioxin-6-yl, 5,6,7,8-tetrahydroquinolin-8-yl, 4,5,6,7-tetrahydrobenzothiophen-4-yl or 4,5,6,7-tetrahydrobenzothiophen-7-yl, more especially 2,3-dihydrobenzofuran-5-yl or 4,5,6,7-tetrahydrobenzothiophen-7-yl.

[0116] R 6 When R is an aromatic 5- to 14-membered heterocycle, 6 is preferably an aromatic 5- or 6-membered monocyclic heterocycle, a 9- or 10-membered aromatic bicyclic heterocycle comprising a 5- or 6-membered monocyclic heteroaromatic ring fused with an aryl, or a 9- or 10-membered aromatic bicyclic heterocycle comprising two fused 5- or 6-membered monocyclic heteroaromatic rings.

[0117] Preferred aromatic 5- or 6-membered monocyclic heterocycles include furanyl, thienyl, pyrazolyl, imidazolyl, triazolyl, oxazolyl, oxadiazolyl, thiazolyl, thiadiazolyl, pyridinyl, pyridazinyl and pyrimidinyl.

[0118] Preferred 9- or 10-membered aromatic bicyclic heterocycles comprising an aromatic 5- or 6-membered monocyclic heterocycle fused to an aryl (phenyl) include indolyl, benzimidazolyl, indazolyl, benzofuranyl, benzothiophenyl, benzothiazolyl (e.g., 1,3-benzothiazolyl, 2,1-benzothiazolyl, 1,2-benzothiazolyl), benzoxazolyl (e.g., 1,3-benzoxazolyl, 2,1-benzoxazolyl, 1,2-benzoxazolyl), quinolinyl, isoquinolinyl, and quinoxalinyl.

[0119] Preferred 9- or 10-membered aromatic bicyclic heterocycles comprising two fused 5- or 6-membered monocyclic aromatic heterocycles include pyrrolo[3,2-c]pyridinyl, imidazo[1,2-a]pyridinyl, [1,2,4]triazolo[4,3-a]pyridinyl, imidazo[1,2-a]pyridinyl, thieno[3,2-b]pyrrolyl, thieno[3,2-b]thiophenyl, imidazo[2,1-b]oxazolyl, furo[2,3-d]isoxazolyl, and thieno[2,3-d]isothiazolyl.

[0120] R 6 When R is an aromatic 5- to 14-membered heterocycle, 6 is more preferably an aromatic 5- or 6-membered monocyclic heterocycle selected from the group consisting of furanyl, thienyl, pyrazolyl, pyridinyl and pyrimidinyl, a 9- or 10-membered aromatic bicyclic heterocycle comprising a 5- or 6-membered monocyclic aromatic heterocycle fused with an aryl selected from the group consisting of indolyl, benzofuranyl, benzoxazolyl, quinolinyl and isoquinolinyl, or imidazo[1,2-a]pyridinyl.

[0121] R6 When R is an aromatic 5- to 14-membered heterocycle, 6 is even more preferably furan-2-yl, thien-3-yl, pyrazol-4-yl, pyridin-2-yl, pyridin-3-yl, pyrimidin-2-yl, quinolin-2-yl, quinolin-3-yl, quinolin-5-yl, isoquinolin-3-yl, isoquinolin-4-yl, isoquinolin-5-yl, isoquinolin-7-yl, indol-3-yl, benzofuran-4-yl, 1,3-benzoxazol-4-yl or imidazo[1,2-a]pyridin-2-yl, and more especially R 6 is pyridin-2-yl, 1,3-benzoxazol-4-yl or indol-3-yl.

[0122] R 6 is aromatic C6~C 14 -carbocyclyloxy, when R 6 is preferably phenoxy.

[0123] R 6 However, aromatic C6~C 14 - C1-C3-alkoxy substituted by a carbocycle, R 6 is preferably C1-C3-alkoxy substituted by phenyl, more preferably benzyloxy.

[0124] R 6 However, aromatic C6~C 14 -C1-C3-haloalkoxy substituted with a carbocycle, R 6 is preferably C1-C3-haloalkoxy substituted by phenyl, more preferably -OCF2-phenyl.

[0125] In some embodiments, R 6 is a non-aromatic polycyclic C7-C 12 -Carbocyclic, aromatic C6~C 14 -Carbocycles (phenyl, naphthyl), non-aromatic polycyclic 6- to 14-membered heterocycles, aromatic 5- to 14-membered heterocycles, non-aromatic polycyclic C7 to C 12-Carbocyclyloxy, phenoxy, aromatic 5- to 14-membered heterocyclyloxy, non-aromatic polycyclic 6- to 14-membered heterocyclyloxy, non-aromatic polycyclic C7-C 12 -C1-C3-alkoxy substituted by a carbocycle, C1-C3-alkoxy substituted by a non-aromatic polycyclic 6- to 14-membered heterocycle, C1-C3-alkoxy substituted by an aromatic 5- to 14-membered heterocycle, non-aromatic polycyclic C7-C 12 -C1-C3-haloalkoxy substituted by a carbocycle, C1-C3-haloalkoxy substituted by a phenyl or naphthyl, C1-C3-haloalkoxy substituted by a non-aromatic 6- to 14-membered polycyclic heterocycle, and C1-C3-haloalkoxy substituted by an aromatic 5- to 14-membered heterocycle.

[0126] In some embodiments, R 6 is a non-aromatic polycyclic C7-C 12 -Carbocyclic, aromatic C6~C 14 -Carbocycle, non-aromatic 6- to 14-membered polycyclic heterocycle, aromatic 5- to 14-membered heterocycle, aromatic C6 to C 14 -Carbocyclyloxy, aromatic C6-C 14 -C1-C3-alkoxy and aromatic C6-C substituted by carbocyclic rings 14 -C1-C3-haloalkoxy substituted by a carbocyclic ring.

[0127] In a preferred embodiment, R 6 is a non-aromatic polycyclic C7-C 12 -Carbocyclic, aromatic C6~C 14 -Carbocycle, non-aromatic 6- to 14-membered polycyclic heterocycle, aromatic 5- to 14-membered heterocycle, aromatic C6 to C 14 -Carbocyclyloxy, aromatic C6-C 14 -C1-C3-alkoxy and aromatic C6-C substituted by carbocyclic rings 14 -C1-C3-haloalkoxy substituted by a carbocyclic ring.

[0128] In some embodiments, R6 is selected from the group consisting of indanyl, 1,2,3,4-tetrahydronaphthalenyl, spiro[cyclopropane-1,2'-indan]-1-yl, phenyl, naphthyl, 2,3-dihydrobenzofuranyl, indolinyl, 1,3-benzodioxolyl, chromanyl, isochromanyl, thiochromanyl, 2,3-dihydro-1,4-benzodioxinyl, 5,6,7,8-tetrahydroquinolinyl, 4,5,6,7-tetrahydrobenzothiophenyl, furanyl, thienyl, pyridinyl, pyrimidinyl, indolyl, benzofuranyl, benzoxazolyl, quinolinyl, isoquinolinyl, imidazo[1,2-a]pyridinyl, phenoxy, benzyloxy, and -OCF2-phenyl.

[0129] In a more preferred embodiment, R 6 is selected from the group consisting of indanyl, 1,2,3,4-tetrahydronaphthalenyl, spiro[cyclopropane-1,2'-indan]-1-yl, phenyl, naphthyl, 2,3-dihydrobenzofuranyl, indolinyl, 1,3-benzodioxolyl, chromanyl, isochromanyl, thiochromanyl, 2,3-dihydro-1,4-benzodioxinyl, 5,6,7,8-tetrahydroquinolinyl, 4,5,6,7-tetrahydrobenzothiophenyl, furanyl, thienyl, pyridinyl, pyrimidinyl, indolyl, benzofuranyl, benzoxazolyl, quinolinyl, isoquinolinyl, imidazo[1,2-a]pyridinyl, phenoxy, benzyloxy, and -OCF2-phenyl.

[0130] In some embodiments, R 6 teeth,

[0131] [ka] or

[0132] [ka] wherein: R 6s1 is hydrogen or R 6s and R 6s2 is hydrogen or R 6s and R 6s is as described herein (above or below), preferably R 6s1 and R 6s2 At least one of is different from hydrogen.

[0133] In an even more preferred embodiment, R 6 teeth,

[0134] [ka] or

[0135] [ka] wherein: R 6s1 is hydrogen or R 6s and R 6s2 is hydrogen or R 6s and R 6s is halogen, cyano, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-haloalkylsulfanyl, C3-C6-cycloalkyl, phenyl, pyridinyl, pyrazolyl, imidazolyl, triazolyl, oxetanyl, tetrahydrofuranyl and tetrahydropyranyl, and cyclic R 6S The substituents may be substituted with 1 to 3 substituents independently selected from the group consisting of halogen, C1-C6-alkyl, C1-C6-haloalkyl and C1-C6-alkoxycarbonyl; However, R 6s1 and R 6s2 At least one of is different from hydrogen.

[0136] R disclosed herein 6 The group may be one or more of the R groups disclosed herein above or disclosed herein below. 6S It may be substituted with a substituent.

[0137] In some embodiments, R 6 is one or more R as disclosed herein above or as disclosed herein below, which may be the same or different. 6S It is substituted by a substituent.

[0138] R 6S The substituents are preferably halogen, cyano, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-haloalkylsulfanyl, C3-C8-cycloalkyl (e.g., cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl), aromatic C6-C 14 - selected from the group consisting of carbocycles (e.g., phenyl), aromatic 5- or 6-membered monocyclic heterocycles (e.g., pyridinyl, pyrimidinyl, thienyl, furanyl, imidazolyl, triazolyl, pyrazolyl, oxazolyl, thiazolyl, preferably pyridinyl, pyrazolyl, imidazolyl, triazolyl) and non-aromatic 3- to 7-membered monocyclic heterocycles (e.g., oxetanyl, tetrahydrofuranyl, tetrahydropyranyl (oxanyl), pyrrolidinyl, azetidinyl, morpholinyl, preferably oxetanyl, tetrahydrofuranyl, tetrahydropyranyl (oxanyl)), and the cyclic group R 6S The substituents may be substituted with one or more substituents independently selected from the group consisting of halogen, C1-C6-alkyl, C1-C6-haloalkyl and C1-C6-alkoxycarbonyl.

[0139] R 6SThe substituents are more preferably halogen (e.g., chlorine, bromine, iodine, fluorine), cyano, C1-C6-alkyl (e.g., methyl), C1-C6-haloalkyl (e.g., CF3, CHF2), C1-C6-alkoxy (e.g., methoxy, isopropoxy), C1-C6-haloalkoxy (e.g., difluoromethoxy), C2-C6-alkenyl (e.g., prop-1-en-2-yl), C2-C6-alkynyl (e.g., ethyl), is selected from the group consisting of C1-C6-haloalkylsulfanyl (e.g., -SCH2CF3), cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, phenyl, pyridin-2-yl, pyridin-4-yl, pyrazol-4-yl, imidazol-2-yl, triazol-4-yl, oxetan-3-yl, tetrahydrofuran-3-yl, and tetrahydropyran-4-yl(oxan-4-yl), and the cyclic R 6S The substituents may be substituted with one or more substituents independently selected from the group consisting of halogen (e.g., chlorine), C1-C6-alkyl (e.g., methyl), C1-C6-haloalkyl (e.g., CF3) and C1-C6-alkoxycarbonyl (e.g., methoxycarbonyl).

[0140] appropriate

[0141] [ka]

[0142] Non-limiting examples of chains include those listed in column "

[0143] [ka]

[0144] "

[0145] [ka]

[0146] Any of the chains may be mentioned.

[0147] In the above formula (I), R 7 is preferably hydrogen, halogen, cyano, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C1-C6-alkylcarbonyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-alkylsulfanyl, C1-C6-alkylsulfinyl, C3-C8-cycloalkyl, aromatic 5- or 6-membered monocyclic heterocycle, non-aromatic 3- to 7-membered monocyclic heterocycle, -N(R e )2, -C(=NR f )R f and -C(=O)N(R g )2, R e is as disclosed above, preferably R e are independently selected from the group consisting of hydrogen, C1-C6-alkyl and C3-C8-cycloalkyl (e.g., cyclopropyl), R f is as disclosed above, preferably R f are independently selected from the group consisting of hydroxyl, amino, C1-C6-alkyl and C1-C6-alkoxy; R g is as disclosed above, preferably R g are independently selected from the group consisting of hydrogen, C1-C6-alkyl and C3-C8-cycloalkyl (eg cyclopropyl).

[0148] R 7 is C3-C8-cycloalkyl, R 7 is preferably cyclopropyl.

[0149] R 7 When R is an aromatic 5- or 6-membered monocyclic heterocycle, 7is preferably selected from the group consisting of pyridinyl, pyrimidinyl, thienyl, furanyl, imidazolyl, triazolyl, pyrazolyl, oxazolyl and thiazolyl, more preferably selected from the group consisting of pyridinyl (e.g., pyridin-4-yl), imidazolyl (e.g., imidazol-1-yl, imidazol-5-yl) and pyrazolyl (e.g., pyrazol-4-yl).

[0150] R 7 When R is a non-aromatic 3- to 7-membered monocyclic heterocycle, 7 is preferably selected from the group consisting of oxiranyl, oxetanyl, tetrahydrofuranyl, tetrahydropyranyl, pyrrolidinyl, azetidinyl, azelidinyl, morpholinyl and 2-oxa-6-azaspiro[3.3]heptanyl, more preferably selected from the group consisting of oxetanyl (e.g., octetan-3-yl), tetrahydrofuranyl (e.g., tetrahydrofuran-3-yl), tetrahydropyranyl (e.g., tetrahydropyran-4-yl), pyrrolidinyl (e.g., pyrrolidin-1-yl) and azetidinyl (e.g., azetidin-1-yl).

[0151] R 7 -N(R e )2, then R 7 is preferably dimethylamino or cyclopropylamino.

[0152] R 7 -C(=NR f )R f If R 7 is preferably 1-hydrazinylideneethyl, 1-(methoxyimino)ethyl or 1-hydroxyiminoethyl.

[0153] R 7 is -C(=O)N(R g )2, then R g is preferably independently selected from the group consisting of hydrogen, methyl, propyl and cyclopropyl.

[0154] In some embodiments, R 7 is selected from the group consisting of hydrogen, halogen, cyano, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C1-C6-alkylcarbonyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-alkylsulfanyl, C1-C6-alkylsulfinyl, cyclopropyl, pyridinyl, pyrazolyl, oxetanyl, tetrahydrofuranyl, tetrahydropyranyl, pyrrolidinyl, azetidinyl, cyclopropylamino, cyclopropylaminocarbonyl, 1-hydrazinylideneethyl, 1-(methoxyimino)ethyl and 1-hydroxyiminoethyl.

[0155] Preferred aliphatic R 7 , R e , R f and R g The substituents may be one or more of the R groups disclosed herein above or disclosed herein below. 7Sa It may be substituted with a substituent.

[0156] R 7Sa The substituents are preferably hydroxyl, cyano, C1-C6-alkoxy (e.g., methoxy), C3-C8-cycloalkyl (e.g., cyclobutyl), C1-C6-alkoxycarbonyl (e.g., ethoxycarbonyl) and aromatic C6-C 14 - carbocycle (e.g., phenyl).

[0157] Preferred cyclic R 7 and R e The substituents may be one or more of the R groups disclosed herein above or disclosed herein below. 7Sc It may be substituted with a substituent.

[0158] R 7ScThe substituents are preferably selected from the group consisting of halogen (eg fluorine, chlorine), hydroxyl, C1-C6-alkyl (eg methyl) and C1-C6-alkoxy (eg methoxy).

[0159] In some embodiments, R 7 is unsubstituted pyridinyl (eg pyridin-4-yl) or pyridinyl substituted by halogen (eg fluorine, chlorine), C1-C6-alkyl (eg methyl) or C1-C6-alkoxy (eg methoxy).

[0160] In some embodiments, R 7 is unsubstituted imidazolyl (eg, imidazol-1-yl, imidazol-5-yl) or imidazolyl substituted by C1-C6-alkyl (eg, methyl).

[0161] In some embodiments, R 7 is unsubstituted azetidinyl (eg, azetidin-1-yl) or azetidinyl substituted with hydroxyl.

[0162] Appropriate R 7 Non-limiting examples of "R 7 R listed in the " column 7 groups.

[0163] In the above formula (I), R 8 is preferably hydrogen, halogen, hydroxyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, C3-C8-cycloalkyl, aromatic C6-C 14 -carbocycle, non-aromatic 3- to 14-membered heterocycle, aromatic 5- to 14-membered heterocycle, C3-C8-cycloalkyloxy, non-aromatic 3- to 14-membered heterocyclyloxy and -N(Rh )2,

[0164] R h is as disclosed above, preferably R h is hydrogen, C1-C6-alkyl, C2-C6-alkenyl, C3-C8-cycloalkyl (e.g., cyclopropyl, cyclohexyl), aromatic C6-C 14 - independently selected from the group consisting of carbocycles (e.g., phenyl) and non-aromatic 3- to 7-membered monocyclic heterocycles (e.g., oxetanyl).

[0165] R 8 is C3-C8-cycloalkyl, R 8 is preferably cyclopropyl.

[0166] R 8 is aromatic C6~C 14 - if R is a carbocyclic ring 8 is preferably phenyl.

[0167] R 8 When R is a non-aromatic 3- to 14-membered heterocycle, 8 is preferably a non-aromatic 3- to 7-membered monocyclic heterocycle.

[0168] Preferred non-aromatic 3- to 7-membered monocyclic heterocycles include oxiranyl, aziridinyl, oxetanyl, azetidinyl, tetrahydrofuranyl, pyrrolidinyl, tetrahydropyranyl (oxanyl), and morpholinyl.

[0169] R 8 When R is a non-aromatic 3- to 14-membered heterocycle, 8 is more preferably selected from the group consisting of oxetanyl, azetidinyl, pyrrolidinyl, tetrahydropyranyl and morpholinyl.

[0170] R 8 When R is a non-aromatic 3- to 14-membered heterocycle, 8is even more preferably selected from the group consisting of oxetan-3-yl, azetidin-1-yl, tetrahydropyran-4-yl and pyrrolidin-1-yl.

[0171] R 8 When R is an aromatic 5- to 14-membered heterocycle, 8 is preferably a 5- or 6-membered aromatic monocyclic heterocycle.

[0172] Preferred 5- or 6-membered aromatic monocyclic heterocycles include furanyl, thienyl, pyrazolyl, imidazolyl, triazolyl, oxazolyl, thiazolyl, pyridinyl and pyrimidinyl.

[0173] R 8 When R is an aromatic 5- to 14-membered heterocycle, 8 is more preferably selected from the group consisting of pyrazolyl, imidazolyl, thiazolyl and pyridinyl.

[0174] R 8 When R is an aromatic 5- to 14-membered heterocycle, 8 is even more preferably selected from the group consisting of pyrazol-1-yl, imidazol-1-yl, thiazol-4-yl, pyridin-2-yl, pyridin-3-yl and pyridin-4-yl.

[0175] R 8 is C3-C8-cycloalkyloxy, R 8 is preferably cyclopropyloxy.

[0176] R 8 is a non-aromatic 3- to 14-membered heterocyclyloxy, R 8 is preferably a non-aromatic 3- to 7-membered monocyclic heterocyclyloxy.

[0177] Preferred non-aromatic 3- to 7-membered monocyclic heterocyclyloxy include oxetanyloxy and azetidinyloxy.

[0178] R 8 is a non-aromatic 3- to 14-membered heterocyclyloxy, R 8 is more preferably oxetan-3-yloxy or azetidin-3-yloxy.

[0179] R 8 is N(R h )2, then R h is preferably hydrogen, C1-C6-alkyl (e.g., methyl, ethyl, propyl, isobutyl), C2-C6-alkenyl (e.g., buten-3-en-2-yl), C3-C8-cycloalkyl (e.g., cyclopropyl, cyclohexyl), aromatic C6-C 14 - independently selected from the group consisting of carbocycles (e.g., phenyl) and non-aromatic 3- to 7-membered monocyclic heterocycles (e.g., oxetanyl).

[0180] In some embodiments, R 8 is selected from hydrogen, halogen, hydroxyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, cyclopropyl, phenyl, oxetanyl, azetidinyl, pyrrolidinyl, tetrahydropyranyl, morpholinyl, pyrazolyl, imidazolyl, thiazolyl, pyridinyl, cyclopropyloxy, oxetanyloxy, azetidinyloxy and -N(R h )2, and R h is preferably hydrogen, C1-C6-alkyl, C2-C6-alkenyl, C3-C8-cycloalkyl (e.g., cyclopropyl, cyclohexyl), aromatic C6-C 14 - independently selected from the group consisting of carbocycles (e.g., phenyl) and non-aromatic 3- to 7-membered monocyclic heterocycles (e.g., oxetanyl).

[0181] In a preferred embodiment, R 8is selected from hydrogen, halogen, hydroxyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, cyclopropyl, phenyl, oxetanyl, azetidinyl, pyrrolidinyl, tetrahydropyranyl, morpholinyl, pyrazolyl, imidazolyl, thiazolyl, pyridinyl, cyclopropyloxy, oxetanyloxy, azetidinyloxy and -N(R h )2, and R h are preferably independently selected from the group consisting of hydrogen, C1-C6-alkyl, C2-C6-alkenyl, C3-C6-cycloalkyl, phenyl and oxetanyl.

[0182] Preferred aliphatic R 8 and R h The substituents may be one or more of the R groups disclosed herein above or disclosed herein below. 8Sa It may be substituted with a substituent.

[0183] R 8Sa The substituents are preferably hydroxyl, carboxyl, C1-C6-haloalkyl (e.g. trifluoromethyl), C1-C6-alkoxy (e.g. methoxy, ethoxy), C1-C6-alkoxy-C1-C6-alkoxy (e.g. -ethoxy-methoxy), C1-C6-alkoxycarbonyl (e.g. methoxycarbonyl), C3-C8-cycloalkyl (e.g. cyclopropyl), C1-C6-alkylsulfanyl (e.g. methylsulfanyl), -O-Si(C1-C6-alkyl)3, non-aromatic 3- to 7-membered monocyclic heterocycle (e.g. 1,3-dioxolanyl) and -N(R a’ )2, and R a’are preferably independently selected from the group consisting of hydrogen, formyl, C1-C6-alkyl (eg methyl) and C1-C6-alkylcarbonyl (eg methylcarbonyl).

[0184] Appropriate N(R a’ Non-limiting examples of 2-amino groups include acetyl(methyl)amino and formyl(methyl)amino.

[0185] Preferred cyclic groups R 8 and R h The substituents may be one or more R groups, which may be the same or different, as disclosed herein above or below. 8Sc It may be substituted with a substituent.

[0186] R 8Sc The substituents are preferably selected from the group consisting of oxo, halogen (e.g., chlorine), cyano, hydroxyl, C1-C6-alkyl (e.g., methyl), C1-C6-haloalkyl (e.g., difluoromethyl), C1-C6-alkoxy (e.g., methoxy), C1-C6-alkoxycarbonyl (e.g., ethoxycarbonyl, propyloxycarbonyl), C3-C8-cycloalkyl (e.g., cyclopropyl) and non-aromatic 3- to 7-membered monocyclic heterocycles (e.g., oxolanyl, oxetanyl, tetrahydrofuranyl), or two R 8Sc The substituents, together with the carbon atoms to which they are attached, form a non-aromatic 3- to 7-membered monocyclic heterocycle (eg, oxetanyl, oxiranyl).

[0187] Appropriate R 8 Non-limiting examples of "R 8 R listed in the " column 8 groups.

[0188] In the above formula (I), Q is an aromatic C6-C 14 When Q is a carbocycle, it is preferably phenyl or naphthyl, more preferably phenyl or naphth-2-yl.

[0189] In the above formula (I), Q is a non-aromatic C3-C 12 When a carbocycle, Q is preferably a C7-C comprising an aryl fused with a C3-C8-cycloalkyl. 12 Bicyclic systems or C7-C comprising aryl fused with C3-C8-cycloalkenyl 12 It is a bicyclic system.

[0190] Preferred C3-C8-cycloalkyl and C7-C comprising aryl fused 12 Bicyclic systems include bicyclo[4.2.0]octa-1(6),2,4-trienyl, indanyl, and 1,2,3,4-tetrahydronaphthalenyl.

[0191] Preferred C3-C8-cycloalkenyl and C7-C comprising aryl fused 12 Bicyclic systems include indenyl and dihydronaphthalenyl.

[0192] Q is non-aromatic C3-C 12 When a carbocycle, Q is more preferably a C7-C comprising an aryl (e.g., phenyl) fused with a C3-C8-cycloalkyl. 12 It is a bicyclic ring system, even more preferably bicyclo[4.2.0]octa-1(6),2,4-trienyl, and more particularly 3-bicyclo[4.2.0]octa-1(6),2,4-trienyl.

[0193] In the above formula (I), when Q is a non-aromatic 3- to 14-membered heterocycle, Q is typically a non-aromatic 6- to 14-membered bicyclic heterocycle, and preferably Q is a non-aromatic bicyclic heterocycle comprising a 4- to 16-membered monocyclic non-aromatic heterocycle fused with an aryl or a non-aromatic bicyclic heterocycle comprising a 5- or 6-membered monocyclic heteroaryl fused with a monocyclic C3-C8-cycloalkyl.

[0194] Preferred non-aromatic bicyclic heterocycles comprising a 4- to 6-membered monocyclic non-aromatic heterocycle fused to an aryl include 2,3-dihydrobenzofuranyl, 1,3-dihydro-1,4-benzodioxinyl, and [1,3]dioxolo[4,5-b]pyridinyl.

[0195] Preferred non-aromatic bicyclic heterocycles comprising a 5- or 6-membered monocyclic heteroaryl fused to a monocyclic C3-C8-cycloalkyl include 5,6,7,8-tetrahydroquinolinyl and 6,7-dihydro-5H-cyclopenta[b]pyridinyl.

[0196] When Q is a non-aromatic 3- to 14-membered heterocycle, Q is more preferably a non-aromatic bicyclic heterocycle comprising a 4- to 6-membered monocyclic non-aromatic heterocycle fused to an aryl, even more preferably Q is 1,3-benzodioxolyl or 2,3-dihydrobenzofuranyl, more particularly Q is 1,3-benzodioxo-5-yl or 2,3-dihydrobenzofuran-5-yl.

[0197] In the above formula (I), when Q is an aromatic 5- to 14-membered heterocycle, Q is preferably an aromatic 5- or 6-membered monocyclic heterocycle, an aromatic 9- or 10-membered bicyclic heterocycle comprising an aromatic 5- or 6-membered monocyclic heterocycle fused with an aryl (phenyl), or a 9- or 10-membered aromatic bicyclic heterocycle comprising two fused aromatic 5- or 6-membered monocyclic heterocycles.

[0198] Preferred aromatic 5- or 6-membered monocyclic heterocycles include pyrrolyl, furanyl, thienyl, imidazolyl, triazolyl, oxazolyl, thiazolyl, pyridinyl, pyridazinyl and pyrimidinyl.

[0199] Preferred aromatic 9- or 10-membered bicyclic heterocycles comprising an aromatic 5- or 6-membered monocyclic heterocycle fused to an aryl (phenyl) include indolyl, benzimidazolyl, indazolyl, benzofuranyl, benzothiophenyl, benzothiazolyl (e.g., 1,2-benzothiazolyl, 1,3-benzothiazolyl), benzoxazolyl (e.g., 1,2-benzoxazolyl, 1,3-benzoxazolyl), and quinolinyl.

[0200] Preferred aromatic 9- or 10-membered bicyclic heterocycles comprising two fused 5- or 6-membered monocyclic aromatic heterocycles include furo[3,2-b]pyridinyl, thieno[3,2-b]thiophenyl, and thieno[2,3-d]thiazolyl.

[0201] When Q is an aromatic 5- to 14-membered heterocycle, Q is more preferably an aromatic 5- or 6-membered monocyclic heterocycle, even more preferably Q is thienyl, pyridinyl or indolyl, more particularly Q is pyridin-2-yl, pyridin-3-yl, indol-5-yl or indol-6-yl.

[0202] In some embodiments, Q is an aromatic C-C 14 -Carbocycle, non-aromatic C7-C comprising aryl fused with C3-C8-cycloalkyl 12 Bicyclic systems, non-aromatic C7-C comprising aryl fused with C3-C8-cycloalkenyl 12 bicyclic systems, non-aromatic 6- to 14-membered bicyclic heterocycles comprising a 4- to 6-membered monocyclic non-aromatic heterocycle fused with an aryl, non-aromatic 6- to 14-membered bicyclic heterocycles comprising a 5- or 6-membered monocyclic heteroaryl fused with a monocyclic C3-C8-cycloalkyl, aromatic 5- or 6-membered monocyclic heterocycles, aromatic 9- or 10-membered bicyclic heterocycles comprising an aromatic 5- or 6-membered monocyclic heterocycle fused with an aryl, and 9- or 10-membered aromatic bicyclic heterocycles comprising two fused aromatic 5- or 6-membered monocyclic heterocycles.

[0203] In a preferred embodiment, Q is an aromatic C-C 14 -Carbocycle, non-aromatic C7-C comprising aryl fused with C3-C8-cycloalkyl 12 Bicyclic systems, non-aromatic C7-C comprising aryl fused with C3-C8-cycloalkenyl 12 bicyclic systems, non-aromatic 6- to 14-membered bicyclic heterocycles comprising a 4- to 6-membered monocyclic non-aromatic heterocycle fused with an aryl, non-aromatic 6- to 14-membered bicyclic heterocycles comprising a 5- or 6-membered monocyclic heteroaryl fused with a monocyclic C3-C8-cycloalkyl, aromatic 5- or 6-membered monocyclic heterocycles, aromatic 9- or 10-membered bicyclic heterocycles comprising an aromatic 5- or 6-membered monocyclic heterocycle fused with an aryl, and 9- or 10-membered aromatic bicyclic heterocycles comprising two fused aromatic 5- or 6-membered monocyclic heterocycles.

[0204] In some embodiments, Q is selected from the group consisting of phenyl, naphthyl, bicyclo[4.2.0]octa-1(6),2,4-trienyl, benzodioxolyl, 2,3-dihydrobenzofuranyl, pyridinyl, thienyl, and indolyl; preferably, Q is phenyl, naphth-2-yl, 3-bicyclo[4.2.0]octa-1(6),2,4-trienyl, 1,3-benzodioxol-5-yl, 2,3-dihydrobenzofuran-5-yl, pyridin-2-yl, pyridin-3-yl, thien-3-yl, indol-5-yl, or indol-6-yl.

[0205] In more preferred embodiments, Q is selected from the group consisting of phenyl, naphthyl, bicyclo[4.2.0]octa-1(6),2,4-trienyl, benzodioxolyl, 2,3-dihydrobenzofuranyl, pyridinyl, thienyl, and indolyl.

[0206] In even more preferred embodiments, Q is selected from the group consisting of phenyl, naphth-2-yl, 3-bicyclo[4.2.0]octa-1(6),2,4-trienyl, 1,3-benzodioxol-5-yl, 2,3-dihydrobenzofuran-5-yl, pyridin-2-yl, pyridin-3-yl, thien-3-yl, indol-5-yl, pyridin-2-yl, pyridin-3-yl, thien-3-yl, indol-5-yl, or indol-6-yl.

[0207] The Q groups disclosed herein may be one or more Q groups, which may be the same or different, as disclosed herein above or as disclosed herein below. S It may be substituted with a substituent.

[0208] In some embodiments, Q is one or more Q groups disclosed herein above or disclosed herein below, which may be the same or different. S It is substituted by a substituent.

[0209] Q S The substituents are preferably halogen (e.g., fluorine, chlorine, bromine, iodine), cyano, nitro, hydroxyl, C1-C6-alkyl (e.g., methyl, ethyl), C1-C6-haloalkyl (e.g., trifluoromethyl, difluoromethyl), C1-C6-alkylcarbonyl (e.g., methylcarbonyl), C1-C6-alkoxy (e.g., methoxy), C1-C6-haloalkoxy (e.g., difluoromethoxy, trifluoromethoxy), C1-C6-alkoxy -C1-C6-alkyl (e.g., methoxymethyl), C2-C6-alkenyl (e.g., vinyl), C2-C6-alkynyl (e.g., ethynyl), C1-C6-alkylsulfanyl (e.g., methylsulfanyl), C1-C6-haloalkylsulfanyl (e.g., trifluoromethylsulfanyl), C3-C8-cycloalkyl (e.g., cyclopropyl, cyclobutyl), non-aromatic 3- to 7-membered monocyclic heterocycles (e.g., oxiranyl, oxetanyl), and -N(R k )2, and R kis hydrogen.

[0210] Aliphatic Q S The substituents may be optionally substituted as disclosed herein.

[0211] cyclic Q S Substituent groups may be optionally substituted as disclosed herein, preferably with one or more halogen atoms (eg, fluorine).

[0212] Non-limiting examples of suitable Q include any of the Q groups listed in the "Q" column of Table 1.

[0213] In some embodiments, Q is

[0214] [ka]

[0215] wherein: Q s1 is hydrogen or halogen (preferably fluorine), Q s2 is hydrogen or Q S and Q S is as described herein above, and preferably Q S2is hydrogen, halogen (e.g., fluorine, chlorine, bromine, iodine), cyano, nitro, hydroxyl, amino, C1-C6-alkyl (e.g., methyl, ethyl), C1-C6-haloalkyl (e.g., trifluoromethyl, difluoromethyl), C1-C6-alkylcarbonyl (e.g., methylcarbonyl), C1-C6-alkoxy (e.g., methoxy), C1-C6-haloalkoxy (e.g., difluoromethoxy, trifluoromethoxy), C1-C6-alkoxy-C1-C6-alkyl (e.g., methoxymethyl), C2-C6-alkanol and more preferably, Q is selected from the group consisting of phenyl (e.g., vinyl), C2-C6-alkynyl (e.g., ethynyl), C1-C6-alkylsulfanyl (e.g., methylsulfanyl), C1-C6-haloalkylsulfanyl (e.g., trifluoromethylsulfanyl), C3-C8-cycloalkyl (e.g., cyclopropyl, cyclobutyl) optionally substituted by one or more halogen atoms and non-aromatic 3- to 7-membered monocyclic heterocycle (e.g., oxiranyl, oxetanyl) optionally substituted by one or more halogen atoms, S2 is selected from the group consisting of fluorine, chlorine, bromine, iodine, cyano, nitro, hydroxyl, amino, methyl, trifluoromethyl, difluoromethyl, methoxy, difluoromethoxy, trifluoromethoxy, vinyl, ethynyl, methylsulfanyl, trifluoromethylsulfanyl, cyclopropyl optionally substituted by one or more halogen atoms, oxiranyl optionally substituted by one or more halogen atoms, and oxetanyl, preferably s1 and Q s2 At least one of these is different from hydrogen.

[0216] In an even more preferred embodiment, Q is

[0217] [ka]

[0218] wherein: Q s1 is hydrogen or halogen, Q s2 is hydrogen or Q S and Q S is selected from the group consisting of hydrogen, halogen, cyano, nitro, hydroxyl, amino, C1-C6-alkyl, C1-C4-haloalkyl, C1-C4-alkylcarbonyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C1-C4-alkoxy-C1-C4-alkyl, C2-C4-alkenyl, C2-C4-alkynyl, C1-C4-alkylsulfanyl, C1-C4-haloalkylsulfanyl, C3-C6-cycloalkyl optionally substituted by 1 or 2 halogen atoms and non-aromatic 3- to 6-membered monocyclic heterocycle optionally substituted by 1 or 2 halogen atoms, with the proviso that Q s1 and Q s2 At least one of these is different from hydrogen.

[0219] Most preferably, Q S2 is selected from the group consisting of fluorine, chlorine, bromine, iodine, cyano, nitro, hydroxyl, amino, methyl, trifluoromethyl, difluoromethyl, methoxy, difluoromethoxy, trifluoromethoxy, vinyl, ethynyl, methylsulfanyl, trifluoromethylsulfanyl, cyclopropyl optionally substituted by one or two halogen atoms, oxiranyl optionally substituted by one or two halogen atoms, and oxetanyl.

[0220] R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 The above-specified definitions of Q (broad definitions as well as preferred, more preferred, and even more preferred definitions) can be combined in various ways. Thus, these combinations of definitions provide subclasses of compounds according to the invention, such as, for example, those disclosed below.

[0221] In some embodiments (herein referred to as embodiment 2), the compound according to the present invention has formula (I):

[0222] [ka]

[0223] wherein: T is O or S; n is 0 or 1; m is 0 or 1; provided that when n is 1, then m is 1; R 1 is hydrogen, hydroxyl, cyano, C1-C6-alkyl, C1-C6-alkoxy, C1-C6-alkoxy-C1-C6-alkyl, -C(=O)R a1 , -C(=O)(OR a1 ), -S(=O)R a1 , -S(=O)2R a1 , -C(=O)N(R a2 )2 and S(=O)2N(R a2 )2, and R a1 is selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, and C2-C6-alkenyl; R a2 is selected from the group consisting of hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl and C2-C6-alkenyl; R 2 and R 3 are independently selected from the group consisting of hydrogen, halogen, cyano, hydroxyl, carboxyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-alkoxycarbonyl and C3-C8-cycloalkyl, or R 2 and R 3 together with the carbon atoms to which they are attached form a C3-C8-cycloalkyl or non-aromatic 3- to 7-membered monocyclic heterocycle; R 4 and R 5are independently selected from the group consisting of hydrogen, halogen, cyano, hydroxyl, carboxyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-alkoxycarbonyl and C3-C8-cycloalkyl, or R 4 and R 5 together with the carbon atoms to which they are attached form a C3-C8-cycloalkyl or non-aromatic 3- to 7-membered monocyclic heterocycle; or R 2 and R 4 together with the carbon atoms to which they are attached form a C3-C8-cycloalkyl or non-aromatic 3- to 7-membered monocyclic heterocycle, and R 3 and R 5 are independently hydrogen or halogen atoms; or R 2 and R 4 form a covalent bond, and R 3 and R 5 are independently hydrogen or C1-C6-alkyl; R 6 is a non-aromatic C3-C 12 -Carbocyclic ring (preferably C7-C 12 Bicyclic systems, more preferably C7-C comprising aryl fused with C3-C8-cycloalkyl. 12 Bicyclic systems, C7-C comprising aryl fused with C3-C8-cycloalkenyl 12 Bicyclic systems or bicyclic systems comprising aryl fused with either C3-C8-cycloalkyl or C3-C8-cycloalkenyl and C9-C comprising cyclopropyl linked by one common atom 12 tricyclic), aromatic C6~C 14- a carbocycle (preferably phenyl or naphthyl), a non-aromatic 3- to 14-membered heterocycle (preferably a non-aromatic 6- to 14-membered polycyclic heterocycle, more preferably a non-aromatic bicyclic heterocycle comprising a 4- to 6-membered monocyclic non-aromatic heterocycle fused with an aryl, a non-aromatic bicyclic heterocycle comprising a 5- or 6-membered monocyclic heteroaryl fused with a monocyclic C3-C8-cycloalkyl, a non-aromatic bicyclic heterocycle comprising a 5- or 6-membered monocyclic heteroaryl fused with a 3- to 7-membered monocyclic non-aromatic heterocycle, a non-aromatic tricyclic heterocycle comprising a cyclopropyl linked by one common atom with a non-aromatic bicyclic heterocycle, a non-aromatic tricyclic heterocycle fused with an aryl a non-aromatic bicyclic heterocycle comprising a 5- or 6-membered monocyclic heteroaryl fused with a monocyclic C3-C8-cycloalkyl and a cyclopropyl linked by one common atom), an aromatic 5- to 14-membered heterocycle (preferably a 5- or 6-membered monocyclic aromatic heterocycle, a 9- or 10-membered aromatic bicyclic heterocycle comprising a 5- or 6-membered monocyclic aromatic heterocycle fused with an aryl, or a 9- or 10-membered aromatic bicyclic heterocycle comprising two fused 5- or 6-membered monocyclic aromatic heterocycles), an aromatic C6-C8-cycloalkyl 14 -Carbocyclyloxy, aromatic C6-C 14 -C1-C3-alkoxy and aromatic C6-C substituted by carbocyclic rings 14 -C1-C3-haloalkyl substituted by a carbocycle, preferably R 6is selected from the group consisting of indanyl, 1,2,3,4-tetrahydronaphthalenyl, spiro[cyclopropane-1,2'-indan]-1-yl, phenyl, naphthyl, 2,3-dihydrobenzofuranyl, indolinyl, 1,3-benzodioxolyl, chromanyl, isochromanyl, thiochromanyl, 2,3-dihydro-1,4-benzodioxinyl, 5,6,7,8-tetrahydroquinolinyl, 4,5,6,7-tetrahydrobenzothiophenyl, furanyl, thienyl, pyridinyl, pyrimidinyl, indolyl, benzofuranyl, benzoxazolyl, quinolinyl, isoquinolinyl, imidazo[1,2-a]pyridinyl, phenoxy, benzyloxy, and -OCF2-phenyl; cyclic R 6 Substituent or R 6 The cyclic portion of the substituent may be one or more R 6S and R 6S are as disclosed herein (preferred and more preferred R 6S including); R 7 is hydrogen, halogen, cyano, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C1-C6-alkylcarbonyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-alkylsulfanyl, C1-C6-alkylsulfinyl, C3-C8-cycloalkyl, aromatic 5- or 6-membered monocyclic heterocycle, non-aromatic 3- to 7-membered monocyclic heterocycle, -N(R e )2, -C(=NR f )R f and -C(=O)N(R g )2, R e is as disclosed above, preferably R e are independently selected from the group consisting of hydrogen, C1-C6-alkyl and C3-C8-cycloalkyl (e.g., cyclopropyl), R f is as disclosed above, preferably R fare independently selected from the group consisting of hydroxyl, amino, C1-C6-alkyl and C1-C6-alkoxy; R g is as disclosed above, preferably R g are independently selected from the group consisting of hydrogen, C1-C6-alkyl and C3-C8-cycloalkyl, Preferably, R 7 is selected from the group consisting of hydrogen, halogen, cyano, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C1-C6-alkylcarbonyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-alkylsulfanyl, C1-C6-alkylsulfinyl, cyclopropyl, pyridinyl, pyrazolyl, oxetanyl, tetrahydrofuranyl, tetrahydropyranyl, pyrrolidinyl, azetidinyl, cyclopropylamino, cyclopropylaminocarbonyl, 1-hydrazinylideneethyl, 1-(methoxyimino)ethyl and 1-hydroxyiminoethyl, aliphatic R 7 , R e , R f and R g The substituents may be one or more R 7Sa may be substituted by a substituent, R 7Sa is as disclosed herein (preferred R 7Sa including cyclic R 7 Substituent or R 7 The cyclic portion of the substituent, cyclic R e and cyclic R g The substituents may be one or more R 7Sc may be substituted by a substituent, R 7Sc is as disclosed herein (preferred R 7Sc including); R 8is hydrogen, halogen, hydroxyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, C3-C8-cycloalkyl, aromatic C6-C 14 -carbocycle, non-aromatic 3- to 14-membered heterocycle (preferably non-aromatic 3- to 7-membered monocyclic heterocycle), aromatic 5- to 14-membered heterocycle (preferably 5- or 6-membered aromatic monocyclic heterocycle), C3-C8-cycloalkyloxy, non-aromatic 3- to 14-membered heterocyclyloxy (preferably non-aromatic 3- to 7-membered monocyclic heterocyclyloxy) and -N(R h )2, and R h is as disclosed above, preferably R h is hydrogen, C1-C6-alkyl, C2-C6-alkenyl, C3-C8-cycloalkyl (e.g., cyclopropyl, cyclohexyl), aromatic C6-C 14 - independently selected from the group consisting of carbocycles (e.g., phenyl) and non-aromatic 3- to 7-membered monocyclic heterocycles (e.g., oxetanyl); Preferably, R 8 is selected from hydrogen, halogen, hydroxyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, cyclopropyl, phenyl, oxetanyl, azetidinyl, pyrrolidinyl, tetrahydropyranyl, morpholinyl, pyrazolyl, imidazolyl, thiazolyl, pyridinyl, cyclopropyloxy, oxetanyloxy, azetidinyloxy and -N(R h )2, and R his preferably hydrogen, C1-C6-alkyl, C2-C6-alkenyl, C3-C8-cycloalkyl (e.g., cyclopropyl, cyclohexyl), aromatic C6-C 14 - independently selected from the group consisting of carbocycles (e.g., phenyl) and non-aromatic 3- to 7-membered monocyclic heterocycles (e.g., oxetanyl); aliphatic R 8 and R h The substituents may be one or more R 8Sa may be substituted by a substituent, R 8Sa is as disclosed herein (preferred R 8Sa including cyclic R 8 Substituent or R h The cyclic portion of the substituent may be one or more R 8Sc may be substituted by a substituent, R 8Sc is as disclosed herein (preferred R 8Sc including Q is an aromatic C6-C 14 -Carbocycle, non-aromatic C7-C comprising aryl fused with C3-C8-cycloalkyl 12 Bicyclic systems, non-aromatic C7-C comprising aryl fused with C3-C8-cycloalkenyl 12 bicyclic systems, 6- to 14-membered non-aromatic bicyclic heterocycles comprising a 4- to 6-membered monocyclic non-aromatic heterocycle fused with an aryl, 6- to 14-membered non-aromatic bicyclic heterocycles comprising a 5- or 6-membered monocyclic heteroaryl fused with a monocyclic C3-C8-cycloalkyl, aromatic 5- or 6-membered monocyclic heterocycles, 9- or 10-membered aromatic bicyclic heterocycles comprising a 5- or 6-membered monocyclic aromatic heterocycle fused with an aryl (phenyl), 9- or 10-membered aromatic bicyclic heterocycles comprising two fused 5- or 6-membered monocyclic aromatic heterocycles, preferably Q is an aromatic C6-C 14 -Carbocycle, C7-C comprising aryl fused with C3-C8-cycloalkyl 12bicyclic systems, 6- to 14-membered non-aromatic bicyclic heterocycles comprising a 4- to 6-membered monocyclic non-aromatic heterocycle fused to an aryl, and aromatic 5- or 6-membered monocyclic heterocycles, more preferably Q is selected from the group consisting of phenyl, naphthyl, 3-bicyclo[4.2.0]octa-1(6),2,4-trienyl, 1,3-benzodioxolyl, 2,3-dihydrobenzofuranyl, pyridinyl, thienyl, and indolyl; Each Q group may be one or more Q groups, which may be the same or different. S may be substituted by a substituent, and Q S is as disclosed herein (preferred Q S (including

[0224] In some embodiments (herein referred to as embodiment 3), the compound according to the invention has formula (I):

[0225] [ka]

[0226] wherein: T is O or S; n is 0 or 1; m is 0 or 1; provided that when n is 1, then m is 1; R 1 is hydrogen, hydroxyl, cyano, C1-C6-alkyl, C1-C6-alkoxy, C1-C6-alkoxy-C1-C6-alkyl, -C(=O)R a1 , -C(=O)(OR a1 ), -S(=O)R a1 , -S(=O)2R a1 , -C(=O)N(R a2 )2 and S(=O)2N(R a2 )2, and R a1 is selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, and C2-C6-alkenyl; R a2is selected from the group consisting of hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl and C2-C6-alkenyl; R 2 and R 3 are independently selected from the group consisting of hydrogen, halogen, cyano, hydroxyl, carboxyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-alkoxycarbonyl and C3-C8-cycloalkyl, or R 2 and R 3 together with the carbon atoms to which they are attached form a C3-C8-cycloalkyl or non-aromatic 3- to 7-membered monocyclic heterocycle; R 4 and R 5 are independently selected from the group consisting of hydrogen, halogen, cyano, hydroxyl, carboxyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-alkoxycarbonyl and C3-C8-cycloalkyl, or R 4 and R 5 together with the carbon atoms to which they are attached form a C3-C8-cycloalkyl or non-aromatic 3- to 7-membered monocyclic heterocycle; or R 2 and R 4 together with the carbon atoms to which they are attached form a C3-C8-cycloalkyl or non-aromatic 3- to 7-membered monocyclic heterocycle, and R 3 and R 5 are independently hydrogen or halogen atoms; or R 2 and R 4 form a covalent bond, and R 3 and R 5 are independently hydrogen or C1-C6-alkyl; R 6 is a non-aromatic C3-C 12 -Carbocyclic ring (preferably C7-C 12 Bicyclic systems, more preferably C7-C comprising aryl fused with C3-C8-cycloalkyl. 12Bicyclic systems, C7-C comprising aryl fused with C3-C8-cycloalkenyl 12 Bicyclic systems or bicyclic systems comprising aryl fused with either C3-C8-cycloalkyl or C3-C8-cycloalkenyl and C9-C comprising cyclopropyl linked by one common atom 12 tricyclic), aromatic C6~C 14 - a carbocycle (preferably phenyl or naphthyl), a non-aromatic 3- to 14-membered heterocycle (preferably a non-aromatic 6- to 14-membered polycyclic heterocycle, more preferably a non-aromatic bicyclic heterocycle comprising a 4- to 6-membered monocyclic non-aromatic heterocycle fused with an aryl, a non-aromatic bicyclic heterocycle comprising a 5- or 6-membered monocyclic heteroaryl fused with a monocyclic C3-C8-cycloalkyl, a non-aromatic bicyclic heterocycle comprising a 5- or 6-membered monocyclic heteroaryl fused with a 3- to 7-membered monocyclic non-aromatic heterocycle, a non-aromatic tricyclic heterocycle comprising a cyclopropyl linked by one common atom with a non-aromatic bicyclic heterocycle, a non-aromatic tricyclic heterocycle fused with an aryl a non-aromatic bicyclic heterocycle comprising a 5- or 6-membered monocyclic heteroaryl fused with a monocyclic C3-C8-cycloalkyl and a cyclopropyl linked by one common atom), an aromatic 5- to 14-membered heterocycle (preferably a 5- or 6-membered monocyclic aromatic heterocycle, a 9- or 10-membered aromatic bicyclic heterocycle comprising a 5- or 6-membered monocyclic aromatic heterocycle fused with an aryl, or a 9- or 10-membered aromatic bicyclic heterocycle comprising two fused 5- or 6-membered monocyclic aromatic heterocycles), an aromatic C6-C8-cycloalkyl 14 -Carbocyclyloxy, aromatic C6-C 14 -C1-C3-alkoxy and aromatic C6-C substituted by carbocyclic rings 14 -C1-C3-haloalkyl substituted by a carbocycle, preferably R 6is selected from the group consisting of indanyl, 1,2,3,4-tetrahydronaphthalenyl, spiro[cyclopropane-1,2'-indan]-1-yl, phenyl, naphthyl, 2,3-dihydrobenzofuranyl, indolinyl, 1,3-benzodioxolyl, chromanyl, isochromanyl, thiochromanyl, 2,3-dihydro-1,4-benzodioxinyl, 5,6,7,8-tetrahydroquinolinyl, 4,5,6,7-tetrahydrobenzothiophenyl, furanyl, thienyl, pyridinyl, pyrimidinyl, indolyl, benzofuranyl, benzoxazolyl, quinolinyl, isoquinolinyl, imidazo[1,2-a]pyridinyl, phenoxy, benzyloxy, and -OCF2-phenyl; cyclic R 6 Substituent or R 6 The cyclic portion of the substituent may be one or more R 6S and R 6S are as disclosed herein (preferred and more preferred R 6S including); 7 is hydrogen, halogen, cyano, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C1-C6-alkylcarbonyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-alkylsulfanyl, C1-C6-alkylsulfinyl, C3-C8-cycloalkyl, aromatic 5- or 6-membered monocyclic heterocycle, non-aromatic 3- to 7-membered monocyclic heterocycle, -N(R e )2, -C(=NR f )R f and -C(=O)N(R g )2, R e is as disclosed above, preferably R e are independently selected from the group consisting of hydrogen, C1-C6-alkyl and C3-C8-cycloalkyl (e.g., cyclopropyl), R f is as disclosed above, preferably R fare independently selected from the group consisting of hydroxyl, amino, C1-C6-alkyl and C1-C6-alkoxy; R g is as disclosed above, preferably R g are independently selected from the group consisting of hydrogen, C1-C6-alkyl and C3-C8-cycloalkyl, Preferably, R 7 is selected from the group consisting of hydrogen, halogen, cyano, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C1-C6-alkylcarbonyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-alkylsulfanyl, C1-C6-alkylsulfinyl, cyclopropyl, pyridinyl, pyrazolyl, oxetanyl, tetrahydrofuranyl, tetrahydropyranyl, pyrrolidinyl, azetidinyl, cyclopropylamino, cyclopropylaminocarbonyl, 1-hydrazinylideneethyl, 1-(methoxyimino)ethyl and 1-hydroxyiminoethyl, aliphatic R 7 , R e , R f and R g The substituents may be one or more R 7Sa may be substituted by a substituent, R 7Sa is as disclosed herein (preferred R 7Sa including cyclic R 7 Substituent or R 7 The cyclic portion of the substituent, cyclic R e and cyclic R g The substituents may be one or more R 7Sc may be substituted by a substituent, R 7Sc is as disclosed herein (preferred R 7Sc including); R 8is hydrogen, halogen, hydroxyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, C3-C8-cycloalkyl, aromatic C6-C 14 -carbocycle, non-aromatic 3- to 14-membered heterocycle (preferably non-aromatic 3- to 7-membered monocyclic heterocycle), aromatic 5- to 14-membered heterocycle (preferably 5- or 6-membered aromatic monocyclic heterocycle), C3-C8-cycloalkyloxy, non-aromatic 3- to 14-membered heterocyclyloxy (preferably non-aromatic 3- to 7-membered monocyclic heterocyclyloxy) and -N(R h )2, and R h is as disclosed above, preferably R h is hydrogen, C1-C6-alkyl, C2-C6-alkenyl, C3-C8-cycloalkyl (e.g., cyclopropyl, cyclohexyl), aromatic C6-C 14 - independently selected from the group consisting of carbocycles (e.g., phenyl) and non-aromatic 3- to 7-membered monocyclic heterocycles (e.g., oxetanyl); Preferably, R 8 is selected from hydrogen, halogen, hydroxyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, cyclopropyl, phenyl, oxetanyl, azetidinyl, pyrrolidinyl, tetrahydropyranyl, morpholinyl, pyrazolyl, imidazolyl, thiazolyl, pyridinyl, cyclopropyloxy, oxetanyloxy, azetidinyloxy and -N(R h )2, and R his preferably hydrogen, C1-C6-alkyl, C2-C6-alkenyl, C3-C8-cycloalkyl (e.g., cyclopropyl, cyclohexyl), aromatic C6-C 14 - independently selected from the group consisting of carbocycles (e.g., phenyl) and non-aromatic 3- to 7-membered monocyclic heterocycles (e.g., oxetanyl); aliphatic R 8 and R h The substituents may be one or more R 8Sa may be substituted by a substituent, R 8Sa is as disclosed herein (preferred R 8Sa including cyclic R 8 Substituent or R h The cyclic portion of the substituent may be one or more R 8Sc may be substituted by a substituent, R 8Sc is as disclosed herein (preferred R 8Sc (including Q is

[0227] [ka]

[0228] wherein: Q s1 is hydrogen or halogen (preferably fluorine), Q s2 is hydrogen or Q S and Q S is as described herein above, and preferably Q S2is hydrogen, halogen (e.g., fluorine, chlorine, bromine, iodine), cyano, nitro, hydroxyl, amino, C1-C6-alkyl (e.g., methyl, ethyl), C1-C6-haloalkyl (e.g., trifluoromethyl, difluoromethyl), C1-C6-alkylcarbonyl (e.g., methylcarbonyl), C1-C6-alkoxy (e.g., methoxy), C1-C6-haloalkoxy (e.g., difluoromethoxy, trifluoromethoxy), C1-C6-alkoxy-C1-C6-alkyl (e.g., methoxymethyl), C2-C6 -alkenyl (e.g., vinyl), C2-C6-alkynyl (e.g., ethynyl), C1-C6-alkylsulfanyl (e.g., methylsulfanyl), C1-C6-haloalkylsulfanyl (e.g., trifluoromethylsulfanyl), C3-C8-cycloalkyl (e.g., cyclopropyl, cyclobutyl) optionally substituted by one or more halogen atoms and non-aromatic 3- to 7-membered monocyclic heterocycle (e.g., oxetanyl) optionally substituted by one or more halogen atoms, more preferably Q S2 is selected from the group consisting of fluorine, chlorine, bromine, iodine, cyano, nitro, hydroxyl, amino, methyl, trifluoromethyl, difluoromethyl, methoxy, trifluoromethoxy, vinyl, ethynyl, methylsulfanyl, trifluoromethylsulfanyl, cyclopropyl optionally substituted by one or more halogen atoms, and oxetanyl optionally substituted by one or more halogen atoms, and preferably Q s1 and Q s2 At least one of these is different from hydrogen.

[0229] In some embodiments (herein referred to as embodiment 4), the compound according to the present invention has formula (I):

[0230] [ka]

[0231] wherein: T is O or S; n is 0 or 1; m is 0 or 1; provided that when n is 1, then m is 1; R 1 is hydrogen, hydroxyl, cyano, C1-C6-alkyl, C1-C6-alkoxy, C1-C6-alkoxy-C1-C6-alkyl, -C(=O)R a1 , -C(=O)(OR a1 ), -S(=O)R a1 , -S(=O)2R a1 , -C(=O)N(R a2 )2 and S(=O)2N(R a2 )2, and R a1 is selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, and C2-C6-alkenyl; R a2 is selected from the group consisting of hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl and C2-C6-alkenyl; R 2 and R 3 are independently selected from the group consisting of hydrogen, halogen, cyano, hydroxyl, carboxyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-alkoxycarbonyl and C3-C8-cycloalkyl, or R 2 and R 3 together with the carbon atoms to which they are attached form a C3-C8-cycloalkyl or non-aromatic 3- to 7-membered monocyclic heterocycle; R 4 and R 5 are independently selected from the group consisting of hydrogen, halogen, cyano, hydroxyl, carboxyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-alkoxycarbonyl and C3-C8-cycloalkyl, or R 4 and R 5 together with the carbon atoms to which they are attached form a C3-C8-cycloalkyl or non-aromatic 3- to 7-membered monocyclic heterocycle; or R2 and R 4 together with the carbon atoms to which they are attached form a C3-C8-cycloalkyl or non-aromatic 3- to 7-membered monocyclic heterocycle, and R 3 and R 5 are independently hydrogen or halogen atoms; or R 2 and R 4 form a covalent bond, and R 3 and R 5 are independently hydrogen or C1-C6-alkyl. R 6 teeth,

[0232] [ka]

[0233] wherein: R 6s1 is hydrogen or R 6s and R 6s2 is hydrogen or R 6s and R 6s are as described herein (preferred and more preferred R 6s ), preferably R 6s1 and R 6s2 At least one of these is different from hydrogen: R 7 is hydrogen, halogen, cyano, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C1-C6-alkylcarbonyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-alkylsulfanyl, C1-C6-alkylsulfinyl, C3-C8-cycloalkyl, aromatic 5- or 6-membered monocyclic heterocycle, non-aromatic 3- to 7-membered monocyclic heterocycle, -N(R e )2, -C(=NR f )R f and -C(=O)N(R g )2, R eis as disclosed above, preferably R e are independently selected from the group consisting of hydrogen, C1-C6-alkyl and C3-C8-cycloalkyl (e.g., cyclopropyl), R f is as disclosed above, preferably R f are independently selected from the group consisting of hydroxyl, amino, C1-C6-alkyl and C1-C6-alkoxy; R g is as disclosed above, preferably R g are independently selected from the group consisting of hydrogen, C1-C6-alkyl and C3-C8-cycloalkyl, Preferably, R 7 is selected from the group consisting of hydrogen, halogen, cyano, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C1-C6-alkylcarbonyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-alkylsulfanyl, C1-C6-alkylsulfinyl, cyclopropyl, pyridinyl, pyrazolyl, oxetanyl, tetrahydrofuranyl, tetrahydropyranyl, pyrrolidinyl, azetidinyl, cyclopropylamino, cyclopropylaminocarbonyl, 1-hydrazinylideneethyl, 1-(methoxyimino)ethyl and 1-hydroxyiminoethyl, aliphatic R 7 , R e , R f and R g The substituents may be one or more R 7Sa may be substituted by a substituent, R 7Sa is as disclosed herein (preferred R 7Sa including cyclic R 7 Substituent or R 7 The cyclic portion of the substituent, cyclic R e and cyclic R g The substituents may be one or more R 7Sc may be substituted by a substituent, R 7Scis as disclosed herein (preferred R 7Sc including); R 8 is hydrogen, halogen, hydroxyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, C3-C8-cycloalkyl, aromatic C6-C 14 -carbocycle, non-aromatic 3- to 14-membered heterocycle (preferably non-aromatic 3- to 7-membered monocyclic heterocycle), aromatic 5- to 14-membered heterocycle (preferably 5- or 6-membered aromatic monocyclic heterocycle), C3-C8-cycloalkyloxy, non-aromatic 3- to 14-membered heterocyclyloxy (preferably non-aromatic 3- to 7-membered monocyclic heterocyclyloxy) and -N(R h )2, R h is as disclosed above, preferably R h is hydrogen, C1-C6-alkyl, C2-C6-alkenyl, C3-C8-cycloalkyl (e.g., cyclopropyl, cyclohexyl), aromatic C6-C 14 - independently selected from the group consisting of carbocycles (e.g., phenyl) and non-aromatic 3- to 7-membered monocyclic heterocycles (e.g., oxetanyl); Preferably, R 8 is selected from hydrogen, halogen, hydroxyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, cyclopropyl, phenyl, oxetanyl, azetidinyl, pyrrolidinyl, tetrahydropyranyl, morpholinyl, pyrazolyl, imidazolyl, thiazolyl, pyridinyl, cyclopropyloxy, oxetanyloxy, azetidinyloxy and -N(R h )2, and Rh is preferably hydrogen, C1-C6-alkyl, C2-C6-alkenyl, C3-C8-cycloalkyl (e.g., cyclopropyl, cyclohexyl), aromatic C6-C 14 - independently selected from the group consisting of carbocycles (e.g., phenyl) and non-aromatic 3- to 7-membered monocyclic heterocycles (e.g., oxetanyl); aliphatic R 8 and R h The substituents may be one or more R 8Sa may be substituted by a substituent, R 8Sa is as disclosed herein (preferred R 8Sa including cyclic R 8 Substituent or R h The cyclic portion of the substituent may be one or more R 8Sc may be substituted by a substituent, R 8Sc are as disclosed herein (preferred R 8Sc (including Q is

[0234] [ka]

[0235] wherein: Q s1 is hydrogen or halogen (preferably fluorine), Q s2 is hydrogen or Q S and Q S is as described herein above, and preferably Q S2is hydrogen, halogen (e.g., fluorine, chlorine, bromine, iodine), cyano, nitro, hydroxyl, amino, C1-C6-alkyl (e.g., methyl, ethyl), C1-C6-haloalkyl (e.g., trifluoromethyl, difluoromethyl), C1-C6-alkylcarbonyl (e.g., methylcarbonyl), C1-C6-alkoxy (e.g., methoxy), C1-C6-haloalkoxy (e.g., difluoromethoxy, trifluoromethoxy), C1-C6-alkoxy-C1-C6-alkyl (e.g., methoxymethyl), C2-C6-alkanol and more preferably, Q is selected from the group consisting of phenyl (e.g., vinyl), C2-C6-alkynyl (e.g., ethynyl), C1-C6-alkylsulfanyl (e.g., methylsulfanyl), C1-C6-haloalkylsulfanyl (e.g., trifluoromethylsulfanyl), C3-C8-cycloalkyl (e.g., cyclopropyl, cyclobutyl) optionally substituted by one or more halogen atoms and non-aromatic 3- to 7-membered monocyclic heterocycle (e.g., oxiranyl, oxetanyl) optionally substituted by one or more halogen atoms, S2 is selected from the group consisting of fluorine, chlorine, bromine, iodine, cyano, nitro, hydroxyl, amino, methyl, trifluoromethyl, difluoromethyl, methoxy, difluoromethoxy, trifluoromethoxy, vinyl, ethynyl, methylsulfanyl, trifluoromethylsulfanyl, cyclopropyl optionally substituted by one or more halogen atoms, and oxetanyl optionally substituted by one or more halogen atoms, and preferably Q s1 and Q s2 At least one of these is different from hydrogen.

[0236] In a preferred embodiment, the compound according to the invention is a compound of formula (I), wherein T is O or S; n is 0 or 1; m is 0 or 1; provided that when n is 1, then m is 1; R 1is hydrogen, hydroxyl, cyano, C1-C6-alkyl, C1-C6-alkoxy, C1-C6-alkoxy-C1-C6-alkyl and -C(=O)(OR a1 ), and R a1 is selected from the group consisting of C1-C6-alkyl and C2-C6-alkenyl, R 2 and R 3 are independently selected from the group consisting of hydrogen, halogen, cyano, C1-C6-alkyl and C1-C6-alkoxycarbonyl, or R 2 and R 3 together with the carbon atoms to which they are attached form a C3-C8-cycloalkyl, R 4 and R 5 are independently selected from the group consisting of hydrogen, halogen and C1-C6-alkyl, or R 4 and R 5 together with the carbon atoms to which they are attached form a C3-C8-cycloalkyl or non-aromatic 3- to 7-membered monocyclic heterocycle; or R 2 and R 4 together with the carbon atoms to which they are attached form a C3-C8-cycloalkyl, and R 3 and R 5 are independently hydrogen or halogen; or R 6 is a non-aromatic C3-C 12 -Carbocyclic, aromatic C6~C 14 -Carbocycle, non-aromatic 3- to 14-membered heterocycle, aromatic 5- to 14-membered heterocycle, aromatic C6 to C 14 -Carbocyclyloxy, aromatic C6-C 14 -C1-C3-alkoxy, non-aromatic C3-C substituted by a carbocyclic ring 12 -C1-C3-haloalkoxy substituted with a carbocyclic ring, aromatic C6-C 14 -C1-C3-haloalkoxy substituted by a carbocycle, wherein the cyclic R 6 Substituent or R 6The cyclic portion of the substituent may be one or three R 6S may be substituted by a substituent, R 6S is halogen, cyano, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-haloalkylsulfanyl, C3-C8-cycloalkylsulfanyl, C3-C8-cycloalkyl, aromatic C6-C 14 - independently selected from the group consisting of carbocycle, aromatic 5- or 6-membered monocyclic heterocycle, and non-aromatic 3- to 7-membered monocyclic heterocycle; cyclic R 6S Substituent or R 6S the cyclic portion of the substituent is optionally substituted with 1 to 3 substituents independently selected from the group consisting of halogen, C1-C6-alkyl, C1-C6-haloalkyl and C1-C6-alkoxycarbonyl; R 7 is hydrogen, halogen, cyano, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C1-C6-alkylcarbonyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C1-C6-alkylsulfanyl, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-haloalkylsulfonyl, C3-C8-cycloalkyl, aromatic 5- or 6-membered monocyclic heterocycle, non-aromatic 3- to 7-membered monocyclic heterocycle and -N(R e )2, R e are independently selected from the group consisting of hydrogen, C1-C6-alkyl, C1-C6-haloalkyl and C3-C8-cycloalkyl, aliphatic R 7 and R e The substituents are cyano, hydroxyl, C1-C6-alkoxy, C3-C8-cycloalkyl, C1-C6-alkoxycarbonyl and aromatic C6-C 14 - 1 to 3 R independently selected from the group consisting of carbocycles 7Saand optionally substituted by cyclic R 7 Substituent or R 7 The cyclic moiety of the substituent and the cyclic R e is 1 to 3 R independently selected from the group consisting of halogen, hydroxyl, C1-C6-alkyl and C1-C6-alkoxy 7Sc may be substituted by a substituent, R 8 is hydrogen, halogen, hydroxyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, C3-C8-cycloalkyl, aromatic C6-C 14 -carbocycle, non-aromatic 3- to 14-membered heterocycle, aromatic 5- to 14-membered heterocycle, C3-C8-cycloalkyloxy, non-aromatic 3- to 14-membered heterocyclyloxy and -N(R h )2, R h is hydrogen, C1-C6-alkyl, C2-C6-alkenyl, C3-C8-cycloalkyl, aromatic C6-C 14 - independently selected from the group consisting of carbocycles and non-aromatic 3- to 7-membered monocyclic heterocycles; aliphatic R 8 and R h The substituents are hydroxyl, carboxyl, C1-C6-alkoxy, C1-C6-alkoxy-C1-C6-alkoxy, C1-C6-alkoxycarbonyl, C3-C8-cycloalkyl, -O-Si(C1-C6-alkyl)3, non-aromatic 3- to 7-membered monocyclic heterocycle and -N(R a’ ) 1 to 3 R independently selected from the group consisting of 8Sa may be substituted by a substituent, R a’ is independently selected from the group consisting of hydrogen, formyl, C1-C6-alkyl and C1-C6-alkylcarbonyl, cyclic R 8 Substituent or R 8The cyclic moiety of the substituent and the cyclic R h The substituents are 1 to 3 R independently selected from the group consisting of halogen, cyano, hydroxyl, oxo, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-alkoxycarbonyl, C3-C8-cycloalkyl and non-aromatic 3- to 7-membered monocyclic heterocycle. 8Sc may be substituted by a substituent, or two R 8Sc the substituents, together with the carbon atoms to which they are attached, form a non-aromatic 3- to 7-membered monocyclic heterocycle; Q is a C7-C aryl fused with phenyl, naphthyl, C3-C8-cycloalkyl. 12 Bicyclic systems, C7-C comprising aryl fused with C3-C8-cycloalkenyl 12 from the group consisting of bicyclic systems, non-aromatic bicyclic heterocycles comprising a 4- to 6-membered monocyclic non-aromatic heterocycle fused with an aryl, non-aromatic bicyclic heterocycles comprising a 5- or 6-membered monocyclic heteroaryl fused with a monocyclic C3-C8-cycloalkyl, aromatic 5- or 6-membered monocyclic heterocycles, aromatic 9- or 10-membered bicyclic heterocycles comprising an aromatic 5- or 6-membered monocyclic heterocycle fused with an aryl (phenyl), and 9- or 10-membered aromatic bicyclic heterocycles comprising two fused aromatic 5- or 6-membered monocyclic heterocycles. and either said carbocyclic or heterocyclic group is selected from halogen, cyano, nitro, hydroxyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkylcarbonyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkoxy-C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C3-C8-cycloalkyl, non-aromatic 3- to 7-membered monocyclic heterocycle and -N(R k ) 1 to 4 Q independently selected from the group consisting of S and optionally substituted by R k is hydrogen, cyclic Q s Substituent or Q sThe cyclic portion of the substituent is selected from the group consisting of 1 to 3 R Qs It may be substituted with a substituent.

[0237] In a more preferred embodiment, the compound according to the invention is a compound of formula (I), wherein: T is O; n is 0 or 1; m is 0 or 1; provided that when n is 1, then m is 1; R 1 is hydrogen, hydroxyl, C1-C6-alkyl and -C(=O)(OR a1 ), and R a1 is selected from the group consisting of C1-C4-alkyl and C2-C4-alkenyl, R 2 and R 3 is hydrogen or R 2 and R 3 together with the carbon atoms to which they are attached form a C3-C6-cycloalkyl, R 4 and R 5 are independently selected from the group consisting of hydrogen, fluorine, chlorine and C1-C4-alkyl, or R 4 and R 5 together with the carbon atoms to which they are attached form a C3-C6-cycloalkyl; or R 2 and R 4 together with the carbon atom to which they are attached form a C3-C6-cycloalkyl, and R 3 and R 5 are independently hydrogen or halogen; or R 6is selected from the group consisting of indanyl, 1,2,3,4-tetrahydronaphthalenyl, spiro[cyclopropane-1,2'-indan]-1-yl, phenyl, naphthyl, a 4- to 6-membered monocyclic non-aromatic heterocycle fused with phenyl, a 5- or 6-membered monocyclic heteroaryl fused with a monocyclic C3-C8-cycloalkyl, an aromatic 5- or 6-membered monocyclic heterocycle, a 5- or 6-membered monocyclic aromatic heterocycle fused with an aryl, phenoxy, benzyloxy or -OCF2-phenyl; and the cyclic R 6 Substituent or R 6 the cyclic moiety of the substituents is selected from the group consisting of fluorine, chlorine, cyano, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C2-C6-alkenyl, C2-C6-alkynyl, C1-C4-haloalkylsulfanyl, C3-C6-cycloalkyl, phenyl, pyridyl, pyrazolyl, imidazolyl, triazolyl, oxetanyl and tetrahydrofuranyl; cyclic R 6S Substituent or R 6S the cyclic portion of the substituent is optionally substituted with 1 to 3 substituents independently selected from the group consisting of fluorine, chlorine, C1-C4-alkyl, C1-C4-haloalkyl and C1-C4-alkoxycarbonyl; R 7 is hydrogen, chlorine, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-hydroxyalkyl, C1-C4-alkylcarbonyl, C1-C4-alkoxy, C2-C6-alkenyl, C2-C6-alkynyl, C3-C6-cycloalkyl, pyridinyl, imidazolyl, pyrazolyl, oxetanyl, tetrahydrofuranyl, tetrahydropyranyl, pyrrolidinyl, azetidinyl and -N(R e )2, R e are independently selected from the group consisting of hydrogen, C1-C4-alkyl and C3-C6-cycloalkyl, aliphatic R 7 and R eThe substituents are one or two R independently selected from the group consisting of C1-C4-alkoxy, C3-C6-cycloalkyl, C1-C2-alkoxycarbonyl and phenyl. 7Sa may be substituted by a substituent, cyclic R 7 Substituent or R 7 The cyclic moiety of the substituent and the cyclic R e is one or two R independently selected from the group consisting of fluorine, chlorine, hydroxyl, C1-C4-alkyl and C1-C4-alkoxy; 7Sc may be substituted by a substituent, R 8 is hydrogen, halogen, hydroxyl, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C2-C6-alkenyl, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C1-C4-alkylsulfanyl, C1-C4-haloalkylsulfanyl, C1-C4-alkylsulfinyl, C1-C4-alkylsulfonyl, C3-C6-cycloalkyl, phenyl, non-aromatic 3- to 7-membered heterocycle, aromatic 5- or 6-membered heterocycle, non-aromatic 3- to 7-membered heterocyclyloxy and -N(R h )2, R h are independently selected from the group consisting of hydrogen, C1-C4-alkyl, C2-C6-alkenyl, C3-C6-cycloalkyl, phenyl and non-aromatic 3- to 7-membered monocyclic heterocycles; aliphatic R 8 and R h The substituents are hydroxyl, carboxyl, C1-C4-alkoxy, C1-C4-alkoxy-C1-C4-alkoxy, C1-C4-alkoxycarbonyl, C3-C6-cycloalkyl, non-aromatic 3- to 7-membered monocyclic heterocycle and -N(R a’ ) 1 to 3 R independently selected from the group consisting of 8Sa may be substituted by a substituent, R a’ are independently selected from the group consisting of hydrogen, C1-C4-alkyl and C1-C2-alkylcarbonyl, cyclic R 8 Substituent or R8 The cyclic moiety of the substituent and the cyclic R h The substituents are 1 to 3 R independently selected from the group consisting of chlorine, cyano, hydroxyl, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-alkoxycarbonyl, C3-C6-cycloalkyl, oxolanyl, oxetanyl and tetrahydrofuranyl. 8Sc may be substituted by a substituent, or two R 8Sc the substituents, together with the carbon atoms to which they are attached, form an oxetanyl or oxiranyl group; Q is phenyl, naphth-2-yl, bicyclo[4.2.0]octa-1(6),2,4-trienyl, indanyl, 1,2,3,4-tetrahydronaphthalenyl, indenyl, dihydronaphthalenyl, bicyclo[4.2.0]octa-1(6),2,4-trienyl, 2,3-dihydrobenzofuranyl, 1,3-dihydroisobenzofuranyl, indolinyl, 1,3-benzodioxolyl, chromanyl, 2,3-dihydro-1,4-benzodioxinyl, [1,3]dioxolo[4,5-b]pyridinyl, 5,6,7,8-tetrahydroquinolinyl, selected from the group consisting of 6,7-dihydro-5H-cyclopenta[b]pyridinyl, 1,3-benzodioxolyl, 2,3-dihydrobenzofuranyl, pyrrolyl, furanyl, thienyl, imidazolyl, triazolyl, oxazolyl, thiazolyl, pyridinyl, pyridazinyl and pyrimidinyl, indolyl, benzimidazolyl, indazolyl, benzofuranyl, benzothiophenyl, benzothiazolyl, benzoxazolyl, quinolinyl, furo[3,2-b]pyridinyl, thieno[3,2-b]thiophenyl and thieno[2,3-d]thiazolyl; Any of the carbocyclic or heterocyclic groups may be selected from halogen, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C2-C4-alkenyl, C2-C4-alkynyl, C1-C4-alkylsulfanyl, C1-C4-haloalkylsulfanyl, C3-C6-cycloalkyl, oxiranyl, oxetanyl and -N(R k ) 1 to 3 Q independently selected from the group consisting ofS may be substituted by a substituent, R k is hydrogen, cyclic Q s Substituent or Q s The cyclic portion of the substituent may contain one or two R independently selected from the group consisting of fluorine and chlorine. Qs It may be substituted with a substituent.

[0238] In an even more preferred embodiment, the compound according to the invention is a compound of formula (I), wherein T is O; R 1 is hydrogen; R 2 and R 3 is hydrogen, if present (i.e., n=1), or R 2 and R 3 together with the carbon atom to which they are attached form cyclopropyl or cyclobutyl, R 4 and R 5 are independently selected from the group consisting of hydrogen and halogen, when present (i.e., m=1); R 6 is indanyl, 1,2,3,4-tetrahydronaphthalenyl, spiro[cyclopropane-1,2'-indan]-1-yl, phenyl, 2,3-dihydrobenzofuranyl, 1,3-benzodioxolyl, 2,3-dihydro-1,4-benzodioxinyl, 4,5,6,7-tetrahydrobenzothiophenyl, thienyl, pyridinyl, indolyl, benzoxazolyl, quinolinyl or isoquinolinyl, wherein the indanyl, 1,2,3,4-tetrahydronaphthalenyl, spiro[cyclopropane-1,2'-indan]-1-yl, phenyl, 2,3-dihydrobenzofuranyl, 1,3-benzodioxolyl, 2,3-dihydro-1,4-benzodioxinyl, 4,5,6,7-tetrahydrobenzothiophenyl, thienyl, pyridinyl, indolyl, benzoxazolyl, quinolinyl or isoquinolinyl is selected from the group consisting of halogen, cyano, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyl, C2-C6-alkynyl, cyclopropyl 6S may be substituted by a substituent, R 7 is hydrogen, halogen, cyano, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-hydroxyalkyl, C1-C4-alkylcarbonyl, C1-C4-alkoxy, C2-C6-alkenyl, C2-C6-alkynyl or cyclopropyl, aliphatic R 7 is one or two R 7Sa optionally substituted by the substituent methoxy; R 8 is hydrogen, halogen, C1-C4-alkyl, C1-C4-alkoxy, C2-C4-alkenyl, C1-C4-alkylsulfanyl, pyrazolyl, imidazolyl, thiazolyl, pyridinyl or -N(R h )2, R h are independently selected from the group consisting of hydrogen, C1-C4-alkyl and cyclopropyl; The aliphatic R 8 The substituents are one or two R independently selected from the group consisting of C-C-haloalkyl, C-C-alkoxy, C-C-alkoxy-C-C-alkoxy, cyclopropyl and cyclobutyl. 8Sa may be substituted by a substituent, The cyclic R 8 The substituents are one or two R independently selected from the group consisting of halogen. 8Scmay be substituted by a substituent, Q is phenyl, thienyl or pyridinyl; The phenyl, thienyl and pyridinyl are each independently selected from the group consisting of halogen, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C2-C4-alkenyl, C2-C4-alkynyl, C1-C4-alkylsulfanyl, C1-C4-haloalkylsulfanyl, cyclopropyl, cyclobutyl, oxiranyl and oxetanyl. S It may be substituted by a substituent.

[0239] In some embodiments, the compound according to the invention is a compound of formula (I) according to embodiment 1, 2, 3, or 4, wherein n is 0 and m is 1.

[0240] In some embodiments, the compound according to the invention is a compound of formula (I) according to embodiment 1, 2, 3 or 4, wherein n is 0 and m is 0.

[0241] In some embodiments, the compound according to the invention is a compound of formula (I) according to embodiment 1, 2, 3, or 4, wherein n is 1 and m is 1.

[0242] In some embodiments, the compounds described herein can be any of the compounds according to embodiment 1, 2, 3, or 4, wherein Q, as described herein, can be the same or different, and wherein one or more Q, as described herein, can be any of the compounds according to embodiment 1, 2, 3, or 4. S A compound of formula (I) substituted by a substituent.

[0243] In some embodiments, the compounds described herein are compounds according to embodiment 1, 2, 3, or 4, wherein R 6 may be the same or different and may be one or more of the R 6S A compound of formula (I) substituted by a substituent.

[0244] In embodiments 2, 3 and 4, R 1 is hydrogen, hydroxyl and -C(=O)(OR a1 ), and R a1 is a hydrogen atom, a C1-C6 alkyl or a C2-C6 alkenyl. 1 Non-limiting examples of "R 1 R disclosed in the " column 1 Preferably, R 1 is hydrogen.

[0245] In embodiments 2, 3 and 4, R 2 and R 3 When present (i.e., n=1), may be independently selected from the group consisting of hydrogen, cyano, C1-C6-alkyl (e.g., methyl) and C1-C6-alkoxycarbonyl (e.g., methoxycarbonyl), or R 2 and R 3 together with the carbon atom to which they are attached form a C3-C8-cycloalkyl (e.g., cyclopropyl). Preferably, R 2 and R 3 are, if present, both hydrogen or R 2 and R 3 together with the carbon atom to which they are attached form a C3-C8-cycloalkyl (eg cyclopropyl).

[0246] In embodiments 2, 3 and 4, R 4 and R 5 When present (i.e., m=1), may be independently selected from the group consisting of hydrogen, halogen, hydroxyl, and C1-C6-alkyl (e.g., methyl), or R 4 and R 5 together with the carbon atoms to which they are attached form a C3-C8-cycloalkyl (e.g., cyclopropyl) or a non-aromatic 3- to 7-membered monocyclic heterocycle (e.g., a non-aromatic 3- to 7-membered saturated monocyclic heterocycle, e.g., oxetanyl). Preferably, R 4 and R 5are, when present, independently selected from the group consisting of hydrogen, halogen (e.g., fluorine) and C1-C6-alkyl (e.g., methyl), or R 4 and R 5 together with the carbon atom to which they are attached form a C3-C8-cycloalkyl (eg cyclopropyl).

[0247] In embodiments 2, 3 and 4, R 2 and R 4 together with the carbon atom to which they are attached form a C3-C8-cycloalkyl, R 2 and R 4 preferably forms a cyclopropyl, R 3 and R 5 is independently hydrogen or halogen (e.g., fluorine).

[0248] In some embodiments, the compound according to the present invention is a compound of formula (I) according to embodiment 1, 2, 3, or 4, wherein when n=1 and m=1, R 2 and R 3 are both hydrogen, or both C1-C6-alkyl (e.g., methyl), or R 2 is hydrogen and R 3 is C1-C6-alkoxycarbonyl (e.g., methoxycarbonyl), or R 2 and R 3 together with the carbon atoms to which they are attached form a C3-C8-cycloalkyl (e.g. cyclopropyl),

[0249] R 4 and R 5 are both hydrogen or both halogen (e.g., fluorine), or R 4 is hydrogen and R 5 is a halogen (e.g., fluorine), or R 4 and R 5 together with the carbon atom to which they are attached form a C3-C8-cycloalkyl (e.g. cyclopropyl), or

[0250] R 2 and R 4 together with the carbon atoms to which they are attached form a C3-C8-cycloalkyl (e.g., cyclopropyl), and R 3 and R 5 are independently hydrogen or halogen (e.g., fluorine).

[0251] In some embodiments, the compound according to the present invention is a compound of formula (I) according to embodiment 1, 2, 3, or 4, wherein when n=0 and m=1, R 4 and R 5 are both hydrogen, or both C1-C6-alkyl (e.g., methyl), or R 4 is hydrogen and R 5 is C1-C6-alkyl (e.g., methyl), or R 4 and R 5 forms a non-aromatic 3- to 7-membered monocyclic heterocycle (eg, a non-aromatic 3- to 7-membered saturated monocyclic heterocycle, eg, oxetanyl).

[0252] In some embodiments, the compound according to the present invention is a compound of formula (I) according to embodiment 1, 2, 3, or 4, wherein when n=0 and m=0, R 6 is a non-aromatic C3-C 12 -Carbocyclic ring (preferably C7-C 12 Bicyclic systems, more preferably C7-C comprising aryl fused with C3-C8-cycloalkyl. 12 bicyclic systems), non-aromatic 3- to 14-membered heterocycles (preferably non-aromatic bicyclic heterocycles comprising a 4- to 6-membered monocyclic non-aromatic heterocycle fused with an aryl or a 5- or 6-membered monocyclic heteroaryl fused with a monocyclic C3-C8-cycloalkyl), aromatic C6-C 14 -C1-C3-alkoxy and aromatic C6-C substituted by carbocyclic rings 14 -C1-C3-haloalkoxy substituted by a carbocycle, preferably R6 is selected from the group consisting of indanyl, 1,2,3,4-tetrahydronaphthalenyl, spiro[cyclopropane-1,2'-indan]-1-yl, 2,3-dihydrobenzofuranyl, chromanyl, isochromanyl, thiochromanyl, 5,6,7,8-tetrahydroquinolinyl, 4,5,6,7-tetrahydrobenzothiophenyl, benzyloxy, and -OCF2-phenyl.

[0253] In some embodiments, the compound according to the present invention is a compound of formula (I) according to embodiment 1, 2, 3, or 4, wherein when n=0 and m=1, R 6 is a non-aromatic C3-C 12 -Carbocyclic ring (preferably C7-C 12 Bicyclic systems, more preferably C7-C comprising aryl fused with C3-C8-cycloalkyl. 12 bicyclic system), aromatic C6~C 14 -carbocycle, non-aromatic 3- to 14-membered heterocycle (preferably a non-aromatic bicyclic heterocycle comprising a 4- to 6-membered monocyclic non-aromatic heterocycle fused with an aryl), aromatic 5- to 14-membered heterocycle (preferably a 9- or 10-membered aromatic bicyclic heterocycle comprising a 5- or 6-membered monocyclic aromatic heterocycle fused with an aryl or a 9- or 10-membered aromatic bicyclic heterocycle comprising two fused 5- or 6-membered monocyclic aromatic heterocycles), aromatic C6-C 14 -Carbocyclyloxy, aromatic C6-C 14 -C1-C3-alkoxy and aromatic C6-C substituted by carbocyclic rings 14 -C1-C3-haloalkoxy substituted by a carbocycle, preferably R 6 is selected from the group consisting of indanyl, 1,2,3,4-tetrahydronaphthalenyl, phenyl, naphthyl, 2,3-dihydrobenzofuranyl, indolinyl, 1,3-benzodioxolyl, chromanyl, indolyl, quinolinyl, isoquinolinyl, imidazo[1,2-a]pyridinyl, phenoxy, benzyloxy, and -OCF2-phenyl.

[0254] In some embodiments, the compound according to the present invention is a compound of formula (I) according to embodiment 1, 2, 3, or 4, wherein when n=1 and m=1, R 6 is an aromatic C6-C 14 -carbocycle, non-aromatic 3- to 14-membered heterocycle (preferably a non-aromatic bicyclic heterocycle comprising a 4- to 6-membered monocyclic non-aromatic bicyclic heterocycle fused with an aryl), aromatic 5- to 14-membered heterocycle (preferably a 5- or 6-membered monocyclic aromatic heterocycle or a 9- or 10-membered aromatic bicyclic heterocycle comprising a 5- or 6-membered monocyclic aromatic heterocycle fused with an aryl), aromatic C6-C 14 -Carbocyclyloxy, aromatic C6-C 14 -Carbocyclic substituted C1-C3-alkoxy and aromatic C6-C 14 -C1-C3-haloalkoxy substituted by a carbocycle, preferably R 6 is selected from the group consisting of phenyl, 2,3-dihydrobenzofuranyl, 1,3-benzodioxolyl, 2,3-dihydro-1,4-benzodioxinyl, furanyl, thienyl, pyridinyl, pyrimidinyl, benzofuranyl, 1,3-benzoxazolyl, phenoxy, benzyloxy, and -OCF2-phenyl.

[0255] In some embodiments, the compound according to the invention is a compound of formula (I) according to embodiment 1, 2, 3, or 4, wherein T is O.

[0256] In some embodiments, the compound according to the invention is a compound of formula (I) according to embodiment 1, 2, 3 or 4, wherein T is S.

[0257] The present invention relates to any compound of formula (I) disclosed in Table 1.

[0258] The compounds of formula (I) may be used as fungicides (for the control of plant pathogenic fungi), in particular in methods for controlling plant pathogenic fungi which comprise spraying one or more compounds of formula (I) on plants.

[0259] Methods for preparing compounds of formula (I) and intermediates The present invention relates to a process for preparing compounds of formula (I) and intermediates thereof. Unless otherwise indicated, radicals Q, T, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , m and n have the meanings given above for compounds of formula (I). These definitions apply not only to the final product of formula (I) but also to all intermediates.

[0260] The compounds of formulae (Ia) through (Ig) are various subsets of formula (I). The compounds of formulae (Ia-1) through (Ia-8) are various subsets of formula (Ia). All substituents for formulae (Ia) through (Ig) and (Ia-1) through (Ia-8) are as defined above for formula (I) unless otherwise stated.

[0261] Compounds of general formula (I) can be prepared by various routes, similarly to known methods (see, for example, the references thereto). Non-limiting examples of suitable methods are described herein.

[0262] A compound of formula (I) may be obtained directly by carrying out Method A or B, or by conversion or derivatization of another compound of formula (I) prepared according to the methods described herein. For example, a compound of formula (I) can be converted to another compound of formula (I) by replacing one or more substituents of the starting compound of formula (I) with other substituents. Non-limiting examples of such conversions or derivatizations are described below (Methods C-H).

[0263] The methods described herein may be suitably carried out using one or more inert organic solvents customary for the reactions under consideration. Suitable inert organic solvents may be selected from the following: aliphatic, alicyclic or aromatic hydrocarbons (e.g., petroleum ether, pentane, hexane, heptane, cyclohexane, methylcyclohexane, ligroin, benzene, toluene, xylene or decalin), halogenated aliphatic, alicyclic or aromatic hydrocarbons (e.g., chlorobenzene, dichlorobenzene, dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane or trichloroethane), ethers (e.g., diethyl ether, diisopropyl ether, methyl t-butyl ether, methyl t-amyl ether, dioxane, tetrahydrofuran, 2-methyltetrahydrofuran, 1,2-dimethoxyethane, 1,2-diethoxyethane or anisole), ketones (e.g., acetone, methyl ethyl ketone ... methyl isopropyl ketone and methyl isobutyl ketone), esters (e.g., methyl acetate, ethyl acetate, or butyl acetate), alcohols (e.g., methanol, ethanol, propanol, isopropanol, butanol, tert-butanol), nitriles (e.g., acetonitrile, propionitrile, n- or i-butyronitrile, or benzonitrile), amides (e.g., N,N-dimethylformamide, N,N-dimethylacetamide, N-methylformanilide, N-methylpyrrolidone, or hexamethylphosphoric triamide), sulfoxides (e.g., dimethyl sulfoxide) or sulfones (e.g., sulfolane), ureas (e.g., 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone), or mixtures of any of these.

[0264] Some of the processes described herein may require or be carried out using one or more inorganic or organic bases customary for such reactions. Examples of suitable inorganic and organic bases include alkaline earth or alkali metal carbonates (e.g., sodium carbonate, potassium carbonate, potassium bicarbonate, sodium bicarbonate, or cesium carbonate), alkali metal hydrides (e.g., sodium hydride), alkaline earth or alkali metal hydroxides (e.g., sodium hydroxide, calcium hydroxide, potassium hydroxide, or other ammonium hydroxide derivatives), alkaline earth or alkali metal fluorides (e.g., potassium fluoride, cesium fluoride, or tetrabutylammonium fluoride), alkaline earth or alkali metal acetates (e.g., sodium acetate, lithium acetate, potassium acetate, or calcium acetate), alkali metal fluorides (e.g., potassium fluoride, cesium fluoride, or tetrabutylammonium fluoride), alkali ... Examples of suitable bases include, but are not limited to, potassium metal alcoholates (e.g., potassium tert-butoxide or sodium tert-butoxide), alkali metal phosphates (e.g., tripotassium phosphate), tertiary amines (e.g., trimethylamine, triethylamine, tributylamine, N,N-dimethylamine, N,N-dicyclohexylmethylamine, N,N-diisopropylethylamine, N-methylpiperidine, N,N-dimethylaminopyridine, diazabicyclooctane (DABCO), diazabicyclononane (DBN), diazabicycloundecane (DBU), quinuclidine, 3-acetoxyquinuclidine), guanidines, or aromatic bases (e.g., pyridines, picolines, lutidines, or collidines).

[0265] Some of the processes described herein may be carried out in the presence of a transition metal catalyst, such as a metal (eg, copper or palladium) salt or complex in the presence of a ligand, where appropriate.

[0266] Suitable copper salts or complexes and hydrates thereof include, but are not limited to, copper metal, copper(I) iodide, copper(I) chloride, copper(I) bromide, copper(II) chloride, copper(II) bromide, copper(II) oxide, copper(I) oxide, copper(II) acetate, copper(I) acetate, copper(II) thiophene-2-carboxylate, copper(I) cyanide, copper(II) sulfate, copper(II) bis(2,2,6,6-tetramethyl-3,5-heptanedioate), copper(II) trifluoromethanesulfonate, copper(I) tetraoxy(acetonitrile)hexafluorophosphate, copper(I) tetraoxy(acetonitrile)tetrafluoroborate.

[0267] Copper salts and ligands or salts, for example, ethylenediamine, N,N-dimethylethylenediamine, N,N'-dimethylethylenediamine, rac-trans-1,2-diaminocyclohexane, rac-trans-N,N'-dimethylcyclohexane-1,2-diamine, 1,1'-binaphthyl-2,2'-diamine, N,N,N',N'-tetramethylethylenediamine, proline, N,N-dimethylglycine, quinolin-8-ol, ethanol, pyridine, 2-aminopyridine, 4-(dimethylamino)pyridine, 2,2'-bipyridyl, 2,6-di(2-pyridyl)pyridine, 2-picolinic acid, 2-(dimethylaminomethyl)-3-hydroxypyridine, 1,10-phenanthroline, 3,4,7,8-tetramethyl-1,10-phenanthroline, 2,9-dimethyl-1,10-phenanthroline, 4,7-dimethoxy-1,10-phenanthroline, N,N'-bis[ It is also possible to generate the appropriate copper complex in situ in the reaction mixture by separate addition to reactants such as [(E)-pyridin-2-ylmethylidene]cyclohexane-1,2-diamine, N-[(E)-phenylmethylidene], N-[(E)-phenylmethylidene]-cyclohexanamine, 1,1,1-tris(hydroxymethyl)ethane, ethylene glycol, 2,2,6,6-tetramethylheptane-3,5-dione, 2-(2,2-dimethylpropanoyl)cyclohexanone, acetylacetone, dibenzoylmethane, 2-(2-methylpropanoyl)cyclohexanone, biphenyl-2-yl(di-tert-butyl)phosphane, ethylene bis-(diphenylphosphine), N,N-diethylsalicylamide, 2-hydroxybenzaldehyde oxime, oxo[(2,4,6-trimethylphenyl)amino]acetic acid or 1H-pyrrole-2-carboxylic acid.

[0268] Suitable palladium salts or complexes include, but are not limited to, palladium chloride, palladium acetate, tetrakis(triphenylphosphine)palladium(0), bis(dibenzylideneacetone)palladium(0), tris(dibenzylideneacetone)dipalladium(0), bis(triphenylphosphine)palladium(II) dichloride, [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II), bis(cinnamyl)dichlorodipalladium(II), bis(allyl)-dichlorodipalladium(II) or [1,1′-bis(di-tert-butylphosphino)ferrocene]dichloropalladium(II).

[0269] Palladium salts and ligands or salts, for example, triethylphosphine, tri-tert-butylphosphine, tri-tert-butylphosphonium tetrafluoroborate, tricyclohexylphosphine, 2-(dicyclohexylphosphino)biphenyl, 2-(di-tert-butylphosphino)biphenyl, 2-(dicyclohexylphosphino)-2'-(N,N-dimethylamino)biphenyl, 2-(tert-butylphosphino)-2'-(N,N-dimethylamino)biphenyl, (ethylamino)biphenyl, 2-di-tert-butylphosphino-2',4',6'-triisopropylbiphenyl, 2-dicyclohexylphosphino-2',4',6'-triisopropylbiphenyl, 2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl, 2-dicyclohexylphosphino-2',6'-diisopropoxybiphenyl, triphenylphosphine, tris-(o-tolyl)phosphine, 3-(diphenylphosphino)benzenes Sodium sulfonate, tris-(2-methoxy-phenyl)phosphine, 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl, 1,4-bis(diphenylphosphino)butane, 1,2-bis(diphenylphosphino)ethane, 1,4-bis(dicyclohexylphosphino)butane, 1,2-bis(dicyclohexylphosphino)-ethane, 2-(dicyclohexylphosphino)-2'-(N,N-dimethylamino)-biphenyl, 1,1'-bis(di It is also possible to form palladium complexes in the reaction mixture by separate addition to reactants such as (R)-(-)-1-[(S)-2-diphenylphosphino)ferrocene, (R)-(-)-1-[(S)-2-diphenylphosphino)ferrocenyl]ethyldicyclohexylphosphine, tris-(2,4-tert-butyl-phenyl)phosphite, di(1-adamantyl)-2-morpholinophenylphosphine or 1,3-bis(2,4,6-trimethylphenyl)imidazolium chloride.

[0270] Suitable catalysts and / or ligands may be selected from commercial catalogs or reviews such as "Metal Catalysts for Organic Synthesis" by Strem Chemicals (Chemical Society Reviews (2014), 43, 3525, Coordination Chemistry Reviews (2004), 248, 2337 and references therein).

[0271] Some of the methods described herein may be modified in accordance with the literature (Nature chemistry review, (2017) 0052 and references therein; Science (2016) 352, 6291, 1304; Org. Lett. 2016, 18, 4012, J. Org. Chem 2016, 81, 6898; J. Am. Chem. Soc. 2016, 138, 12715, J. Am. Chem. Soc. 2016, 138, 13862; J. Am. Chem. Soc. 2016, 138, 8034; J. Org. Chem. 2016, 81, 12525, J. Org. Chem. 2015, 80, This reaction may be carried out by metal photoredox catalysis according to the method reported in [Publication ID No. 7642]. The process is then carried out in the presence of a photosensitizer or organic dye, such as Ir and Ru complexes, and a metal catalyst, such as a Ni complex. The reaction can be carried out in the presence of a ligand, if appropriate, under irradiation with blue or white light, and in the presence of a base.

[0272] Suitable photosensitizers include [Ir(dFCF3ppy)2(bpy)]PF6 (dFCF3ppy = 2-(2,4-difluorophenyl)-5-trifluoromethylpyridine, bpy = 2,2'-bipyridine), [Ir(dFCF3ppy)2(dtbbpy)]PF6 (dtbbpy = 4,4'-di-tert-butyl-2,2'-bipyridine), Ir(ppy)2(dtbbpy)PF6 (ppy = 2-phenylpyridine), Ir(ppy)2(bpy)PF6, Ir(dFppy)3PF6 (dFCF3ppy = 2-(2,4-difluorophenyl)pyridine), fac-Ir(ppy)3, (Ir[diF(5-Me)ppy ]2(tetraMePhen)PF6 (diF(5-Me)ppy = 2-(2,4-difluorophenyl)-5-methylpyridine, tetraMePhen = 3,4,7,8-tetramethyl-1,10-phenanthroline), organic dyes such as Ru(bpy)3Cl2 or Ru(bpy)3(PF6)2 or 9-mesityl-10-acridinium, salts such as perchlorates or tetrafluoroborates, or 2,4,5,6-tetra-9H-carbazol-9-yl-1,3-benzenedicarbonitrile, 9-fluorenone, and 9,10-phenanthrenequinone.

[0273] Suitable nickel catalysts include, but are not limited to, their anhydrides or hydrates, or dimethoxyethane complexes such as bis(1,5-cyclooctadiene)nickel(0), nickel(II) chloride, nickel(II) bromide, nickel(II) iodide, nickel(II) acetylacetonate, and nickel(II) nitrate hexahydrate. These nickel catalysts can be used in combination with bipyridine ligands such as 2,2'-bipyridine, 4,4'-di-tert-butyl-2,2'-bipyridine, 4,4'-dimethoxy-2,2'-bipyridine, and 4,4'-dimethyl-2,2'-bipyridine, or phenanthrolines such as 1,10-phenanthroline, 4,7-dimethyl-1,10-phenanthroline, and 4,7-dimethoxy-1,10-phenanthroline, or diamines such as N,N,N',N'-tetramethylethylenediamine, or diones such as tetramethylheptanedione.

[0274] The processes described herein may be carried out at temperatures ranging from -105°C to 250°C, preferably from -78°C to 185°C.

[0275] The reaction time varies depending on the scale of the reaction and the reaction temperature, but is generally from a few minutes to 48 hours.

[0276] The processes described herein are generally carried out under standard pressure, however, they can also be carried out under elevated or reduced pressure.

[0277] In the processes described herein, the starting materials are generally used in approximately equimolar amounts, although it is also possible to use one of the starting materials in a relatively large excess.

[0278] Methods for preparing compounds of formula (I) Method A Formula (Ia) (i.e., where T is O and R 1Compounds of formula (I)), wherein R is hydrogen, hydroxyl, cyano, C1-C6-alkyl or C1-C6-alkoxy, can be prepared by a process comprising the step of reacting a compound of formula (1) with an amine of formula (2) or a salt thereof, as shown in Scheme 1.

[0279] [ka] U 1 = hydroxyl, halogen, C1-C6-alkoxy, R 1 = hydrogen, hydroxyl, cyano, C1-C6-alkyl, C1-C6-alkoxy, -C(=O)R a1 , -C(=O)(OR a1 ), -S(=O)R a1 , -S(=O)2R a1 , -C(=O)N(R a2 )2 and S(=O)2N(R a2 )2 and R a1 and R a2 is as described herein.

[0280] In the formula, U 1Compounds of formula (1), in which is a hydroxyl group, can be reacted with amines of formula (2) in the presence of a condensing reagent by methods described in the literature (e.g., Tetrahedron 2005, 61, 10827-10852). Examples of suitable condensing reagents include halogenating agents (e.g., phosgene, phosphorus tribromide, phosphorus trichloride, phosphorus pentachloride, phosphorus trichloride oxide, oxalyl chloride, or thionyl chloride), dehydrating agents (e.g., ethyl chloroformate, methyl chloroformate, isopropyl chloroformate, isobutyl chloroformate, or methanesulfonyl chloride), carbodiimides (e.g., N,N'-dicyclohexylcarbodiimide (DCC)) or other customary condensation (or peptide coupling) reagents (e.g., phosphorus pentoxide, polyphosphoric acid, bis(2-oxo-3-oxazolidinyl)phosphinic chloride, , 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate (HATU), 2-ethoxy-N-ethoxycarbonyl-1,2-dihydroquinoline (EEDQ), triphenylphosphine / tetrachloro-methane, 4-(4,6-dimethoxy[1.3.5]-triazin-2-yl)-4-methylmorpholinium chloride hydrate, bromo-tripyrrolidinophosphonium hexafluorophosphate or propanephosphonic anhydride (T3P).

[0281] In the formula, U 1 A compound of formula (1), in which is a halogen atom, can be reacted with an amine of formula (2) in the presence of an acid scavenger by well-known methods. Suitable acid scavengers include any of the inorganic and organic bases customary for such reactions and described herein. Alkali metal carbonates, alkaline earth metal acetates, tertiary amines, or aromatic bases are preferred.

[0282] In the formula, U 1 A compound of formula (1), wherein is a C1-C6-alkoxy group, can be reacted with an excess of an amine of formula (2), optionally in the presence of a Lewis acid such as trimethylaluminum.

[0283] Compounds of formula (1) may be prepared by one or more of the methods described herein (see Methods I, J and K).

[0284] Amines of formula (2) may be commercially available or may be prepared according to methods described in the literature (e.g., WO 2007 / 141009, WO 2013 / 064460, WO 2015 / 078800, WO 2016 / 066574, U.S. Patent Application Publication No. 2006 / 0116370, WO 2007 / 134799, WO 2014 / 177487, WO 2011 / 144338, EP 0807629).

[0285] Method B Formula (Ia-1) (i.e., where T is O and R 1 is hydrogen, cyano, hydroxyl, C1-C6-alkyl or C1-C6-alkoxy, and R 7 and R 8 is as defined in Scheme 2, a compound of formula (I) can be prepared by a process comprising reacting a compound of formula (3) with a compound of formula (4) in the presence of a base (e.g., an organic base or an inorganic base), as shown in Scheme 2.

[0286] [ka] G=halogen; R 1 = hydrogen, hydroxyl, cyano, C1-C6-alkyl, C1-C6-alkoxy, R 8 = hydrogen, C1-C6-alkyl, R 7= hydrogen, halogen, hydroxyl, mercapto, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C2-C6-alkynyloxy, C2-C6-haloalkynyloxy, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, C3-C8-cycloalkyloxy, aromatic C6-C 14 -carbocyclyloxy, aromatic 5- or 6-membered monocyclic heterocyclyloxy, non-aromatic 3- to 7-membered monocyclic heterocyclyloxy, -N(R e )2.

[0287] In Scheme 2, R e is as disclosed herein, and R 7 , R 8 and R e may be substituted as disclosed herein.

[0288] Process B may be carried out in the presence of a transition metal catalyst, such as a copper salt or complex, where appropriate in the presence of a ligand.

[0289] Compounds of formula (3) can be prepared by Method M described herein.

[0290] Compounds of formula (4) may be commercially available or may be obtained by conversion or derivatization of other compounds of formula (4) according to well-known methods.

[0291] Method C Formula (Ib) (i.e., where T is S and R 1 is hydrogen) to a compound of formula (1-a-2) (wherein T is O and R 1 is hydrogen, with a thionating agent.

[0292] [ka]

[0293] Suitable thione oxidizing agents for carrying out Method C include, but are not limited to, sulfur (S), sulfhydric acid (HS), sodium sulfide (NaS), sodium hydrosulfide (NaHS), boron trisulfide (BS), bis(diethylaluminum) sulfide ((AlEt)S), ammonium sulfide ((NH)S), phosphorus pentasulfide (PS), Lawesson's reagent (2,4-bis(4-methoxyphenyl)-1,2,3,4-dithiadiphosphetane 2,4-disulfide) or polymer-supported thione oxidizing reagents such as those described in Journal of the Chemical Society, Perkin 1 (2001), 358.

[0294] The process may be carried out in the presence of a catalyst or a base (inorganic and organic) in a stoichiometric or excess amount. Alkali metal carbonates (e.g., sodium carbonate, potassium carbonate, potassium bicarbonate, sodium bicarbonate), heterocyclic aromatic bases (e.g., pyridine, picoline, lutidine, collidine), and tertiary amines (e.g., trimethylamine, triethylamine, tributylamine, N,N-dimethylaniline, N,N-dimethylpyridin-4-amine, or N-methylpiperidine) are preferred.

[0295] Compounds of formula (Ia-2) can be prepared by one or more of the methods described herein.

[0296] Method D Formula (Ic) (i.e., where R 1 is -C(=O)R a1 , -C(=O)(OR a1 ) and R a1 is as described herein, to a compound of formula (1-a-2) (i.e., where T is O and R 1is hydrogen) or a compound of formula (Ib) (i.e., wherein T is S and R 1 is hydrogen) with a compound of formula (5).

[0297] [ka] W=hydrogen, -O-(C=O)R a1 , or -C(=O)(OR a1 ) and R a1 is selected from the group consisting of C1-C6-alkyl and C1-C6-haloalkyl, R 1 =-C(=O)R a1 , and -C(=O)(OR a1 ) and R a1 and R a2 is as described herein.

[0298] Method D can be carried out by methods described in the literature (e.g., Tetrahedron Lett. 1995, 36, 8949; Greene's Protective Groups in organic Synthesis; Peter GM Wuts; Wiley; Fifth Edition; 2014; 1174-1175).

[0299] The compound of formula (5) is commercially available.

[0300] Compounds of formula (Ia-2) or (Ib) can be prepared by one or more of the methods described herein.

[0301] Method E Formula (Ia-3) (i.e., in the formula, R 1 is H, T is O, and R 7 is shown in Scheme 5 7aCompounds of formula (I) (wherein R 1 is H, T is O, and R 7 is shown in Scheme 5 7b Formula (I)) or compound (1-a-5) (i.e., in which R 1 is H, T is O, and R 7 is shown in Scheme 5 7c can be converted to formula (I)

[0302] [ka] R 7a = hydrogen or halogen (preferably chlorine), R 7b = hydrogen, halogen, cyano, C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C3-C8-cycloalkylsulfanyl, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, aromatic C6-C 14 -carbocycle, aromatic 5- or 6-membered monocyclic heterocycle, non-aromatic 3- to 7-membered monocyclic heterocycle, -N(R e )2, -C(=O)(OR g ) and R 7c = nitro, formyl, C1-C6-alkylcarbonyl, C1-C6-haloalkylcarbonyl, C1-C6-hydroxyalkyl, C1-C6-fluoroalkyl, C1-C6-alkylsulfinyl, C1-C6-haloalkylsulfinyl, C3-C8-cycloalkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-haloalkylsulfonyl, C3-C8-cycloalkylsulfonyl, -C(=NR f )R f , -C(=O)N(R g )2, -S(=O)(=NRg )R g , -S(=O)2N(R g )2.

[0303] In Scheme 5, R e , R f , R g is as described herein, and the aliphatic and cyclic substituents R 7b , R 7c , R e , R f , R g may be substituted as disclosed herein.

[0304] Non-limiting examples of transformations performed according to Scheme 5 are shown below.

[0305] In the formula, R 7a The compound of formula (Ia-3) in which R is a chlorine atom can be prepared by the method described in the literature (e.g., WO 2016 / 185342, WO 2007 / 022937). 7b can be converted to a compound of formula (Ia-4) in which is a bromine or iodine atom.

[0306] In the formula, R 7a is a halogen atom, in the presence of a palladium catalyst as reported in the literature (Journal of Molecular Catalysis A: Chemical, 2014, 393, 191-209), 7b can be converted to a compound of formula (Ia-4) in which is a halogen atom.

[0307] In the formula, R 7a is a hydrogen atom or a halogen atom, by a transition metal catalysis method or a metal photoredox catalysis method as described herein, 7bare cyano, C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, aromatic C6-C 14 -Carbocycle, aromatic 5- or 6-membered monocyclic heterocycle, non-aromatic 3- to 7-membered monocyclic heterocycle, -N(R e )2 or -C(=O)(OR g ) to a compound of formula (Ia-4).

[0308] In the formula, R 7b is a C2-C6-alkenyl group substituted by C1-C3-alkoxy, by a method described in the literature (e.g., J. Org. Chem. 1993, 55, 3114). 7c can be converted to a compound of formula (Ia-5) in which is a C1-C6-alkylcarbonyl group.

[0309] In the formula, R 7c The compound of formula (Ia-5), wherein R is a C1-C6-alkylcarbonyl group, can be prepared by the method described in the literature (e.g., Greene's Protective Groups in organic Synthesis; Peter GM Wuts; Wiley; Fifth Edition; 2014; 655, 661, 667). 7c -C(=NR f )—C1-C6-alkyl group can be further converted to a compound of formula (Ia-5).

[0310] In the formula, R 7c Compounds of formula (Ia-5), where R is a C1-C6-alkylcarbonyl group, can be converted to compounds of formula (Ia-6) by classical functional group interconversion, such as reduction of the ketone to an alcohol in the presence of NaBH4 in MeOH. 7c can be further converted to a compound of formula (Ia-5) in which is a C1-C6-hydroxyalkyl group.

[0311] R 7c is a C1-C6-hydroxyalkyl group, in the presence of a fluorinating agent, 7c can be further converted to compound (Ia-5), in which is C1-C6-fluoroalkyl. Non-limiting examples of fluorinating agents include sulfur fluorides such as sulfur tetrafluoride, diethylaminosulfur trifluoride, morpholinosulfur trifluoride, bis(2-methoxyethyl)aminosulfur trifluoride, 2,2-difluoro-1,3-dimethylimidazolidine, or 4-tert-butyl-2,6-dimethylphenylsulfur trifluoride.

[0312] Compounds of formula (Ia-3) can be prepared by one or more of the methods described herein.

[0313] Method F Formula (Ia-6) (i.e., in the formula, R 1 is H, T is O, and R 7 is a halogen and R 8 is hydrogen) by literature methods to convert a compound of formula (1-a-7) (i.e., where R 1 is H, T is O, and R 7 is a halogen and R 8 is shown in Scheme 6 8a or the corresponding compound of formula (I)) (i.e., in which R 1 is H, T is O, and R 7 is a halogen and R 8 is shown in Scheme 6 8b can be converted to a compound of formula (I)

[0314] [ka] R 7 = hydrogen, R 8a= halogen, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C3-C6-cycloalkenyl, aromatic C6-C 14 - a carbocycle, a 5- to 14-membered aromatic heterocycle, or a 3- to 14-membered non-aromatic heterocycle; R 8b = halogen, cyano, nitro, amino, mercapto, hydroxyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C2-C6-alkynyloxy, C2-C6-haloalkynyloxy, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, aromatic 5- to 14-membered heterocycle, C3-C8-cycloalkyloxy, aromatic C6-C 14 -carbocyclyloxy, non-aromatic 3- to 14-membered heterocyclyloxy, aromatic 5- to 14-membered heterocyclyloxy, -N(R h )2, -SR i , -S(=O)R i and -S(=O)2R i and;

[0315] In Scheme 6, R h and R i is as disclosed herein, and the aliphatic and cyclic substituents R 8a and R 8b may be substituted as disclosed herein.

[0316] Non-limiting examples of transformations performed according to Scheme 6 are shown below.

[0317] Compounds of formula (Ia-6) can be prepared by the method described in the literature (Org. Lett. 2009, 11, 1837) in the presence of a base and an electrophilic reagent such as NCS, NBS, NIS, hexachloroethane, bromine or iodine, where R 8acan be converted to a compound of formula (Ia-7) in which R is a halogen. A suitable base for carrying out the process can be selected from lithium diisopropylamide, lithium 2,2,6,6-tetramethylpiperidide, n-butyllithium, methyllithium, TMPZn·LiCl (2,2,6,6-tetramethylpiperidinyl zinc chloride-lithium chloride complex), TMP2Zn·2MgCl2·2LiCl (bis(2,2,6,6-tetramethylpiperidinyl)zinc magnesium chloride-lithium chloride complex), see, for example, Dissertation Albrecht Metzer 2010, University Munich.

[0318] Compounds of formula (Ia-6), where R 8a is C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C3-C6-cycloalkenyl, aromatic C6-C 14 - a compound of formula (Ia-7), which is a carbocyclic ring, a 5- to 14-membered aromatic heterocyclic ring, or a 3- to 14-membered non-aromatic heterocyclic ring.

[0319] In the formula, R 8a is a halogen atom, in the presence of a base, optionally in the presence of a transition metal catalyst such as a metal salt or complex, and, if appropriate, in the presence of a ligand, 8b is cyano, nitro, amino, mercapto, hydroxyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, aromatic 5- to 14-membered heterocycle, C3-C8-cycloalkyloxy, aromatic C6-C14 -carbocyclyloxy, non-aromatic 3- to 14-membered heterocyclyloxy, aromatic 5- to 14-membered heterocyclyloxy, -N(R h )2 or -SR i can be converted to a compound of formula (Ia-8):

[0320] In the formula, R 8b is a C2-C6-alkenyl group, by reacting the compound of formula (Ia-8) with an oxygen, sulfur or amino nucleophilic reagent to give the compound of formula (Ia-8) 8b is substituted by C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkoxy-C1-C6-alkoxy, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, non-aromatic 3- to 7-membered monocyclic heterocycle and -N(R a’ )2, can be further converted to compounds of formula (Ia-8) a’ are independently selected from the group consisting of hydrogen, C1-C6-alkyl, C1-C6-haloalkyl and C3-C8-cycloalkyl.

[0321] In the formula, R 8b is SR i Compounds of formula (Ia-8), where R 8b -S(=O)R i or -S(=O)2R i The compound of formula (Ia-8) can be further converted to the compound of formula (Ia-8).

[0322] Compounds of formula (Ia-6) can be prepared by one or more of the methods described herein.

[0323] Method G Formula (Id) (i.e., where R 6S is halogen) or a compound of formula (6) with a compound of formula (7) to give a compound of formula (Ie) (i.e., where R 6SCompounds of formula (I) can be obtained, wherein:

[0324] [ka] G 1 = halogen, G 2 = a leaving group (e.g., OS(=O)2-C1-C6-alkyl or OS(=O)2-aryl, such as a triflate, mesylate or tosylate group), W=hydrogen, halogen, boronic acid, boronate ester derivatives or potassium trifluoroborate derivatives, or -Sn(C1-C6-alkyl)3, -MgX, -ZnX (X is halogen), R 6S = cyano, C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C3-C8-cycloalkyl, C3-C8-cycloalkenyl, aromatic C6-C 14 -Carbocycle, aromatic 5- or 6-membered monocyclic heterocycle, non-aromatic 3- to 7-membered monocyclic heterocycle.

[0325] In Scheme 7, aliphatic and cyclic R 6S The substituents may be substituted as disclosed herein.

[0326] Method G can be carried out with metal catalysts as described herein.

[0327] Alternatively, method G can be carried out by a metal photoredox catalyst. More specifically, in the formula: 1Compounds of formula (Id), where is preferably Br or I, can be converted to compounds of formula (Ie) by metal photoredox catalysis in the presence of a photosensitizer such as an Ir or Ru complex or an organic dye and a metal catalyst such as a Ni complex. The reaction can be carried out in the presence of a ligand, if appropriate under irradiation with blue or white light, and in the presence of a base.

[0328] Compounds of formula (Id) may be prepared by one or more of the methods described herein.

[0329] Compounds of formula (6) can be prepared by well-known methods.

[0330] The compound of formula (7) is commercially available.

[0331] Method H Formula (If) (i.e., where Q S is a halogen) with a compound of formula 9 to give a compound of formula (Ig) (i.e., where Q is a halogen) as shown in Scheme 8. S Compounds of formula (I) can be obtained, wherein:

[0332] [ka] G 1 = halogen, G 2 = a leaving group, for example OS(=O)2-C1-C6-alkyl or OS(=O)2-aryl, W=hydrogen, halogen, boronic acid, boronate ester derivative or potassium trifluoroboronate derivative, or -Sn(C1-C6-alkyl)3, -MgX, -ZnX (X is halogen), Q S= cyano, C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, non-aromatic 3- to 7-membered monocyclic heterocycle, aromatic 5- to 6-membered heterocycle.

[0333] In Scheme 8, aliphatic and cyclic Q S The substituents may be substituted as disclosed herein.

[0334] Method H can be carried out by transition metal catalysis.

[0335] Alternatively, method H can be carried out by a metal photoredox catalyst. More specifically, 1 Compounds of formula (If), where is preferably Br or I, can be converted to compounds of formula (Ig) by metal photoredox catalysis in the presence of a photosensitizer such as an Ir or Ru complex or an organic dye and a metal catalyst such as a Ni complex. The reaction can be carried out in the presence of a ligand, if appropriate under irradiation with blue or white light, and in the presence of a base.

[0336] Compounds of formula (If) may be prepared by one or more of the methods described herein.

[0337] Compounds of formula (8) can be prepared by well-known methods.

[0338] The compound of formula (9) is commercially available.

[0339] Method for producing the compound of formula (1) Compounds of formula (I) may be obtained directly by carrying out Method I below, or by conversion or derivatization of another compound of formula (1) prepared according to the methods described herein. Compounds of formulas (Ia)-(Ie) are various subsets of formula (1).

[0340] Method I Formula (1-a) (i.e., in the formula, R 7 and R 8 Compounds of formula (1)), wherein R is as defined in Scheme 9, can be prepared by a process comprising reacting a compound of formula (10) with a reagent of formula (4) as shown in Scheme 9 in the presence of a base.

[0341] [ka] U 1 =C1-C6-alkoxy, U 2 = hydroxyl, halogen, G=halogen; R 8 = hydrogen, C1-C6-alkyl, R 7 = hydrogen, halogen, hydroxyl, mercapto, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C2-C6-alkynyloxy, C2-C6-haloalkynyloxy, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, C3-C8-cycloalkyloxy, aromatic C6-C 14 -carbocyclyloxy, aromatic 5- or 6-membered monocyclic heterocyclyloxy, non-aromatic 3- to 7-membered monocyclic heterocyclyloxy, -N(R e )2.

[0342] In Scheme 9, R e is as disclosed herein, and R 7 , R 8 and R e may be substituted as disclosed herein.

[0343] Method I can be carried out in the presence of a suitable transition metal catalyst salt or complex, where appropriate in the presence of a ligand.

[0344] The resulting compound of formula (1-a) can then be converted in one or more steps to a compound of formula (1-b).

[0345] Non-limiting examples of such conversions are described below.

[0346] In the formula, U 1 Compounds of formula (1-a) where U is C1-C6-alkoxy can be converted to compounds of formula (1-b) by well-known functional group interconversion methods, for example, by hydrolysis of the ester group using LiOH in THF / water, where U 2 can be converted to a compound of formula (1-b) in which is a hydroxyl group.

[0347] In the formula, U 2 is a hydroxyl group, in the presence of a halogenating agent, by a well-known method, 2 can be converted to a compound of formula (1-b) in which is a halogen. Suitable halogenating agents include, but are not limited to, phosphorus tribromide, phosphorus trichloride, phosphorus pentachloride, phosphorus trichloride oxide, oxalyl chloride, or thionyl chloride.

[0348] Compounds of formula (10) are commercially available or may be prepared by Method M described herein.

[0349] Compounds of formula (4) may be commercially available or may be obtained by conversion or derivatization of other compounds of formula (4) according to well-known methods.

[0350] Method J Formula (1-c) (i.e., in the formula, R 7 is defined in Scheme 10 7a in one or more steps, as shown in Scheme 10, to a compound of formula (1-d) (i.e., wherein R 7 is defined in Scheme 10 7b Formula (1)) or formula (1-e) (i.e., in which R 7 is defined in Scheme 10 7ccan be converted to the corresponding compound of formula (1) by known methods.

[0351] [ka] U 1 =C1-C6-alkoxy, R 7a = hydrogen or halogen (preferably chlorine), R 7b = hydrogen, halogen, cyano, C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C3-C8-cycloalkylsulfanyl, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, aromatic C6-C 14 -carbocycle, aromatic 5- or 6-membered monocyclic heterocycle, non-aromatic 3- to 7-membered monocyclic heterocycle, -N(R e )2, -C(=O)(OR g ) and R 7c = nitro, formyl, C1-C6-alkylcarbonyl, C1-C6-haloalkylcarbonyl, C1-C6-hydroxyalkyl, C1-C6-fluoroalkyl, C1-C6-alkylsulfinyl, C1-C6-haloalkylsulfinyl, C3-C8-cycloalkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-haloalkylsulfonyl, C3-C8-cycloalkylsulfonyl, -C(=NR f )R f , -C(=O)N(R g )2, -S(=O)(=NR g )R g , -S(=O)2N(R g )2.

[0352] In Scheme 10, R e , R f , R g is as described herein, and the aliphatic and cyclic substituents R7b , R 7c , R e , R f , R g may be substituted as disclosed herein.

[0353] A non-limiting example of the conversion may be carried out according to the instructions provided in Method E.

[0354] The resulting compounds of formula (1-d) and (1-e) are then reacted with the compound represented by formula (1-d) to form a compound represented by formula (1-e) 1 can be converted to compounds of formula (1-d) and (1-e) in which (C1-C6-alkoxy) is substituted with hydroxyl or halogen.

[0355] Examples of such conversions are described below.

[0356] In the formula, U 1 Compounds of formula (1-c), (1-d), (1-e) where U is C1-C6-alkoxy can be converted to compounds of formula (1-c), (1-d), (1-e) where U is C1-C6-alkoxy by well-known functional group interconversion methods, for example, by hydrolysis of the ester group using LiOH in THF / water. 1 can be converted to compounds of formula (1-b), (1-c), (1-d) in which is substituted with a hydroxyl group.

[0357] In the formula, U 1 The compounds of formula (1-c), (1-d), and (1-e), in which R is replaced by a hydroxyl group, can be further converted to compounds of formula (1-b), (1-c), and (1-d), in which the hydroxyl group is replaced by a halogen, in the presence of a halogenating agent by well-known methods. Suitable halogenating agents include, but are not limited to, phosphorus tribromide, phosphorus trichloride, phosphorus pentachloride, phosphorus trichloride oxide, oxalyl chloride, or thionyl chloride.

[0358] Compounds of formula (1-c) can be prepared by one or more of the methods described herein.

[0359] Method K Formula (1-f) (i.e., in the formula, R8 is H, can be converted in one or more steps to a compound of formula (1-g) (i.e., where R 8 is R as defined in Scheme 11 a or a corresponding compound of formula (1-h) (i.e., wherein R 8 is R as defined in Scheme 11 8b can be converted to compounds of formula (1) by methods described in the literature.

[0360] [ka] U 1 =C1-C6-alkoxy, R 8a = halogen, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C3-C6-cycloalkenyl, aromatic C6-C 14 - a carbocycle, a 5- to 14-membered aromatic heterocycle, or a 3- to 14-membered non-aromatic heterocycle; R 8b = halogen, cyano, nitro, amino, mercapto, hydroxyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C2-C6-alkynyloxy, C2-C6-haloalkynyloxy, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, aromatic 5- to 14-membered heterocycle, C3-C8-cycloalkyloxy, aromatic C6-C 14 -carbocyclyloxy, non-aromatic 3- to 14-membered heterocyclyloxy, aromatic 5- to 14-membered heterocyclyloxy, -N(R h )2, -SR i , -S(=O)R i and -S(=O)2R i is.

[0361] In Scheme 11, R h and R i is as disclosed herein, and the aliphatic and cyclic substituents R 8a and R 8b may be substituted as disclosed herein.

[0362] A non-limiting example of the conversion may be carried out according to the instructions provided in Method F.

[0363] The resulting compounds of formula (1-f) and (1-g) are then reacted with the compound represented by formula (1-f) to form a compound represented by formula (1-g) 1 can be converted to compounds of formula (1-f) and (1-g) in which (C1-C6-alkoxy) is substituted with hydroxyl or halogen.

[0364] In the formula, U 1 Compounds of formula (1-f), (1-g), (1-h) where U is C1-C6-alkoxy can be converted to compounds of formula (1-f), (1-g), (1-h) where U is C1-C6-alkoxy by well-known functional group interconversion methods, for example, by hydrolysis of the ester group using LiOH in THF / water. 1 can be converted to compounds of formula (1-f), (1-g), (1-h) in which is substituted with a hydroxyl group.

[0365] In the formula, U 1 The compounds of formula (1-f), (1-g), and (1-h), in which R is replaced by a hydroxyl group, can be further converted to compounds of formula (1-f), (1-g), and (1-h), in which the hydroxyl group is replaced by a halogen, in the presence of a halogenating agent by well-known methods. Suitable halogenating agents include, but are not limited to, phosphorus tribromide, phosphorus trichloride, phosphorus pentachloride, phosphorus trichloride oxide, oxalyl chloride, or thionyl chloride.

[0366] Compound (1-f) can be prepared by one or more of the methods described herein.

[0367] Method for producing the compound of formula (3) Method L Compounds of formula (3) can be prepared by a process comprising reacting a compound of formula (10) with an amine of formula (2), as shown in Scheme 13.

[0368] [ka] U 1 = hydroxyl, halogen, C1-C6-alkoxy, G=halogen; R 1 = hydrogen, hydroxyl, C1-C6-alkyl, C1-C6-alkoxy, R 8 = hydrogen, C1-C6-alkyl, R 7 = hydrogen, halogen, hydroxyl, mercapto, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C2-C6-alkynyloxy, C2-C6-haloalkynyloxy, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C3-C8-cycloalkylsulfanyl, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, C3-C8-cycloalkyloxy, aromatic C6-C 14 -carbocyclyloxy, aromatic 5- or 6-membered monocyclic heterocyclyloxy, non-aromatic 3- to 7-membered monocyclic heterocyclyloxy, -N(R e )2;R e is as disclosed herein, and R 7 and R e may be substituted as disclosed herein.

[0369] Method L can be carried out using the same conditions as described in Method A.

[0370] Compounds of formula (10) are commercially available or can be obtained by method M.

[0371] Method for producing the compound of formula (10) Method M A compound of formula (10-a) (i.e., in which R 7 is a halogen) to a compound of formula (10-b) (i.e., where R 7 can be converted to compounds of formula 10, which are as shown in Scheme 13, by known methods (WO 2000 / 044755).

[0372] [ka] U 1 =C1-C6-alkoxy, G=halogen; R 8 = hydrogen, C1-C6-alkyl, R 7 = halogen, hydroxyl, mercapto, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C2-C6-alkynyloxy, C2-C6-haloalkynyloxy, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C3-C8-cycloalkylsulfanyl, C3-C8-cycloalkyloxy, aromatic C6-C 14 -carbocyclyloxy, aromatic 5- or 6-membered monocyclic heterocyclyloxy, non-aromatic 3- to 7-membered monocyclic heterocyclyloxy, -N(R e )2;R e is as disclosed herein, and R 7 and R e may be substituted as disclosed herein.

[0373] Compounds of formula (10-a) and (10-b) can be prepared by the same procedure as described in Method K, where U 1can be converted to compounds of formula (10-a) and (10-b) in which (C1-C6-alkoxy) is substituted with hydroxyl or halogen.

[0374] The starting compound of formula (10-a) is commercially available.

[0375] The compounds according to the invention can be prepared according to the methods described above. Nevertheless, it will be understood that, based on general knowledge and available publications, a person skilled in the art will be able to adapt these methods according to the specifics of each compound according to the invention that he wishes to synthesize.

[0376] Intermediates for the preparation of compounds of formula (I) The present invention also relates to intermediates for preparing compounds of formula (I).

[0377] The intermediate according to the present invention has the formula (1):

[0378] [ka]

[0379] is a compound of the formula Q is as described herein; U 1 is hydroxyl, halogen, C1-C6-alkoxy; R 7 , R 8 is as described herein and is selected from hydrogen, C1-C6-alkyl, and aromatic C6-C 14 -Not a carbon ring; However, the compound of formula (1) is

[0380] [Table 1]

[0381] No. The intermediate according to the present invention has the formula (3):

[0382] [ka]

[0383] wherein: G is halogen and; n=1 and m=1; R 1 is hydrogen; R 2 , R 3 is hydrogen; R 4 and R 5 is hydrogen or fluorine; R 6 is a non-aromatic polycyclic C7-C 12 -Carbocyclic, aromatic C6~C 14 - selected from the group consisting of carbocycles (phenyl), and non-aromatic 6- to 14-membered polycyclic heterocycles; R 7 is hydrogen, halogen, hydroxyl, mercapto, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C2-C6-alkynyloxy, C2-C6-haloalkynyloxy, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, C3-C8-cycloalkyloxy, aromatic C6-C 14 -carbocyclyloxy, aromatic 5- or 6-membered monocyclic heterocyclyloxy, non-aromatic 3- to 7-membered monocyclic heterocyclyloxy, and -N(R e )2, and R e is as disclosed herein, and R 7 and R e may be substituted as disclosed herein; R 8 is hydrogen or C1-C6-alkyl; However, the compound of formula (3) is

[0384] [Table 2]

[0385] Not (r4 and f5 are both hydrogen). A further intermediate is represented by formula (3):

[0386] [ka]

[0387] wherein: G is halogen and; n=0 and m=0; R 1 is hydrogen, hydroxyl, C1-C6-alkyl or C1-C6-alkoxy, R 6 is a non-aromatic polycyclic C7-C 12 - selected from the group consisting of carbocycles and non-aromatic 7- to 14-membered polycyclic heterocycles; R 7 is hydrogen, halogen, hydroxyl, mercapto, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C2-C6-alkynyloxy, C2-C6-haloalkynyloxy, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, C3-C8-cycloalkyloxy, aromatic C6-C 14 -carbocyclyloxy, aromatic 5- or 6-membered monocyclic heterocyclyloxy, non-aromatic 3- to 7-membered monocyclic heterocyclyloxy, and -N(R e )2, and R e is as disclosed herein, and R 7 and R e may be substituted as disclosed herein; R 8is hydrogen or C1-C6-alkyl; However, the compound of formula (3) is

[0388] [Table 3] TIFF0007578593000037.tif248165TIFF0007578593000038.tif53166

[0389] No. A further intermediate is represented by formula (3):

[0390] [ka]

[0391] wherein: G is halogen and n=0 and m=1, R 1 is hydrogen, hydroxyl, C1-C6-alkyl or C1-C6-alkoxy, R 4 and R 5 is as described herein; R 6 is a non-aromatic polycyclic C7-C 12 -Carbocyclic, aromatic C6~C 14 - selected from the group consisting of carbocycles (phenyl), aromatic 5- to 14-membered heterocycles and non-aromatic 6- to 14-membered polycyclic heterocycles; R 7 is hydrogen, halogen, hydroxyl, mercapto, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C2-C6-alkynyloxy, C2-C6-haloalkynyloxy, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, C3-C8-cycloalkyloxy, aromatic C6-C14 -carbocyclyloxy, aromatic 5- or 6-membered monocyclic heterocyclyloxy, non-aromatic 3- to 7-membered monocyclic heterocyclyloxy, and -N(R e )2, and R e is as disclosed herein, and R 7 and R e may be substituted as disclosed herein; R 8 is hydrogen or C1-C6-alkyl; However, the compound of formula (3) is

[0392] [Table 4] TIFF0007578593000041.tif246165TIFF0007578593000042.tif245165TIFF0007578593000043.tif245167TIFF0007578593 000044.tif244166TIFF0007578593000045.tif242163TIFF0007578593000046.tif244166TIFF0007578593000047.tif24716 5TIFF0007578593000048.tif243166TIFF0007578593000049.tif244164TIFF0007578593000050.tif244164TIFF0007578593 000051.tif245166TIFF0007578593000052.tif247164TIFF0007578593000053.tif249164TIFF0007578593000054.tif74167

[0393] No. A further intermediate is represented by formula (3):

[0394] [ka]

[0395] wherein: G is halogen and; n=1 and m=1; R 1 is hydrogen, hydroxyl, C1-C6-alkyl or C1-C6-alkoxy, R 2 , R 3 , R 4 and R 5 is as described herein; R 6 is a non-aromatic polycyclic C7-C 12 -Carbocyclic, aromatic C6~C 14 - selected from the group consisting of carbocycles (phenyl), aromatic 5- to 14-membered heterocycles and non-aromatic 6- to 14-membered polycyclic heterocycles; R 7 is hydrogen, halogen, hydroxyl, mercapto, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C2-C6-alkynyloxy, C2-C6-haloalkynyloxy, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, C3-C8-cycloalkyloxy, aromatic C6-C 14 -carbocyclyloxy, aromatic 5- or 6-membered monocyclic heterocyclyloxy, non-aromatic 3- to 7-membered monocyclic heterocyclyloxy, and -N(R e )2, and R e is as disclosed herein, and R 7 and R e may be substituted as disclosed herein; R 8 is hydrogen or C1-C6-alkyl; However, the compound of formula (3) is

[0396] [Table 5] TIFF0007578593000057.tif249169TIFF0007578593000058.tif250169TIFF0007578593000059.tif102169

[0397] No. A further intermediate is represented by formula (3):

[0398] [ka]

[0399] wherein: G is halogen and; n=1 and m=1; R 1 is hydrogen, hydroxyl, C1-C6-alkyl or C1-C6-alkoxy, R 3 and R 4 together with the carbon atoms to which they are attached form a C3-C8-cycloalkyl, R 2 and R 5 is as described herein; R 6 is as described herein; R 7 is hydrogen, halogen, hydroxyl, mercapto, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C2-C6-alkynyloxy, C2-C6-haloalkynyloxy, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, C3-C8-cycloalkyloxy, aromatic C6-C 14 -carbocyclyloxy, aromatic 5- or 6-membered monocyclic heterocyclyloxy, non-aromatic 3- to 7-membered monocyclic heterocyclyloxy, and -N(R e )2, and R eis as disclosed herein, and R 7 and R e may be substituted as disclosed herein; R 8 is hydrogen or C1-C6-alkyl; However, the compound of formula (3) is

[0400] [Table 6]

[0401] No. A further intermediate is represented by formula (3):

[0402] [ka]

[0403] wherein: G is halogen and; n=0 and m=0; R 1 is hydrogen, hydroxyl, C1-C6-alkyl or C1-C6-alkoxy, R 6 is a non-aromatic C7-C 12 -Carbocyclyloxy, aromatic C6-C 14 -Carbocyclyloxy, aromatic 5- to 14-membered heterocyclyloxy, non-aromatic 7- to 14-membered heterocyclyloxy, non-aromatic C7-C 12 -Carbocyclic, aromatic C6~C 14 - C1-C3-alkoxy substituted by a carbocycle, a non-aromatic 7- to 14-membered heterocycle or an aromatic 5- to 14-membered heterocycle, and non-aromatic C7-C 12 -Carbocyclic, aromatic C6~C 14 -C1-C3-haloalkoxy substituted by a carbocycle, a non-aromatic 7- to 14-membered heterocycle or an aromatic 5- to 14-membered heterocycle; R 7is hydrogen, halogen, hydroxyl, mercapto, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C2-C6-alkynyloxy, C2-C6-haloalkynyloxy, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, C3-C8-cycloalkyloxy, aromatic C6-C 14 -carbocyclyloxy, aromatic 5- or 6-membered monocyclic heterocyclyloxy, non-aromatic 3- to 7-membered monocyclic heterocyclyloxy, and -N(R e )2, and R e is as disclosed herein, and R 7 and R e may be substituted as disclosed herein; R 8 is hydrogen or C1-C6-alkyl; However, the compound of formula (3) is

[0404] [Table 7]

[0405] No. The intermediate according to the present invention has the formula (4): Q-OH (4) wherein Q is:

[0406] [ka]

[0407] wherein: A is CH or N; Q S is selected from the group consisting of C-C-cycloalkyl, C-C-halocycloalkyl, C-C-alkenyl, C-C-haloalkenyl and C-C-alkynyl, However, the compound of formula (4) is

[0408] [Table 8] No.

[0409] Compositions and Formulations The present invention further relates to compositions, in particular compositions for controlling unwanted plant pathogenic microorganisms. The compositions may be applied to the microorganisms and / or their habitat.

[0410] The compositions usually comprise at least one compound of formula (I) and at least one agriculturally suitable adjuvant, such as a carrier and / or surfactant.

[0411] Carriers are generally inert solid or liquid, natural or synthetic, organic or inorganic substances. Carriers generally improve the application of compounds to plants, plant parts, or seeds, for example. Examples of suitable solid carriers include, but are not limited to, ammonium salts, natural rock powders such as kaolin, clay, talc, chalk, quartz, attapulgite, montmorillonite, and diatomaceous earth, and synthetic rock powders such as finely divided silica, alumina, and silicates. Examples of commonly useful solid carriers for granulation production include, but are not limited to, crushed and divided natural stones such as calcite, marble, pumice, sepiolite, and dolomite, synthetic granules of inorganic and organic powders, and granules of organic materials such as paper, sawdust, coconut shell flour, corn cobs, and tobacco stalks. Examples of suitable liquid carriers include, but are not limited to, water, organic solvents, and combinations thereof. Examples of suitable organic solvents include, for example, polar and non-polar organic chemical liquids from the aromatic and non-aromatic hydrocarbon classes (such as cyclohexane, paraffins, alkylbenzenes, xylenes, toluene, alkylnaphthalenes, chlorinated aromatic compounds or chlorinated aliphatic hydrocarbons such as chlorobenzene, chloroethylene, or methylene chloride), alcohols and polyols (such as butanol or glycols, which may be substituted, etherified, and / or esterified), ketones (acetone, methyl ethyl ketone, methyl isobutyl ketone, or cyclohexanone), esters (including fats and oils) and (poly)ethers, unsubstituted and substituted amines, amides (such as dimethylformamide), lactams (N-alkylpyrrolidone) and lactones, sulfones and sulfoxides (such as dimethyl sulfoxide). The carrier may also be a liquefied gas extender, i.e., a liquid that is a gas at standard temperature and pressure, such as an aerosol propellant, for example, halohydrocarbons, butane, propane, nitrogen, and carbon dioxide. The amount of the carrier is usually in the range of 1 to 99.99% by weight, preferably 5 to 99.9% by weight, more preferably 10 to 99.5% by weight, and most preferably 20 to 99% by weight of the composition.

[0412] The surfactants may be ionic (cationic or anionic) or non-ionic surfactants, such as, for example, ionic or non-ionic emulsifiers, foaming agents, dispersing agents, wetting agents, and mixtures of any of these. Examples of suitable surfactants include, but are not limited to, polyacrylates, lignosulfonates, phenolsulfonates, or naphthalenesulfonates, polycondensates of ethylene oxide and / or propylene oxide with aliphatic alcohols, fatty acids, or fatty amines (polyoxyethylene fatty acid esters, polyoxyethylene fatty alcohol ethers, e.g., alkylaryl polyglycol ethers), substituted phenols (preferably alkylphenols or arylphenols), sulfosuccinate salts, taurine derivatives (preferably alkyl taurates), phosphate esters of polyethoxylated alcohols or phenols, fatty esters of polyols, and derivatives of compounds containing sulfates, sulfonates, or phosphates (e.g., alkylsulfonates, alkyl sulfates, arylsulfonates), and protein hydrolysates, lignosulfite waste liquors, and methylcellulose. Surfactants are typically used when the compound of formula (I) and / or the carrier are water-insoluble and the application is carried out in water. The amount of surfactant is then usually in the range of 5 to 40% by weight of the composition.

[0413] Further examples of suitable auxiliaries include water repellents, drying agents, binders (adhesives, tackifiers, fixatives, such as, for example, carboxymethylcellulose, natural and synthetic polymers in the form of powders, granules or latexes, such as gum arabic, polyvinyl alcohol and polyvinyl acetate, natural and synthetic phospholipids, such as cephalin and lecithin, polyvinylpyrrolidone and tylose), thickeners, stabilizers (for example, cold stabilizers, preservatives, antioxidants, light stabilizers or other agents which improve chemical and / or physical stability), dyes or pigments (inorganic pigments, for example, iron oxide, titanium oxide and Prussian blue), organic dyes, such as alizarin, azo and metal phthalocyanine dyes, antifoaming agents (such as silicone antifoams and magnesium stearate), preservatives (such as dichlorophen and benzyl alcohol hemiformal), secondary thickeners (cellulose derivatives, acrylic acid derivatives, xanthan, modified clays and finely divided silica), fixing agents, gibberellins and processing aids, mineral and vegetable oils, fragrances, waxes, nutrients (such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc, including micronutrients), protective colloids, thixotropic substances, penetrating agents, sequestering agents and complexing agents.

[0414] The choice of adjuvant is related to the intended method of application and / or physical properties of the compound of formula (I). Furthermore, the adjuvant may be selected to impart specific properties (technical, physical and / or biological properties) to the composition or to the use of the form produced therefrom. The choice of adjuvant may allow the composition to be customized to specific needs.

[0415] The compositions may be in any customary form, such as solutions (e.g., aqueous solutions), emulsifiable concentrates, wettable powders, water- and oil-based suspensions, dusts, dusts, pastes, water-soluble, soluble granules, granules for general application, suspoemulsion concentrates, natural or synthetic products impregnated with a compound of formula (I), microencapsulation of fertilizers and polymeric materials, etc. The compound of formula (I) may be present in suspended, emulsified or dissolved form.

[0416] The compositions may be provided to the end user as a ready-to-use formulation, i.e., the composition may be applied directly to the plants or seeds by suitable equipment such as a sprayer or duster, or alternatively, the compositions may be provided to the end user in the form of a concentrated formulation that must be diluted, preferably with water, before use.

[0417] For example, compositions can be formulated in a conventional manner by mixing a compound of formula (I) with one or more suitable auxiliaries such as those disclosed herein above.

[0418] The composition generally contains 0.01 to 99% by weight, 0.05 to 98% by weight, preferably 0.1 to 95% by weight, more preferably 0.5 to 90% by weight, and most preferably 1 to 80% by weight of a compound of formula (I). The composition may comprise more than one compound of formula (I). In such cases, the approximate ranges represent the total amount of compounds of the invention.

[0419] Mixtures / Combinations The compounds of formula (I) and compositions containing them can be mixed with other active ingredients such as fungicides, bactericides, acaricides, nematicides, insecticides, herbicides, fertilizers, growth regulators, safeners, or semiochemicals. These can broaden the spectrum of activity and prevent resistance development. Examples of known fungicides, insecticides, acaricides, nematicides, and bactericides are disclosed in the Pesticide Manual, 17th Edition.

[0420] Examples of particularly preferred fungicides that can be mixed with the compounds and compositions of formula (I) are: 1) Inhibitors of ergosterol biosynthesis, for example: (1.001) cyproconazole, (1.002) difenoconazole, (1.003) epoxiconazole, (1.004) fenhexamid, (1.005) fenpropidin, (1.006) fenpropimorph, (1.007) fenpyrazamine, (1.008) fluquinconazole, (1.009) flutriafol, (1.010) imazalil, (1.011) imazalil sulfate, (1.012) ipconazole, (1.013) metconazole, (1.01 4) Myclobutanil, (1.015) Paclobutrazol, (1.016) Prochloraz, (1.017) Propiconazole, (1.018) Prothioconazole, (1.019) Pyrisoxazole, (1.020) Spiroxamine, (1.021) Tebuconazole, (1.022) Tetraconazole, (1.023) Triadimenol, (1.024) Tridemorph, (1.025) Triticonazole, (1.026) (1R,2S,5S)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1 (1.027) (1S,2R,5R)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol, (1.028) (2R)-2-(1-chlorocyclopropyl)-4-[(1R)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (1.029) (2R)-2-(1-chlorocyclopropyl) -4-[(1S)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (1.030)(2R)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol, (1.031)(2S)-2-(1-chlorocyclopropyl)-4-[(1R)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (1.032) (2S)-2-(1-chlorocyclopropyl)-4-[(1S)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (1.033) (2S)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol, (1.034) (R)-[3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl) (1.035)(S)-[3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol, (1.036)[3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol, (1.037) 1-({(2R,4S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl}methyl )-1H-1,2,4-triazole, (1.038) 1-({(2S,4S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole, (1.039) 1-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-yl thiocyanate, (1.040) 1-{[rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-yl thiocyanate (1.041) 1-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-yl thiocyanate, (1.042) 2-[(2R,4R,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.043) 2-[(2R,4R,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.044) 2-[(2R,4S,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.045) 2-[(2R,4S,5S)-1-(2,4-dichlorophenyl) )-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.046) 2-[(2S,4R,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.047) 2-[(2S,4R,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2 ,4-Dihydro-3H-1,2,4-triazole-3-thione, (1.048) 2-[(2S,4S,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.049) 2-[(2S,4S,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1. 050) 2-[1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.051) 2-[2-chloro-4-(2,4-dichlorophenoxy)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol, (1.052) 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (1.053) 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (1.054) 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)pentan-2-ol, (1.055) Mefentrifluconazole, (1.056) 2-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4-dihydro-3H-1,2, 4-Triazole-3-thione, (1.057) 2-{[rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.058) 2-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.059) 5-(4-chlorobenzyl)-2-(chloromethyl)-2- Methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol, (1.060) 5-(allylsulfanyl)-1-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole, (1.061) 5-(allylsulfanyl)-1-{[rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole, (1.062) 5-(allylsulfanyl)- 1-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole, (1.063) N'-(2,5-dimethyl-4-{[3-(1,1,2,2-tetrafluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamide, (1.064) N'-(2,5-dimethyl-4-{[3-(2,2,2-trifluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamide, (1.065) N'-(2,5-dimethyl-4-{[3-(2,2,3,3-tetrafluoropropoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamide, (1.066) N'-(2,5-dimethyl-4-{[3-(pentafluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamide, (1.067) N'-(2,5-dimethyl-4-{3-[(1,1,2,2-tetrafluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methyl Imidoformamide, (1.068) N'-(2,5-dimethyl-4-{3-[(2,2,2-trifluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimidoformamide, (1.069) N'-(2,5-dimethyl-4-{3-[(2,2,3,3-tetrafluoropropyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimidoformamide, (1.070) N'-(2,5-dimethyl-4-{3-[(pentafluoroethyl)sulfanyl]phenoxy}phenyl)-N -ethyl-N-methylimidoformamide, (1.071) N'-(2,5-dimethyl-4-phenoxyphenyl)-N-ethyl-N-methylimidoformamide, (1.072) N'-(4-{[3-(difluoromethoxy)phenyl]sulfanyl}-2,5-dimethylphenyl)-N-ethyl-N-methylimidoformamide, (1.073) N'-(4-{3-[(difluoromethyl)sulfanyl]phenoxy}-2,5-dimethylphenyl)-N-ethyl-N-methylimidoformamide, (1.074) N'-[5 -bromo-6-(2,3-dihydro-1H-inden-2-yloxy)-2-methylpyridin-3-yl]-N-ethyl-N-methylimidoformamide, (1.075) N'-{4-[(4,5-dichloro-1,3-thiazol-2-yl)oxy]-2,5-dimethylphenyl}-N-ethyl-N-methylimidoformamide, (1.076) N'-{5-bromo-6-[(1R)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidoformamide, (1.077) N'-{5-bromo-6-[(1S)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidoformamide, (1.078) N'-{5-bromo-6-[(cis-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidoformamide, (1.079) N'-{5-bromo-6-[(trans-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidoformamide, (1.080) N'-{5-bromo-6-[1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidoformamide. Mido, (1.081) Ipfentrifluconazole.

[0421] 2) Inhibitors of the respiratory chain in complexes I or II, such as (2.001) benzovindiflupyr, (2.002) bixafen, (2.003) boscalid, (2.004) carboxin, (2.005) fluopyram, (2.006) flutolanil, (2.007) fluxapyroxad, (2.008) furametpyr, (2.009) isofetamide, (2.010) isopyrazam (anti-epimer enantiomer 1R,4S,9S), (2.011) isopyrazam (anti-epimer enantiomer 1S,4R,9R), (2.012) isopyrazam (Anti-epimer racemic mixture 1RS,4SR,9SR), (2.013) Isopyrazam (syn-epimer racemic mixture 1RS,4SR,9RS and anti-epimer racemic mixture 1RS,4SR,9SR), (2.014) Isopyrazam (syn-epimer enantiomer 1R,4S,9R), (2.015) Isopyrazam (syn-epimer enantiomer 1S,4R,9S), (2.016) Isopyrazam (syn-epimer racemic mixture 1RS,4SR,9RS), (2.017) Penflufen, (2.018) Penthiopyrad, (2.019) Pydiflumetofen, ( 2.020) Pyraziflumide, (2.021) Sedaxane, (2.022) 1,3-dimethyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazole-4-carboxamide, (2.023) 1,3-dimethyl-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (2.024) 1,3-dimethyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole (2.025) 1-methyl-3-(trifluoromethyl)-N-[2'-(trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide, (2.026) 2-fluoro-6-(trifluoromethyl)-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)benzamide, (2.027) 3-(difluoromethyl)-1-methyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazole-4-carboxamide, (2.028) 3-(difluoromethyl)-1-methyl-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (2.029) 3-(difluoromethyl)-1-methyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (2.030) Fluindapyr, (2.031) 3-(difluoromethyl)-N-[(3R)-7-fluoro-1,1,3- Trimethyl-2,3-dihydro-1H-inden-4-yl]-1-methyl-1H-pyrazole-4-carboxamide, (2.032) 3-(difluoromethyl)-N-[(3S)-7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1-methyl-1H-pyrazole-4-carboxamide, (2.033) 5,8-difluoro-N-[2-(2-fluoro-4-{[4-(trifluoromethyl)pyridin-2-yl]oxy}phenyl)ethyl]quinazolin-4-amine , (2.034) N-(2-cyclopentyl-5-fluorobenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.035) N-(2-tert-butyl-5-methylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.036) N-(2-tert-butylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro -1-methyl-1H-pyrazole-4-carboxamide, (2.037) N-(5-chloro-2-ethylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.038) isoflucipram, (2.039) N-[(1R,4S)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.040) N-[(1S,4R)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.041) N-[1-(2,4-dichlorophenyl)-1-methoxypropan-2-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.042) N-[2-chloro-6-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5- Fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.043) N-[3-chloro-2-fluoro-6-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.044) N-[5-chloro-2-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.045) N-cyclopropyl-3-(difluoro Methyl)-5-fluoro-1-methyl-N-[5-methyl-2-(trifluoromethyl)benzyl]-1H-pyrazole-4-carboxamide, (2.046) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-fluoro-6-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.047) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropyl-5-methylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.048) ) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carbothioamide, (2.049) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.050) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(5-fluoro-2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.051) N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-4,5-dimethylbenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.052) N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-fluorobenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.053) N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-methylbenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.054) N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-methylbenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide Cyclopropyl-N-(2-cyclopropyl-5-fluorobenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.055) N-cyclopropyl-N-(2-cyclopropyl-5-methylbenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.056) N-cyclopropyl-N-(2-cyclopropylbenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.057) Pyrapropoin.

[0422] 3) Inhibitors of the respiratory chain in complex III, such as (3.001) ametoctrazine, (3.002) amisulbrom, (3.003) azoxystrobin, (3.004) methoxystrobin, (3.005) cumostrobin, (3.006) cyazofamid, (3.007) dimoxystrobin, (3.008) enoxastrobin, (3.009) famoxadone, (3.010) fenamidone, (3.011) flufenoxystrobin, (3.012) fluoxastrobin, (3.013) kresoxim-methyl, (3.0 14) Metominostrobin, (3.015) Orysastrobin, (3.016) Picoxystrobin, (3.017) Pyraclostrobin, (3.018) Pyrametstrobin, (3.019) Pyraoxystrobin, (3.020) Trifloxystrobin, (3.021) (2E)-2-{2-[({[(1E)-1-(3-{[(E)-1-fluoro-2-phenylvinyl]oxy}phenyl)ethylidene]amino}oxy)methyl]phenyl}-2-(methoxyimino)-N-methylacetamide, (3.022) (2E,3Z)- 5-{[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide, (3.023) (2R)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide, (3.024) (2S)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide, (3.025) (3S,6S,7R,8R)-8-benzyl-3-[({3-[(isobutyryloxy)meth oxy]-4-methoxypyridin-2-yl}carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl 2-methylpropanoate, (3.026) mandestrobin, (3.027) N-(3-ethyl-3,5,5-trimethylcyclohexyl)-3-formamido-2-hydroxybenzamide, (3.028) (2E,3Z)-5-{[1-(4-chloro-2-fluorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide, (3.029) Methyl {5-[3-(2,4-dimethylphenyl)-1H-pyrazol-1-yl]-2-methylbenzyl}carbamate, (3.030) Methyltetraprole, (3.031) Florylpicoxamide.

[0423] 4) Inhibitors of mitosis and cell division, for example (4.001) carbendazim, (4.002) diethofencarb, (4.003) ethaboxam, (4.004) fluopicolide, (4.005) pencycuron, (4.006) thiabendazole, (4.007) thiophanate methyl, (4.008) zoxamide, (4.009) 3-chloro-4-(2,6-difluorophenyl)-6-methyl-5-phenylpyridazine, (4.010) 3-chloro-5-(4-chlorophenyl)-4-(2,6-difluorophenyl)- (4.011) 3-chloro-5-(6-chloropyridin-3-yl)-6-methyl-4-(2,4,6-trifluorophenyl)pyridazine, (4.012) 4-(2-bromo-4-fluorophenyl)-N-(2,6-difluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.013) 4-(2-bromo-4-fluorophenyl)-N-(2-bromo-6-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.014) 4-(2-bromo-4-fluorophenyl)-N-(2-bromo-6-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.015) 4-(2-bromo-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.016) 4-(2-bromo-4-fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.017) 4-(2-bromo-4-fluorophenyl)-N-(2-fluorophenyl)-1H-pyrazol-5-amine ,3-dimethyl-1H-pyrazol-5-amine, (4.018) 4-(2-chloro-4-fluorophenyl)-N-(2,6-difluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.019) 4-(2-chloro-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.020) 4-(2-chloro-4-fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.021) 4-(2-chloro-4-fluorophenyl)-N-(2-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.022) 4-(4-chlorophenyl)-5-(2,6-difluorophenyl)-3,6-dimethylpyridazine, (4.023) N-(2-bromo-6-fluorophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.024) N-(2-bromophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.025) N-(4-chloro-2,6-difluorophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine.

[0424] 5) Compounds capable of multisite action, for example: (5.001) Bordeaux mixture, (5.002) captafol, (5.003) captan, (5.004) chlorothalonil, (5.005) copper hydroxide, (5.006) copper naphthenate, (5.007) copper oxide, (5.008) copper chloride basic, (5.009) copper(II) sulfate, (5.010) dithianon, (5.011) dodain, (5.012) folpet, (5.013) mancozeb, (5.014) maneb, (5.015). Metiram, (5.016) metiram zinc, (5.017) oxine copper, (5.018) propineb, (5.019) sulfur preparations containing sulfur and calcium polysulfide, (5.020) thiuram, (5.021) zineb, (5.022) ziram, (5.023) 6-ethyl-5,7-dioxo-6,7-dihydro-5H-pyrrolo[3',4':5,6][1,4]dithiino[2,3-c][1,2]thiazole-3-carbonitrile.

[0425] 6) Compounds capable of inducing biological defenses, such as (6.001) acibenzolar-S-methyl, (6.002) isotianil, (6.003) probenazole, (6.004) tiadinil.

[0426] 7) Inhibitors of amino acid and / or protein biosynthesis, for example (7.001) cyprodinil, (7.002) kasugamycin, (7.003) kasugamycin hydrochloride hydrate, (7.004) oxytetracycline, (7.005) pyrimethanil, (7.006) 3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinoline.

[0427] 8) Inhibitors of ATP production, for example (8.001) silthiofam.

[0428] 9) Inhibitors of cell wall synthesis, for example (9.001) benthiavalicarb, (9.002) dimethomorph, (9.003) flumorph, (9.004) iprovalicarb, (9.005) mandipropamide, (9.006) pyrimorph, (9.007) valifenalate, (9.008) (2E)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one, (9.009) (2Z)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one.

[0429] 10) Inhibitors of lipid and membrane synthesis, for example, (10.001) propamocarb, (10.002) propamocarb hydrochloride, (10.003) tolclofos methyl.

[0430] 11) Inhibitors of melanin biosynthesis, for example, (11.001) tricyclazole, (11.002) 2,2,2-trifluoroethyl{3-methyl-1-[(4-methylbenzoyl)amino]butan-2-yl}carbamate.

[0431] 12) Inhibitors of nucleic acid synthesis, for example (12.001) benalaxyl, (12.002) benalaxyl-M (chiralaxyl), (12.003) metalaxyl, (12.004) metalaxyl-M (mefenoxam).

[0432] 13) Inhibitors of signal transduction, for example (13.001) fludioxonil, (13.002) iprodione, (13.003) procymidone, (13.004) proquinazide, (13.005) quinoxyfen, (13.006) vinclozolin.

[0433] 14) Compounds capable of acting as uncouplers, for example (14.001) fluazinam, (14.002) meptyldinocap.

[0434] 15) Further compounds, for example: (15.001) abscisic acid, (15.002) benthiazole, (15.003) bethoxadin, (15.004) capsimycin, (15.005) carbone, (15.006) chinomethionate, (15.007) khuflaneb, (15.008) cyflufenamid, (15.009) cymoxanil, (15.010) cyprosulfamide, (15.011) fluthianil, (15.012) fosetylaluminium, (15.013) fosetylca Calcium, (15.014) fosetyl sodium, (15.015) methyl isothiocyanate, (15.016) metrafenone, (15.017) mildiomycin, (15.018) natamycin, (15.019) nickel dimethyldithiocarbamate, (15.020) nitrotar isopropyl, (15.021) oxamocarb, (15.022) oxathiapiproline, (15.023) oxyfenthiin, (15.024) pentachlorophenol and salts, ( 15.025) Phosphorous acid and its salts, (15.026) Propamocarb-fosetylate, (15.027) Pyriophenone (clazaphenone), (15.028) Tebufloquine, (15.029) Tecloftalam, (15.030) Tolnifanide, (15.031) 1-(4-{4-[(5R)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-( trifluoromethyl)-1H-pyrazol-1-yl]ethanone, (15.032) 1-(4-{4-[(5S)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone, (15.033) 2-(6-benzylpyridin-2-yl)quinazoline, (15.034) dipimethitrone, (15.035) 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, (15.036) 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-chloro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazole -3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, (15.037) 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-fluoro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, (15.038) 2-[6-(3-fluoro-4-methoxyphenyl)-5-methylpyridin-2-yl]quinazoline, (15. 039) 2-{(5R)-3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate, (15.040) 2-{(5S)-3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazole- 5-yl}-3-chlorophenyl methanesulfonate, (15.041) Ipflufenoquine, (15.042) 2-{2-fluoro-6-[(8-fluoro-2-methylquinolin-3-yl)oxy]phenyl}propan-2-ol, (15.043) 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate, (15.044) 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}phenyl methanesulfonate, (15.045) 2-phenylphenol and salts, (15.046) 3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline, (15.047) quinofumeline, (15.048) 4-amino-5-fluoropyrimidine- 2-ol (tautomer: 4-amino-5-fluoropyrimidin-2(1H)-one), (15.049) 4-oxo-4-[(2-phenylethyl)amino]butanoic acid, (15.050) 5-amino-1,3,4-thiadiazole-2-thiol, (15.051) 5-chloro-N'-phenyl-N'-(prop-2-yn-1-yl)thiophene-2-sulfonohydrazide, (15.052) 5-fluoro-2-[(4-fluorobenzyl)oxy]pyrimidin-4-amine, (15.053) 5-fluoro-2-[(4-methylbenzyl)oxy]pyrimidin-4-amine (15.054) 9-fluoro-2,2-dimethyl-5-(quinolin-3-yl)-2,3-dihydro-1,4-benzoxazepine, (15.055) but-3-yn-1-yl{6-[({[(Z)-(1-methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate, (15.056) ethyl (2Z)-3-amino-2-cyano-3-phenylacrylate, (15.057) phenazine-1-carboxylic acid, (15.058) Propyl 3,4,5-trihydroxybenzoate, (15.059) quinolin-8-ol, (15.060) quinolin-8-ol sulfate (2:1), (15.061) tert-butyl {6-[({[(1-methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate, (15.062) 5-fluoro-4-imino-3-methyl-1-[(4-methylphenyl)sulfonyl]-3,4-dihydropyrimidin-2(1H)-one, (15.063) aminopyrifen.

[0435] All named mixing partners of classes (1) to (15) described herein above can be present in the form of free compounds and / or their agriculturally acceptable salts, if their functional groups allow this.

[0436] The compounds and compositions of formula (I) may be combined with one or more biocontrol agents.

[0437] Examples of biocontrol agents that may be combined with the compounds of formula (I) and compositions comprising same are: (A) Antibacterial drugs selected from the following group: (A1) Bacteria, for example: (A1.1) Bacillus subtilis, in particular the strain QST713 / AQ713 available from Bayer CropScience LP (USA) as SERENADE OPTI or SERENADE ASO (with NRRL accession number B21661 and described in U.S. Pat. No. 6,060,051); (A1.2) Bacillus amyloliquefaciens, in particular the strain D747 available from Certis (USA) as Double Nickel™ (with accession number FERM BP-8234 and described in U.S. Pat. No. 7,094,592); (A1.3) Bacillus pumilus, in particular the strain BU F-33 (NRRL accession number B21661 and described in U.S. Pat. No. 7,094,592); Accession number 50185; (A1.4) Bacillus subtilis var. amyloliquefaciens strain FZB24 (available as Taegro® from Novozymes, USA); (A1.5) Paenibacillus sp. strain, having accession number NRRL B-50972 or accession number NRRL B-67129 and described in WO 2016 / 154297; and (A2) Fungi, for example: (A2.1) Aureobasidium pullulans, in particular blastospores of the strain DSM 14940, (A2.2) Aureobasidium pullulans strain DSM 14941; (A2.3) Aureobasidium pullulans, in particular a mixture of blastospores of the strains DSM 14940 and DSM 14941; (B) a fungicide selected from the group consisting of: (B1) Bacteria, for example: (B1.1) Bacillus subtilis, in particular the strain QST713 / AQ713 (available from Bayer CropScience LP, USA, as SERENADE OPTI or SERENADE ASO, with NRRL accession number B21661 and described in U.S. Pat. No. 6,060,051); (B1.2) Bacillus pumilus, in particular the strain QST2808 (available from Bayer CropScience LP, USA, as SONATA®, with NRRL accession number B-30087 and described in U.S. Pat. No. 6,245,551); (B1.3) Bacillus pumilus, in particular the strain GB34 (available from Bayer AG, Germany, as Yield Shield®); (B1.4) Bacillus pumilus, in particular strain BU F-33 (NRRL accession number 50185); (B1.5) Bacillus amyloliquefaciens, in particular strain D747 (available from Certis, USA, as Double Nickel™, with accession number FERM BP-8234 and disclosed in U.S. Pat. No. 7,094,592); (B1.6) Bacillus subtilis Y1336 (available from BioNTech, Taiwan, as BIOBAC® WP, registered as a Taiwanese biofungicide under registration numbers 4764, 5454, 5096 and 5277); (B1.7) Bacillus amyloliquefaciens strain MBI600 (BASF (B1.8) Bacillus subtilis strain GB03 (available as Kodiak® from Bayer AG, Germany); (B1.9) Bacillus subtilis var. amyloliquefaciens strain FZB24 (available as Kodiak® from Novozymes Biologicals Inc.(B1.10) Bacillus mycoides, isolate J (available from Certis, USA as BmJ TGAI or WG); (B1.11) Bacillus licheniformis, specifically strain SB3086 (available from Novozymes as EcoGuard™ Biofungicide and Green Releaf); (B1.12) Paenibacillus sp. strains, having accession number NRRL B-50972 or accession number NRRL B-67129, and described in WO 2016 / 154297.

[0438] In some embodiments, the biocontrol agent is a Bacillus subtilis or Bacillus amyloliquefaciens strain that produces a fengycin or plipastatin-type compound, an iturin-type compound, and / or a surfactin-type compound. For background, see the following review article: Ongena, M., et al., "Bacillus Lipopeptides: Versatile Weapons for Plant Disease Biocontrol," Trends in Microbiology, Vol. 16, No. 3, March 2008, pp. 115-125.Bacillus strains capable of producing lipopeptides include Bacillus subtilis QST713 (available from Bayer CropScience LP, USA, as SERENADE OPTI or SERENADE ASO, with NRRL accession number B21661, and described in U.S. Pat. No. 6,060,051), Bacillus amyloliquefaciens strain D747 (available from Certis, USA, as Double Nickel™, with accession number FERM BP-8234, and disclosed in U.S. Pat. No. 7,094,592); Bacillus subtilis MBI600 (available from Becker Underwood, USA, as SUBTILEX™, with EPA registration number 71840-8); Bacillus subtilis Y1336 (available from BioNTech, Taiwan as BIOBAC® WP, registered as a Taiwanese biofungicide under registration numbers 4764, 5454, 5096, and 5277); Bacillus amyloliquefaciens, specifically strain FZB42 (available from ABiTEP, Germany as RHIZOVITAL®); and Bacillus subtilis var. amyloliquefaciens FZB24 (available from Novozymes Biologicals Inc., Salem, Virginia, USA, or Syngenta Crop Protection, LLC, Greensboro, North Carolina, USA, as the fungicide TAEGRO® or TAEGRO® ECO, (EPA registration number 70127-5); and (B2) Fungi, for example: (B2.1) Coniothyrium minitans, in particular the strain CON / M / 91-8 (accession number DSM-9660; e.g., Contans® from Bayer); (B2.2) Metschnikowia fructicola, in particular the strain NRRL Y-30752 (e.g., Shemer®); (B2.3) Microsphaeropsis ochracea (e.g., Microx® from Prophyta); (B2.5) Trichoderma, including Trichoderma atroviride. spp., strain SC1, described in International Patent Application No. PCT / IT2008 / 000196); (B2.6) Trichoderma harzianum rifai, strain KRL-AG2 (also known as strain T-22, / ATCC208479, e.g., PLANTSHIELD T-22G, Rootshield®, and TurfShield from BioWorks (USA); (B2.14) Gliocladium roseum, strain 321U from WF Stoneman Company LLC; (B2.35) Talaromyces flavus, strain V117b; (B2.36) Trichoderma asperellum asperellum, strain ICC012 from Isagro; (B2.37) Trichoderma asperellum, strain SKT-1 (e.g., ECO-HOPE® from Kumiai Chemical Industry); (B2.38) Trichoderma atroviride, strain CNCMI-1237 (e.g., Esquive® WP, Agrauxine (France)); (B2.39) Trichoderma atroviride, strain number V08 / 002387; (B2.40) Trichoderma atroviride, strain NMI number V08 / 002388; (B2.41) Trichoderma atroviride, strain NMI number V08 / 002389; (B2.42) Trichoderma atroviride, strain NMI number V08 / 002390; (B2.43) Trichoderma atroviride, strain LC52 (e.g., Tenet by Agrimm Technologies Limited); (B2.44) Trichoderma atroviride, strain ATCC20476 (IMI 206040); (B2.45) Trichoderma atroviride atroviride, strain T11 (IMI352941 / CECT20498); (B2.46) Trichoderma harmatum; (B2.47) Trichoderma harzianum; (B2.48) Trichoderma harzianum rifai (Trichoderma harzianum rifai) T39 (e.g., Trichodex®, from Makhteshim, USA); (B2.49) Trichoderma harzianum, in particular strain KD (e.g., Trichoplus from Biological Control Products, SA (acquired by Becker Underwood)); (B2.50) Trichoderma harzianum harzianum), strain ITEM908 (e.g., Trianum-P, from Koppert); (B2.51) Trichoderma harzianum, strain TH35 (e.g., Root-Pro by Mycontrol); (B2.52) Trichoderma virens (also known as Gliocladium virens), in particular the strain GL-21 (e.g., SoilGard 12G from Certis, USA); (B2.53) Trichoderma viride, strain TV1 (e.g., Trianum-P from Koppert); (B2.54) Ampelomyces quisqualis, in particular the strain AQ10 (e.g., AQ10® from IntrachemBio Italia); (B2.56) Aureobasidium pullulans, in particular blastospores of the strain DSM 14940; (B2.57) Aureobasidium pullulans pullulans, in particular blastospores of the strain DSM 14941; (B2.58) Aureobasidium pullulans, in particular a mixture of blastospores of the strains DSM 14940 and DSM 14941 (e.g., Botector® by bio-ferm, Switzerland); (B2.64) Cladosporium cladosporioides, strain H39 (by Stichting Dienst Landbouwkundig Onderzoek); (B2.69) Gliocladium catenulatum (syn. Clonostachys rosea f. catenulate) strain J1446 (e.g., Prestop® by AgBio Inc., furthermore, for example, by Kemira Agro Primastop® by Oy; (B2.70) conidia of Lecanicillium lecanii (formerly known as Verticillium lecanii) strain KV01 (e.g. Vertalec® by Koppert / Arysta); (B2.71) Penicillium vermiculatum; (B2.72) Pichia anomala, strain WRL-076 (NRRL Y-30842); (B2.75) Trichoderma atroviride, strain SKT-1 (FERM P-16510); (B2.76) Trichoderma atroviride, strain SKT-2 (FERM P-16511); (B2.77) Trichoderma atroviride, strain SKT-3 (FERM P-17021); (B2.78) Trichoderma gamsii gamsii (formerly T. viride), strain ICC080 (IMI CC392151 CABI, e.g., BioDerma by AGROBIOSOL DE MEXICO, SADE CV); (B2.79) Trichoderma harzianum, strain DB103 (e.g., T-Gro 7456 by Dagutat Biolab); (B2.80) Trichoderma polysporum, strain IMI206039 (e.g., Binab TF WP by BINAB Bio-Innovation AB, Sweden); (B2.81) Trichoderma stromaticum (e.g., Tricovab by Ceplac, Brazil); (B2.83) Ulocladium audemani oudemansii, in particular strain HRU3 (e.g., Botry-Zen® by Botry-Zen Ltd, New Zealand); (B2.84) Verticillium albo-atrum (formerly V. dahliae), strain WCS850 (CBS 276.92; e.g., Dutch Trig by Tree Care Innovations); (B2.86) Verticillium chlamydosporium; (B2.87) A mixture of Trichoderma asperellum strain ICC 012 and Trichoderma gamsii strain ICC 080 (e.g., a product known as BIO-TAM™ from Bayer CropScience LP, USA).

[0439] Further examples of biocontrol agents that may be combined with the compounds of formula (I) and compositions comprising same are: Bacillus cereus, in particular B. cereus strain CNCM I-1562 and Bacillus firmus, strain I-1582 (accession number CNCM I-1582), Bacillus subtilis strain OST 30002 (accession number NRRL B-50421), Bacillus thuringiensis, in particular B. thuringiensis (B. israelensis (serotype H-14), strain AM65-52 (accession number ATCC 1276), B. thuringiensis subsp. aizawai, in particular, strain ABTS-1857 (SD-1372), B. thuringiensis subsp. kurstaki strain HD-1, B. thuringiensis subsp. tenebrionis strain NB176 (SD-5428), Pasteuria penetrans, Pasteuria spp. (Rotylenchulus reniformis nematode)-PR3 (accession number ATCC SD-5834), Streptomyces microflavus strain AQ6121 (= QRD 31.013, NRRL B-50550), and Streptomyces galbus strain AQ 6047 (accession number NRRL 30232);

[0440] Beauveria bassiana, in particular strain ATCC 74040, Lecanicillium spp., in particular strain HRO LEC12, Metarhizium anisopliae, in particular strain F52 (DSM3884 or ATCC 90448), Paecilomyces fumosoroseus (now Isaria fumosorosea), in particular strain IFPC 200613, or strain Apopka 97 (accession number ATCC 20874), and Paecilomyces lilacinus fungi and yeasts selected from the group consisting of P. lilacinus, in particular P. lilacinus strain 251 (AGAL89 / 030550);

[0441] a virus selected from the group consisting of Adoxophyes orana (smaller apple tortrix moth) granulosis virus (GV), Cydia pomonella (codling moth) granulosis virus (GV), Helicoverpa armigera (cotton budworm larvae) nuclear polyhedrosis virus (NPV), Spodoptera exigua (beet armyworm larvae) mNPV, Spodoptera frugiperda (stalk fall armyworm) mNPV, and Spodoptera littoralis (African cotton leafworm) NPV;

[0442] Bacteria and fungi that can be transferred as "inoculants" to plants or plant parts or plant organs and that, due to their specific properties, promote plant growth and plant health. For example, Agrobacterium spp., Azorhizobium caulinodans, Azospirillum spp., Azotobacter spp., Bradyrhizobium spp., Burkholderia spp., in particular Burkholderia cepacia (formerly known as Pseudomonas cepacia), Gigaspora spp. or Gigaspora monosporum, Glomus spp., Laccaria spp. spp.), Lactobacillus buchneri, Paraglomus spp., Pisolithus tinctorus, Pseudomonas spp., Rhizobium spp., in particular Rhizobium trifolii, Rhizopogon spp., Scleroderma spp., Suillus spp., and Streptomyces spp.,

[0443] Allium sativum, Artemisia absinthium, Azadirachtin, Biokeeper WP, Cassia nigricans, Celastrus angulatus, Chenopodium anthelminticum, Chitin, Armour-Zen, Dryopteris filix-mas, Equisetum arvense, Fortune Aza, Fungastop, Heads Up (Chenopodium quinoa saponin extract), Pyrethrum / Pyrethrins, Cassia amara amara, Quercus, Quillaja, Regalia, "Requiem™ Insecticide", rotenone, ryania / ryanodine, Symphytum officinale, Tanacetum vulgare, thymol, Triact 70, TriCon, Tropaeulum majus, Urtica dioica, veratrine, Viscum album, Brassicaceae extracts, particularly plant extracts and products produced by microorganisms containing proteins and secondary metabolites that can be used as biological control agents, such as canola flour or mustard powder.

[0444] Examples of insecticides, acaricides and nematicides, respectively, which can be mixed with the compounds of formula (I) and compositions comprising them are as follows: (1) acetylcholinesterase (AChE) inhibitors, such as carbamates, for example, alanycarb, aldicarb, bendiocarb, benfuracarb, butocarboxim, butoxycarboxim, carbaryl, carbofuran, carbosulfan, ethiofencarb, fenobucarb, formetanate, furathiocarb, isoprocarb, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, triazamate, trimethacarb, XMC, and xylylcarb; or organic phosphates, for example, acephate, azamethiphos, azinphos-ethyl, azinphos-methyl, cadusafos, chlorethoxyphos, chlorfenvinphos, chlormephos, chlorpyrifos-methyl, coumaphos, cyanophosphos, demeton-S-methyl, diazinon, dichlorvos / DDVP, Dicrotophos, dimethoate, dimethylvinphos, disulfoton, EPN, ethion, ethoprophos, famfur, fenamiphos, fenitrothion, fenthion, fosthiazate, heptenophos, imicyaphos, isofenphos, isopropyl O-(methoxyaminothiophosphoryl)salicylate, isoxathion, malathion, mecarbam, methamidophos, methidathion, mevinphos, monocrotophos, naled, omethoate, oxydemeton methyl, parathion methyl, phenthoate, phorate, phosalone, phosmet, phosphamidon, phoxim, pirimiphos methyl, profenofos, propetamphos, prothiofos, pyraclofos, pyridaphenthion, quinalphos, sulfotep, tebupirimfos, temephos, terbufos, tetrachlorvinphos, thiometon, triazophos, trichlorfon and vamidothion, etc.

[0445] (2) GABA-gated chloride channel blockers, such as cyclodiene-organochlorines, such as chlordane and endosulfan, or phenylpyrazoles (fiproles), such as ethiprole and fipronil.

[0446] (3) Sodium channel modulators, for example, pyrethroids, such as acrinathrin, allethrin, d-cis-trans allethrin, d-trans allethrin, bifenthrin, bioallethrin, bioallethrin s-cyclopentenyl isomer, bioresmethrin, cycloprothrin, cyfluthrin, β-cyhalothrin, cyhalothrin, λ-cyhalothrin, γ-cyhalothrin, cypermethrin, α-cypermethrin, β-cypermethrin, θ-cypermethrin, zeta-cypermethrin, cyphenothrin [(1R)-trans isomer], deltamethrin, empenthrin, thrin [(EZ)-(1R) isomer], esfenvalerate, etofenprox, fenpropathrin, fenvalerate, flucythrinate, flumethrin, taufluvalinate, halfenprox, imiprothrin, kadesrin, momfluorotrin, permethrin, fenothrin [(1R)-trans isomer], prallethrin, pyrethrins (pyrethrum), resmethrin, silafluofen, tefluthrin, tetramethrin, tetramethrin [(1R)-isomer)], tralomethrin and transfluthrin or DDT or methoxychlor, etc.

[0447] (4) Nicotinic acetylcholine receptor (nAChR) competitive modulators, such as neonicotinoids, such as acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid and thiamethoxam or nicotine or sulfoxaflor or flupyradifurone.

[0448] (5) Nicotinic acetylcholine receptor (nAChR) allosteric modulators, such as spinosyns, e.g., spinetoram and spinosad.

[0449] (6) Glutamate-gated chloride channel (GluCl) allosteric modulators, such as avermectins / mibemycins, such as abamectin, emamectin benzoate, lepimectin, and milbemectin.

[0450] (7) Juvenile hormone mimetics, such as juvenile hormone analogues, such as hydroprene, kinoprene and methoprene or fenoxycarb or pyriproxyfen.

[0451] (8) Various nonspecific (multipoint) inhibitors, such as alkyl halides, e.g., methyl bromide and other alkyl halides; or chloropicrin or sulfuryl fluoride or borax or tartar emetic or methyl isocyanate generating agents, e.g., dazomet and metam.

[0452] (9) Chordotonal organ modulators, such as pymetrozine or flonicamide.

[0453] (10) Acar growth inhibitors, such as clofentezine, hexythiazox, and diflobidazine or etoxazole.

[0454] (11) Microbial disruptors of insect gut membranes, such as Bacillus thuringiensis subsp. israelensis, Bacillus sphaericus, Bacillus thuringiensis subsp. aizawai, Bacillus thuringiensis subsp. kurstaki, Bacillus thuringiensis subsp. tenebrionis, and Bt plant proteins: Cry1Ab, Cry1Ac, Cry1Fa, Cry1A.105, Cry2Ab, Vip3A, mCry3A, Cry3Ab, Cry3Bb, and Cry34Ab1 / 35Ab1.

[0455] (12) ATP disruptors such as inhibitors of mitochondrial ATP synthase, for example, diafenthiuron or organotin compounds, for example, azocyclotin, cyhexatin and fenbutatin oxide or propargite or tetradifon.

[0456] (13) Uncouplers of oxidative phosphorylation by perturbing the proton gradient, such as chlorfenapyr, DNOC, and sulfluramide.

[0457] (14) Nicotinic acetylcholine receptor channel blockers, such as bensultap, cartap hydrochloride, thiosultap sodium salt, and the like.

[0458] (15) Inhibitors of chitin biosynthesis, type 0, such as bistrifluron, chlorfluazuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron, and triflumuron.

[0459] (16) Chitin biosynthesis inhibitors, type 1, such as buprofezin.

[0460] (17) Molting disruptors (especially for Diptera, i.e., for Diptera), such as cyromazine.

[0461] (18) Ecdysone receptor agonists, such as chromafenozide, halofenozide, methoxyfenozide, and tebufenozide.

[0462] (19) Octopamine receptor agonists, such as amitraz.

[0463] (20) Mitochondrial complex III electron transport inhibitors, such as hydramethylnon or acequinocyl or fluacrypyrim.

[0464] (21) Mitochondrial complex I electron transport inhibitors, such as, for example, fenazaquin, fenpyroximate, pyrimidifen, pirdaben, tebufenpyrad and tolfenpyrad or rotenone (Derris) from the group of METI acaricides.

[0465] (22) Voltage-gated sodium channel blockers, such as indoxacarb or metaflumizone.

[0466] (23) Inhibitors of acetyl-CoA carboxylase, such as tetronic acid and tetramic acid derivatives, such as spirodiclofen, spiromesifen, and spirotetramat.

[0467] (24) Mitochondrial complex IV electron transport inhibitors, such as phosphines, such as aluminum phosphide, calcium phosphide, phosphorus hydride, and zinc phosphide, or cyanides, such as calcium cyanide, potassium cyanide, and sodium cyanide.

[0468] (25) Mitochondrial complex II electron transport inhibitors, such as β-ketone nitrile derivatives, such as cyenopyrafen and cyflumetofen, and carboxanilides, such as piflubumid.

[0469] (28) Ryanodine receptor modulators, such as diamides, for example, chlorantraniliprole, cyantraniliprole, and flubendiamide. Further active compounds, such as afidopiropen, afoxolaner, azadirachtin, benclothiaz, benzoximate, bifenazate, brofuranilide, bromopropylate, quinomethionate, chlorprallethrin, cryolite, cyclaniliprole, cycloxapride, cyhalodiamide, dichloromezothiaz, dicofol, ε-metofluthrin, ε-momfluthrin, flometoquin, fluazaindolizine, fluensulfone, flufenerim, flufenoxystrobin, flufiprole, fluhexafon, fluopyra fluralaner, fluxamethamide, fufenozide, guadipyr, heptafluthrin, imidaclothiz, iprodione, kappa-bifenthrin, kappa-tefluthrin, lotilaner, meperfluthrin, paichondine, pyridalyl, pyrifluquinazone, pyriminostrobin, spirobudiclofen, tetramethylfluthrin, tetraniliprole, tetrachlorantraniliprole, tigoraner, thioxazaphen, thiofluoximate, triflumezopyrim, and iodomethane; and further Bacillus firmus (Bacillus firmus) based formulations (I-1582, BioNeem, Votivo), and the following compounds: 1-{2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl}-3-(trifluoromethyl)-1H-1,2,4-triazol-5-amine (known from WO 2006 / 043635) (CAS 885026-50-6), {1'-[(2E)-3-(4-chlorophenyl)prop-2-en-1-yl]-5-fluorospiro[indole-3,4'-piperidine]-1(2H)-yl}(2-chloropyridin-4-yl)ethanone (known from WO 2003 / 106457) (CAS 637360-23-7), 2-chloro-N-[2-{1-[(2E)-3-(4-chlorophenyl)prop-2-en-1-yl]piperidin-4-yl}-4-(trifluoromethyl)phenyl]isonicotinamide (known from WO 2006 / 003494) (CAS 872999-66-1), 3-(4-chloro-2,6-dimethylphenyl)-4-hydroxy-8-methoxy-1,8-Diazaspiro[4.5]dec-3-en-2-one (known from WO 2010052161) (CAS 1225292-17-0), 3-(4-chloro-2,6-dimethylphenyl)-8-methoxy-2-oxo-1,8-diazaspiro[4.5]dec-3-en-4-ylethyl carbonate (known from EP 2647626) (CAS 1440516-42-6), 4-(but-2-yn-1-yloxy)-6-(3,5-dimethylpiperidin-1-yl)-5-fluoropyrimidine (known from WO 2004 / 099160) (CAS 792914-58-0), PF1364 (known from JP 2010 / 018586) (CAS 1204776-60-2), N-[(2E)-1-[(6-chloropyridin-3-yl)methyl]pyridin-2(1H)-ylidene]-2,2,2-trifluoroacetamide (known from WO 2012 / 029672) (CAS 1363400-41-2), (3E)-3-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-1,1,1-trifluoro-propan-2-one (known from WO 2013 / 144213) (CAS 1461743-15-6), N-[3-(benzylcarbamoyl)-4-chlorophenyl]-1-methyl-3-(pentafluoroethyl)-4-(trifluoromethyl)-1H-pyrazole-5-carboxamide (known from WO 2010 / 051926) (CAS 1226889-14-0), 5-bromo-4-chloro-N-[4-chloro-2-methyl-6-(methylcarbamoyl)phenyl]-2-(3-chloro-2-pyridyl)pyrazole-3-carboxamide (known from Chinese Patent 103232431) (CAS 1449220-44-3), 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-2-methyl-N-(cis-1-oxido-3-thietanyl)-benzamide, 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-2-methyl-N-(trans-1-oxido-3-thietanyl)-benzamide and 4-[(5S)-5-(3,5-dichlorophenyl)-4,5-Dihydro-5-(trifluoromethyl)-3-isoxazolyl]-2-methyl-N-(cis-1-oxide-3-thietanyl)benzamide (known from WO 2013 / 050317(A1)) (CAS 1332628-83-7), N-[3-chloro-1-(3-pyridinyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluoropropyl)sulfinyl]-propanamide, (+)-N-[3-chloro-1-(3-pyridinyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluoropropyl)sulfinyl]-propanamide Panamide and (-)-N-[3-chloro-1-(3-pyridinyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluoropropyl)sulfinyl]-propanamide (known from WO 2013 / 162715(A2), WO 2013 / 162716(A2), U.S. Patent Application Publication No. 2014 / 0213448(A1)) (CAS 1477923-37-7), 5-[[(2E)-3-chloro-2-propen-1-yl]amino]-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile (known from Chinese Patent No. 101337937A) (CAS 1105672-77-2), 3-bromo-N-[4-chloro-2-methyl-6-[(methylamino)thiooxomethyl]phenyl]-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide, (Liudaibenjiaxuanan, known from Chinese Patent No. 103109816A) (CAS 1232543-85-9; N-[4-chloro-2-[[(1,1-dimethylethyl)amino]carbonyl]-6-methylphenyl]-1-(3-chloro-2-pyridinyl)-3-(fluoromethoxy)-1H-pyrazole-5-carboxamide (known from WO 2012 / 034403(A1)) (CAS 1268277-22-0), N-[2-(5-amino-1,3,

[0023] 4-thiadiazol-2-yl)-4-chloro-6-methylphenyl]-3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide (known from WO 2011 / 085575(A1)) (CAS 1233882-22-8), 4-[3-[2,6-dichloro-4-[(3,3-dichloro-2-propen-1-yl)oxy]phenoxy]propoxy]-2-methoxy-6-(trifluoromethyl)-pyrimidine (known from Chinese Patent No. 101337940A) (CAS 1108184-52-6; (2E)- and 2(Z)-2-[2-(4-cyanophenyl)-1-[3-(trifluoromethyl)phenyl]ethylidene]-N-[4-(difluoromethoxy)phenyl]-hydrazine e carboxamide (known from Chinese Patent No. 101715774A) (CAS 1232543-85-9); 3-(2,2-dichloroethenyl)-2,2-dimethyl-4-(1H-benzimidazol-2-yl)cyclopropanecarboxylic acid phenyl ester (known from Chinese Patent No. 103524422A) (CAS 1542271-46-4;(4aS)-7-chloro-2,5-dihydro-2-[[(methoxycarbonyl)[4-[(trifluoromethyl)thio]phenyl]amino]carbonyl]-indeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylic acid methyl ester (known from Chinese Patent No. 102391261A) (CAS 1370358-69-2);6-deoxy-3-O-ethyl-2,4-di-O-methyl-,1-[N-[4-[1-[4-(1,1,2,2,2-pentafluoroethoxy)phenyl]-1H-1,2,4-triazol-3-yl]phenyl]carbamate]-α-L-mannopyranose (known from U.S. Patent Application Publication No. 2014 / 0275503(A1)) (CAS 1181213-14-8); 8-(2-cyclopropylmethoxy-4-trifluoromethyl-phenoxy)-3-(6-trifluoromethyl-pyridazin-3-yl)-3-aza-bicyclo[3.2.1]octane (CAS 1253850-56-4), (8-anti)-8-(2-cyclopropylmethoxy-4-trifluoromethyl-phenoxy)-3-(6-trifluoromethyl-pyridazin-3-yl)-3-aza-bicyclo[3.2.1]octane (CAS 933798-27-7), (8-syn)-8-(2-cyclopropylmethoxy-4-trifluoromethyl-phenoxy)-3-(6-trifluoromethyl-pyridazin-3-yl)-3-aza-bicyclo[3.2.1]octane (known from WO 2007040280(A1) and WO 2007040282(A1)) (CAS 934001-66-8), N-[3-chloro-1-(3-pyridinyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluoropropyl)thio]-propanamide (known from WO 2015 / 058021(A1) and WO 2015 / 058028(A1)) (CAS 1477919-27-9), N-[4-(aminothioxomethyl)-2-methyl-6-[(methylamino)carbonyl]phenyl]-3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide (known from Chinese Patent No. 103265527 A) (CAS 1452877-50-7), 5-(1,3-dioxan-2-yl)-4-[[4-(trifluoromethyl)phenyl]methoxy]-pyrimidine (known from WO 2013 / 115391(A1)) (CAS 1449021-97-9), 3-(4-chloro-2,6-dimethylphenyl)-4-hydroxy-8-methoxy-1-methyl-1,8-diazaspiro[4.5]dec-3-en-2-one (known from WO 2010 / 066780(A1) and WO 2011 / 151146(A1)) (CAS 1229023-34-0), 3-(4-chloro-2,6-dimethylphenyl)-8-methoxy-1-methyl-1,8-diazaspiro[4.5]decane-2,4-dione (known from WO 2014 / 187846(A1)) (CAS 1638765-58-8), 3-(4-chloro-2,6-dimethylphenyl)-8-methoxy-1-methyl-2-oxo-1,8-diazaspiro[4.5]dec-3-en-4-ylcarbonic acid ethyl ester (known from WO 2010 / 066780(A1) and WO 2011151146(A1)) (CAS 1229023-00-0), N-[1-[(6-chloro-3-pyridinyl)methyl]-2(1H)-pyridinylidene]-2,2,2-trifluoro-acetamide (known from German Patent Application Publication No. 3639877(A1) and International Publication No. 2012029672(A1)) (CAS 1363400-41-2), [N(E)]-N-[1-[(6-chloro-3-pyridinyl)methyl]-2(1H)-pyridinylidene]-2,2,2-trifluoro-acetamide (known from International Publication No. 2016005276(A1)) (CAS 1689566-03-7), [N(Z)]-N-[1-[(6-chloro-3-pyridinyl)methyl]-2(1H)-pyridinylidene]-2,2,2-trifluoro-acetamide, (CAS 1702305-40-5), 3-endo-3-[2-pro, [5-(trifluoromethyl)-2-pyridinyl]oxy]-9-azabicyclo[3.3.1]nonane (known from WO 2011 / 105506(A1) and WO 2016 / 133011(A1)) (CAS 1332838-17-1).

[0470] Examples of safeners which may be mixed with the compounds of formula (I) and compositions comprising them are, for example, benoxacor, cloquintocet (-mexyl), cyometrinil, cyprosulfamide, dichlormid, fenchlorazole (-ethyl), fenclorim, flurazole, fluxofenim, furilazole, isoxadifen (-ethyl), mefenpyr (-diethyl), naphthalic anhydride, oxabetrinil, 2-methoxy-N-({4-[(methylcarbamoyl)amino]phenyl}sulfonyl)benzamide (CAS 129531-12-0), 4-(dichloroacetyl)-1-oxa-4-azaspiro[4.5]decane (CAS 71526-07-3), 2,2,5-trimethyl-3-(dichloroacetyl)-1,3-oxazolidine (CAS 52836-31-4).

[0471] Examples of herbicides that can be mixed with the compounds of formula (I) and compositions comprising them are: Acetochlor, acifluorfen, acifluorfen sodium, aclonifen, alachlor, allidochlor, alloxydim, alloxydim sodium, ametryn, amicarbazone, amidochlor, amidosulfuron, 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methylphenyl)-5-fluoropyridine-2-carboxylic acid, aminocyclopyrachlor, aminocyclopyrachlor-potassium salt, aminocyclopyrachlor-methyl, aminopyralid, amitrole, sulfur Ammonium fluoride, Anilofos, Asulam, Atrazine, Azafenidine, Azimsulfuron, Beflubutamid, Benazolin, Benazolin-ethyl, Benfluralin, Benfuresate, Bensulfuron, Bensulfuron-methyl, Bensulide, Bentazon, Benzobicyclon, Benzofenap, Benzobicyclon, Bifenox, Biranaphos, Biranaphos-sodium, Bispyribac, Bispyribac-sodium, Bromacil, Bromobutide, Bromofenoxime, Bromoxynil, Bromoxy nyl-butyrate, potassium heptanoate, and potassium octanoate, busoxinone, butachlor, butafenacil, butamiphos, butenachlor, butralin, butroxydim, butyrate, cafenstrole, carbetamide, carfentrazone, carfentrazone-ethyl, chloramben, chlorbromuron, chlorfenac, chlorfenac-sodium, chlorfenprop, chlorflurenol, chlorfenprop-methyl, chloridazon, chlorimuron, chlorimuron-ethyl , chlorphthalim, chlorotoluron, chlorthal-dimethyl, chlorsulfuron, cinidon, cinidon-ethyl, cinmethylin, cinosulfuron, clasifos, clethodim, clodinafop, clodinafop-propargyl, clomazone, clomeprop, clopyralid, chloransulam, chloransulam-methyl, cumyluron, cyanamide, cyanazine, cycloate, cyclopyrimorate, cyclosulfamuron, cycloxydim, cyhalofop, cyhalofop-butyl, cyprazine, 2,4-D, 2,4-D-butylic, butyl, dimethylammonium, diolamine, ethyl, 2-ethylhexyl, isobutyl, isooctyl, isopropylammonium, potassium, triisopropanolammonium, and trolamine, 2,4-DB, 2,4-DB-butyl, dimethylammonium, isooctyl, potassium, and sodium, dymron, dalapon, dazomet, n-decanol , desmedipham, destosyl-pyrazolate (DTP), dicamba, dichlobenil, 2-(2,4-dichlorobenzyl)-4,4-dimethyl-1,2-oxazolidin-3-one, 2-(2,5-dichlorobenzyl)-4,4-dimethyl-1,2-oxazolidin-3-one, dichlorprop, dichlorprop-P, diclofop, diclofop-methyl, diclofop-P-methyl, diclosulam, difenzoquat, diflufenican, diflufenzopyr, Diflufenzopyr-sodium, dimefuron, dimepiperate, dimethachlor, dimethametrin, dimethenamid, dimethenamid-P, dimetrasulfuron, dinitramine, dinoterb, diphenamide, diquat, diquat-dibromide, dithiopyr, diuron, DNOC, endothall, EPTC, esprocarb, ethalfluralin, ethametsulfuron, ethametsulfuron-methyl, etiodin, ethofumesate, ethoxyfen, ethoxyfen-ethyl , ethoxysulfuron, etobenzanide, F-9600, F-5231, i.e., N-{2-chloro-4-fluoro-5-[4-(3-fluoropropyl)-5-oxo-4,5-dihydro-1H-tetrazol-1-yl]phenyl}ethanesulfonamide, F-7967, i.e., 3-[7-chloro-5-fluoro-2-(trifluoromethyl)-1H-benzimidazol-4-yl]-1-methyl-6-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione, fenoxaprop, fenoxaprop-P, fenoxaprop-ethyl, fenoxaprop-P-ethyl, fenoxasulfone, fenquinotrione, fentrazamide, flamprop, flamprop-M-isopropyl, flamprop-M-methyl, flazasulfuron, florasulam, fluazifop, fluazifop-P, fluazifop-butyl, fluazifop-P-butyl, flucarbazone, flucarbazone-sodium, flucetosulfuron fluchloralin, flufenacet, flufenpyr, flufenpyr-ethyl, flumetsulam, flumiclorac, flumiclorac-pentyl, flumioxazin, fluometuron, flurenol, flurenol-butyl, dimethylammonium and methyl, fluoroglycofen, fluoroglycofen-ethyl, flupropanate, flupyrsulfuron, flupyrsulfuron-methyl-sodium, fluridone, flurochloridone, fluroxypyr, fluroxypyr-meptyl, flurtamone, fluthiacet, fluthiacet-methyl, fomesafen, fomesafen-sodium, foramsulfuron, fosamine, glufosinate, glufosinate-ammonium, glufosinate-P-sodium, glufosinate-P-ammonium, glufosinate-P-sodium, glyphosate, glyphosate-ammonium, isopropylammonium, diammonium, dimethylammonium, potassium, sodium, and trimesium, H-92 01, i.e., O-(2,4-dimethyl-6-nitrophenyl) O-ethyl isopropyl phosphoramidothioate, haloxifene, haloxifene-methyl, halosafen, halosulfuron, halosulfuron-methyl, haloxyfop, haloxyfop-P, haloxyfop-ethoxyethyl, haloxyfop-P-ethoxyethyl, haloxyfop-methyl, haloxyfop-P-methyl, hexazinone, HW-02, i.e., 1-(dimethoxyphosphoryl)ethyl-(2,4-Dichlorophenoxy)acetate, imazamethabenz, imazamethabenz-methyl, imazamox, imazamox-ammonium, imazapic, imazapic-ammonium, imazapyr, imazapyr-isopropylammonium, imazaquin, imazaquin-ammonium, imazethapyr, imazethapyr-immonium, imazosulfuron, indanofan, indaziflam, iodosulfuron, iodosulfuron-methyl-sodium, ioxynil, ioxynil-octanoate, potassium and sodium um, ipfencarbazone, isoproturon, isouron, isoxaben, isoxaflutole, carbutilate, KUH-043, i.e., 3-({[5-(difluoromethyl)-1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]methyl}sulfonyl)-5,5-dimethyl-4,5-dihydro-1,2-oxazole, ketospiradox, lactofen, lenacil, linuron, MCPA, MCPA-butyric acid, dimethylammonium, 2-ethylhexyl, isopropylammonium. , -potassium, and sodium, MCPB, MCPB-methyl, -ethyl, and -sodium, mecoprop, mecoprop-sodium, and -butotil, mecoprop-P, mecoprop-P-butotil, -dimethylammonium, -2-ethylhexyl, and -potassium, mefenacet, mefluidide, mesosulfuron, mesosulfuron-methyl, mesotrione, methabenzthiazuron, metam, metamifop, metamitron, metazachlor, metazosulfuron, methabenzthiazuron, methiopyrsulf ron, methiozolin, methyl isothiocyanate, metobromuron, metolachlor, S-metolachlor, metoslam, metoxuron, metribuzin, metsulfuron, metsulfuron-methyl, molinate, monolinuron, monosulfuron, monosulfuron-ester, MT-5950, i.e., N-(3-chloro-4-isopropylphenyl)-2-methylpentanamide, NGGC-011, napropamide, NC-310, i.e., [5-(benzyloxy)-1-methyl-1H-pyrazol-4-yl](2,4-Dichlorophenyl)methanone, nebron, nicosulfuron, nonanoic acid (pelargonic acid), norflurazon, oleic acid (fatty acid), orbencarb, orthosulfamuron, oryzalin, oxadiargyl, oxadiazon, oxasulfuron, oxaziclomefon, oxyfluorfen, paraquat, paraquat dichloride, pebulate, pendimethalin, penoxsulam, pentachlorophenol, pentoxazone, petoxamide, petroleum, phenmedipham, picloram, picolinafen, pinoxaden, piperophos, pretirachlor , primisulfuron, primisulfuron-methyl, prodiamine, profoxydim, prometon, prometryn, propachlor, propanil, propachlor, propazine, propham, propisochlor, propoxycarbazone, propoxycarbazone-sodium, propyrisulfuron, propyzamide, prosulfocarb, prosulfuron, pyraclonil, pyraflufen, pyraflufen-ethyl, pyrasulfotole, pyrazolinate (pyrazolate), pyrazosulfuron, pyrazosulfuron-ethyl, pyrazoxyfen, pyribambenz, Pyribambenz-isopropyl, Pyribambenz-propyl, Pyribenzoxim, Pyributicarb, Pyridafol, Piridate, Piriftalid, Pyriminobac, Pyriminobac-methyl, Pyrimisulfan, Pyrithiobac, Pyrithiobac-sodium, Pyroxasulfone, Piroxsulam, Quinclorac, Quinmelac, Quinoclamine, Quizalofop, Quizalofop-ethyl, Quizalofop-P, Quizalofop-P-ethyl, Quizalofop-P-tefuryl, Rimsulfuron, Saflufenacil, Sethoxydim, Siduron, Simazine, Simetryne , SL-261, sulcotrione, sulfentrazone, sulfometuron, sulfometuron-methyl, sulfosulfuron, SYN-523, SYP-249, i.e., 1-ethoxy-3-methyl-1-oxobut-3-en-2-yl 5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoate, SYP-300, i.e., 1-[7-fluoro-3-oxo-4-(prop-2-yn-1-yl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl]-3-propyl-2-thiooxoimidazolidine-4,5-dione, 2,3,6-TBA, TCA (trichloroacetic acid), TCA-sodium, tebuthiuron, tefuryltrione, tembotrione, tepraloxydim, terbacil, terbugalb, terbumeton, terbuthylazine, terbutryn, thenylchlor, thiazopyr, thiencarbazone, thiencarbazone-methyl, thifensulfuron, thifensulfuron-methyl, thiobencarb, thiafenacil, tolpyralate, topramezone, tralkoxydim, triafamone, triallate, tri Asulfuron, triaziflam, tribenuron, tribenuron-methyl, triclopyr, trietazine, trifloxysulfuron, trifloxysulfuron-sodium, trifludimoxazine, trifluralin, triflusulfuron, triflusulfuron-methyl, tritosulfuron, urea sulfate, vernolate, XDE-848, ZJ-0862, i.e., 3,4-dichloro-N-{2-[(4,6-dimethoxypyrimidin-2-yl)oxy]benzyl}aniline, as well as the following compounds:

[0472] [ka]

[0473] Examples of plant growth regulators are: Acibenzolar, acibenzolar-S-methyl, 5-aminolevulinic acid, ancymidol, 6-benzylaminopurine, brassinolide, catechin, chlormequat chloride, cloprop, cyclanilide, 3-(cycloprop-1-enyl)propionic acid, daminozide, dazomet, n-decanol, dikegulac, dikegulac-sodium, endothal, endothal-dipotassium, disodium, and mono(N,N-dimethylalkylammonium), ethephon, flumetralin, flurenol, flurenol-butyl, flurprimidol, forchlorfenuron, gibberellic acid, inabenfide, indole-3-acetic acid (IAA), 4-isopropyl methyl ... andol-3-ylbutyric acid, isoprothiolane, probenazole, jasmonic acid, maleic hydrazide, mepiquat chloride, 1-methylcyclopropene, methyl jasmonate, 2-(1-naphthyl)acetamide, 1-naphthylacetic acid, 2-naphthyloxyacetic acid, nitrophenolate mixture, paclobutrazol, N-(2-phenylethyl)-β-alanine, N-phenylphthalamic acid, prohexadione, prohexadione-calcium, prohydrojasmone, salicylic acid, strigolactone, tecnazene, thidiazulo, triacontanol, trinexapac, trinexapac-ethyl, tsitodef, uniconazole, and uniconazole-P.

[0474] Methods and Uses The compounds of formula (I) and compositions comprising them have the potential for strong fungicidal activity and / or plant control regulation.They can be used to control unwanted microorganisms such as unwanted fungi and bacteria.As described in more detail below, they can be particularly useful for crop protection (they control microorganisms that cause plant diseases) or for protecting materials (e.g., industrial materials, wood, plants, and possessions).More specifically, the compounds of formula (I) and compositions comprising them can be used to protect seeds, germinated seeds, emergent seedlings, plants, plant parts, fruits, harvested products, and / or the soil in which plants grow from unwanted microorganisms.

[0475] As used herein, control or controlling includes protective, curative, and eradication treatments of unwanted microorganisms. The unwanted microorganisms may be pathogenic bacteria, pathogenic viruses, pathogenic oomycetes, or pathogenic fungi, more particularly, plant pathogenic bacteria, plant pathogenic viruses, plant pathogenic oomycetes, or plant pathogenic fungi. As detailed herein below, these plant pathogenic microorganisms are the cause of a wide spectrum of plant diseases.

[0476] More particularly, the compounds of formula (I) and compositions comprising same can be used as fungicides. For the purpose of description, the term "fungicide" refers to compounds or compositions that can be used in crop protection for the control of unwanted fungi such as Plasmodiophoromycetes, Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and Deuteromycetes, and / or for the control of oomycetes.

[0477] The compounds of formula (I) and compositions comprising them may be used as antimicrobial agents, in particular in crop protection, for example in the control of unwanted bacteria such as Pseudomonadaceae, Rhizobiaceae, Xanthomonadaceae, Enterobacteriaceae, Corynebacteriaceae and Streptomycetaceae.

[0478] The compounds of formula (I) and compositions comprising the same may be used as antiviral agents in crop protection. For example, the compounds of formula (I) and compositions comprising the same may be used to combat Tobacco Mosaic Virus (TMV), Tobacco Rattle Virus, Tobacco Dwarf Virus (TStuV), Tobacco Leaf Curl Virus (VLCV), Tobacco Nervillia Mosaic Virus (TVBMV), Tobacco Necrotic Dwarf Virus (TNDV), Tobacco Streak Virus (TSV), Potato Virus X (PVX), Potato Viruses Y, S, M, and A, Potato Yellow Mottle Virus (PAMV), Potato Mop Top Virus (PMTV), Potato Leaf Curl Virus (PLRV), Alfalfa Mosaic Virus (AMV), Cucumber Mosaic Virus (CMV), Cucumber Green Mottle Virus (PMV), Potato Leaf Curl Virus (PLRV), Potato Virus X (PVX), Potato Virus ... Leaf Curl Virus (PLRV), Potato Leaf Curl Virus (PLRV), Potato Leaf Curl Virus (PLRV), Potato Leaf Curl Virus (PLRV), Potato Leaf The present invention may be effective against diseases caused by plant viruses such as Cucumber yellows virus (CGMMV), Cucumber yellows virus (CuYV), Watermelon mosaic virus (WMV), Tomato yellows dwarf virus (TSWV), Tomato ringspot virus (TomRSV), Sugarcane mosaic virus (SCMV), Rice dwarf virus, Rice stripe virus, Rice black-streaked dwarf virus, Strawberry mottle virus (SMoV), Strawberry vein banding virus (SVBV), Strawberry mild yellow edge virus (SMYEV), Strawberry crinkle virus (SCrV), Broad bean wilt virus (BBWV), and Melon necrotic spot virus (MNSV).

[0479] The present invention also relates to a method for controlling unwanted microorganisms, such as unwanted fungi, oomycetes and bacteria, comprising the step of applying to the microorganisms and / or the locus (plants, plant parts, seeds, fruits or the soil in which the plants grow) at least one compound of formula (I) or at least one composition.

[0480] Typically, when compounds of formula (I) and compositions comprising the same are used in curative or protective methods for controlling phytopathogenic fungi and / or phytopathogenic oomycetes, an effective and plant-compatible amount is applied to plants, plant parts, fruits, seeds, or the soil or substrate on which the plants grow. Suitable substrates that may be used to cultivate plants include inorganic substrates such as mineral wool, especially stone wool, perlite, sand, or gravel; organic substrates such as peat, pine bark, or sawdust; and petroleum-based substrates such as polymer foam or plastic beads. An effective and plant-compatible amount refers to an amount sufficient to control or destroy fungi that tend to be present or appear on agricultural land, without causing noticeable signs of phytotoxicity to the crop. Such amounts can vary within a wide range depending on the fungi to be controlled, the type of crop, the stage of crop development, climatic conditions, and the respective compounds or compositions of formula (I) used. This amount can be determined by systematic field testing, which is within the capabilities of those skilled in the art.

[0481] Plants and plant parts The compounds of formula (I) and compositions comprising same may be sprayed onto any plant or plant part.

[0482] Plants refer to all plants and groups of plants, such as desired and unwanted wild plants or crops (including natural crops). Crops may be obtained by conventional breeding and optimization methods or by biotechnology and genetic engineering methods or a combination thereof, and may include genetically modified plants (GMOs or transgenic plants) and protected and unprotected plant cultivars under plant breeders' rights.

[0483] Genetically modified plants (GMOs) Genetically modified plants (GMO or transgenic plants) are plants in which a heterologous gene has been stably integrated into their genome. The expression "heterologous gene" essentially refers to a gene that is provided or assembled outside the plant's nucleus, chloroplast, or mitochondrial genome when introduced into the plant's nucleus. This gene confers new or improved agronomic or other properties on the transformed plant by expressing a protein or polypeptide of interest or by downregulating or silencing other genes present in the plant (for example, using antisense, co-suppression, RNA interference (RNAi) or microRNA (miRNA) technologies). A heterologous gene present in the genome is also called a transgene. A transgene defined by its specific location in the plant genome is called a transformation or transgenic event.

[0484] Plant cultivars are understood to mean plants having novel properties ("genetic traits") and obtained by conventional breeding, mutagenesis or recombinant DNA techniques. These may be cultivars, varieties, biotypes or genotypes.

[0485] Plant parts are understood to mean all parts and organs of a plant above and below ground level, such as shoots, leaves, needles, stalks, stems, flowers, fruiting bodies, fruits, seeds, roots, tubers and rhizomes, etc. Plant parts also include harvested material as well as plant material and generative propagation material, such as cuttings, tubers, rhizomes, seedlings and seeds.

[0486] Plants that may be treated according to the methods described herein include cotton, flax, grapes, fruits, vegetables, such as Rosaceae sp. (e.g., pome fruits such as apples and pears, as well as stone fruits such as apricots, cherries, almonds, and peaches, and soft fruits such as strawberries), Ribesioidae sp., Juglandaceae sp., Betulaceae sp., Anacardiaceae sp., Fagaceae sp., Moraceae sp., Oleaceae sp., Actinidaceae sp., Lauraceae sp., Musaceae sp. (e.g. banana trees and plantations), Rubiaceae sp. (e.g. coffee), Theaceae sp., Sterculiceae sp., Rutaceae sp. (e.g. lemon, orange and grapefruit); Solanaceae sp. (e.g. tomato), Liliaceae sp., Asteraceae sp. (e.g. lettuce), Umbelliferae sp., Cruciferae sp., Chenopodiaceae sp., Cucurbitaceae sp. (e.g. cucumber), Alliaceae sp.) (e.g., chives, onions), Papilionaceae sp. (e.g., peas); major crops, e.g., Gramineae sp. (e.g., maize, grass, cereals such as wheat, rye, rice, barley, oats, millet and triticale), Asteraceae sp. (e.g., sunflowers), Brassicaceae sp.) (e.g., white cabbage, red cabbage, broccoli, cauliflower, Brussels sprouts, bok choy, turnip cabbage, radish, and rapeseed, mustard greens, horseradish, and watercress), Fabacae sp. (e.g., kidney beans, peanuts), Papilionaceae sp. (e.g., soybeans), Solanaceae sp. (e.g., potatoes), Chenopodiaceae sp., etc.

[0487] Plants and plant cultivars that may be treated by the disclosed methods include plants and plant cultivars that are tolerant to one or more biotic stresses, i.e., the plants exhibit better protection against animal and microbial pests, such as nematodes, insects, mites, plant pathogenic fungi, bacterial viruses and / or viroids.

[0488] Plants and plant cultivars that can be treated by the disclosed methods include plants that are tolerant to one or more abiotic stresses. Abiotic stress conditions can include, for example, drought, low temperature exposure, heat exposure, osmotic stress, flooding, increased soil salinity, increased mineral exposure, ozone exposure, high light exposure, limited availability of nitrogen nutrients, limited availability of phosphorus nutrients, and shade avoidance.

[0489] Plants and plant cultivars that can be treated by the disclosed methods include plants characterized by enhanced yield characteristics. The increased yield of the plants can be the result of, for example, water use efficiency, water retention efficiency, improved nitrogen use, enhanced carbon assimilation, improved photosynthesis, increased germination efficiency, and accelerated maturation. Furthermore, yield is influenced by improved plant architecture (under stress and non-stress conditions), including, but not limited to, early flowering, flowering control for hybrid seed production, seedling vigor, plant size, internode number and distance, root growth, seed size, fruit size, pod size, pod or panicle number, seed number per pod or panicle, seed mass, enhanced seed maturation, reduced seed scattering, reduced pod dehiscence, and lodging resistance. Additional yield characteristics include seed composition, such as carbohydrate content and composition (e.g., cotton or starch), protein content, oil content and composition, nutritional value, reduced non-nutritional compounds, improved processability, and better storage stability.

[0490] Plants and plant cultivars that can be treated by the disclosed methods generally include hybrid plants and plant cultivars that already express heterosis or heterosis traits that result in higher yields, vigor, health, and resistance to biotic and abiotic stresses.

[0491] Plants and plant cultivars (obtained by plant biotechnology methods such as genetic engineering) that can be treated by the methods disclosed above include herbicide-tolerant plants, i.e., plants and plant cultivars that have been made tolerant to one or more given herbicides. Such plants can be obtained either by genetic transformation or by selecting plants that contain mutations that confer herbicide tolerance.

[0492] Plants and plant cultivars (obtained by plant biotechnology methods such as genetic engineering) that can be treated by the methods disclosed above include transgenic insect-resistant plants, i.e., plants and plant cultivars that are made resistant to attack by specific target insects. Such plants can be obtained by genetic transformation or by selecting plants containing mutations that confer herbicide resistance.

[0493] Plants and plant cultivars (obtained by plant biotechnology methods such as genetic engineering) that can be treated by the methods disclosed above include transgenic disease-resistant plants, i.e., plants and plant cultivars that are made resistant to attack by specific target insects. Such plants can be obtained by genetic transformation or by selecting plants containing mutations that confer such insect resistance.

[0494] Plants and plant cultivars (obtained by plant biotechnology methods such as genetic engineering) that can be treated by the methods disclosed above include plants and plant cultivars that are resistant to abiotic stresses. Such plants can be obtained by genetic transformation or by selecting plants that contain mutations that confer resistance to such stresses.

[0495] Plants and plant cultivars (obtained by plant biotechnology methods such as genetic engineering) that can be treated by the disclosed methods include plants and plant cultivars that exhibit altered quality, quality and / or storage stability of the harvested product and / or altered properties of specific components of the harvested product.

[0496] Plants and plant cultivars (obtained by plant biotechnology methods such as genetic engineering) that can be treated by the disclosed methods include plants and plant cultivars, such as cotton, that have altered fiber characteristics. Such plants can be obtained by genetic transformation or by selection of plants containing mutations that confer such altered fiber characteristics.

[0497] Plants and plant cultivars (obtained by plant biotechnology methods such as genetic engineering) that can be treated by the disclosed methods include plants and plant cultivars such as canola or related Brassica plants that have altered oil profile characteristics. Such plants can be obtained by genetic transformation or by selection of plants containing mutations that confer such altered oil profile characteristics.

[0498] Plants and plant cultivars (obtained by plant biotechnology methods such as genetic engineering) that can be treated by the methods disclosed above include plants and plant cultivars such as rapeseed or related Brassica plants with altered seed spill characteristics. Such plants can be obtained by genetic transformation or by selecting plants containing mutations that confer such altered seed spill characteristics, and include plants such as rapeseed plants with delayed or reduced seed spill.

[0499] Plants and plant cultivars (obtained by plant biotechnology methods such as genetic engineering) that can be treated by the methods disclosed above include plants and plant cultivars such as tobacco plants with altered protein post-translational modification patterns.

[0500] pathogen Non-limiting examples of fungal disease pathogens that can be treated according to the present invention include: Powdery mildew pathogens, for example diseases caused by Blumeria species, for example Blumeria graminis; Podosphaera species, for example Podosphaera leucotricha; Sphaerotheca species, for example Sphaerotheca fuliginea; Uncinula species, for example Uncinula necator;

[0501] Rust pathogens, for example Gymnosporangium species, for example Gymnosporangium sabinae; Hemileia species, for example Hemileia vastatrix; Phakopsora species, for example Phakopsora pachyrhizi or Phakopsora meibomiae; Puccinia species, for example Puccinia recondita, Puccinia graminis or Puccinia striiformis; Uromyces species, for example Uromyces appendiculatus appendiculatus);

[0502] Pathogens from the group of the oomycetes, for example Albugo species, for example Albugo candida; Bremia species, for example Bremia lactucae; Peronospora species, for example Peronospora pisi or P. brassicae; Phytophthora species, for example Phytophthora infestans; Plasmopara species, for example Plasmopara viticola; Pseudoperonospora species, for example Pseudoperonospora humuli or Pseudoperonospora cubensis; diseases caused by Pythium species, e.g., Pythium ultimum;

[0503] For example, Alternaria species, such as Alternaria solani; Cercospora species, such as Cercospora beticola; Cladiosporium species, such as Cladiosporium cucumerinum; Cochliobolus species, such as Cochliobolus sativus (conidiophyte: Drechslera, syn: Helminthosporium) or Cochliobolus miyabeanus; Colletotrichum species, such as Colletotrichum lindemtanium. lindemuthanium; Corynespora species, for example, Corynespora cassiicola; Cycloconium species, for example, Cycloconium oleaginum; Diaporthe species, for example, Diaporthe citri; Elsinoe species, for example, Elsinoe fawcettii; Gloeosporium species, for example, Gloeosporium laeticolor; Gloemerella species, for example, Gloemerella cingulata; Guignardia species, for example, Guignardia bidwelli bidwelli); Leptosphaeria species, for example, Leptosphaeria maculans; Magnaporthe species, for example, Magnaporthe grisea;Microdochium species, for example, Microdochium nivale; Mycosphaerella species, for example, Mycosphaerella graminicola, Mycosphaerella arachidicola or Mycosphaerella fijiensis; Phaeosphaeria species, for example, Phaeosphaeria nodorum; Pyrenophora species, for example, Pyrenophora teres or Pyrenophora tritici repentis; Ramularia species, for example, Ramularia collo-cygni or Ramularia areola; Rhynchosporium species, for example, Rhynchosporium secalis; Septoria species, for example, Septoria apii or Septoria lycopersici; Stagonospora species, for example, Stagonospora nodorum; Typhula species, for example, Typhula incarnata; Leaf blight and leaf wilt caused by Venturia species, for example, Venturia inaequalis;

[0504] For example, Corticium species, such as Corticium graminearum; Fusarium species, such as Fusarium oxysporum; Gaeumannomyces species, such as Gaeumannomyces graminis; Plasmodiophora species, such as Plasmodiophora brassicae; Rhizoctonia species, such as Rhizoctonia solani; Sarocladium species, such as Sarocladium oryzae; Sclerotium species, such as Sclerotium oryzae. oryzae; Tapesia species, e.g., Tapesia acuformis; Root and stem diseases caused by Thielaviopsis species, e.g., Thielaviopsis basicola;

[0505] For example, Alternaria species, such as Alternaria spp.; Aspergillus species, such as Aspergillus flavus; Cladosporium species, such as Cladosporium cladosporioides; Claviceps species, such as Claviceps purpurea; Fusarium species, such as Fusarium culmorum; Gibberella species, such as Gibberella zeae; Monographella species, such as Monographella nivalis. nivalis); diseases of ears and panicles (including corn cobs) caused by Stagnospora species, e.g., Stagnospora nodorum;

[0506] diseases caused by smut fungi, for example Sphacelotheca species, for example Sphacelotheca reiliana; Tilletia species, for example Tilletia caries or Tilletia controversa; Urocystis species, for example Urocystis occulta; Ustilago species, for example Ustilago nuda;

[0507] For example, Aspergillus species, such as Aspergillus flavus; Botrytis species, such as Botrytis cinerea; Monilinia species, such as Monilinia laxa; Penicillium species, such as Penicillium expansum or Penicillium purpurogenum; Rhizopus species, such as Rhizopus stolonifer; Sclerotinia species, such as Sclerotinia sclerotiorum; Verticilium species, such as Verticilium alboatorum. alboatrum); fruit rot caused by

[0508] For example, Alternaria species, such as Alternaria brassicicola; Aphanomyces species, such as Aphanomyces euteiches; Ascochyta species, such as Ascochyta lentis; Aspergillus species, such as Aspergillus flavus; Cladosporium species, such as Cladosporium herbarum; Cochliobolus species, such as Cochliobolus sativus (conidiophores: Drechslera, bipolar Syn: Helminthosporium; Colletotrichum spp., e.g., Colletotrichum coccodes; Fusarium spp., e.g., Fusarium culmorum; Gibberella spp., e.g., Gibberella zeae; Macrophomina spp., e.g., Macrophomina phaseolina; Microdochium spp., e.g., Microdochium nivale; Monographella spp., e.g., Monographella nivalis; Penicillium spp., e.g., Penicillium expansum expansum); Phoma species, for example, Phoma lingam; Phomopsis species, for example, Phomopsis sojae; Phytophthora species, for example, Phytophthora cactorum;Pyrenophora species, for example, Pyrenophora graminea; Pyricularia species, for example, Pyricularia oryzae; Pythium species, for example, Pythium ultimum; Rhizoctonia species, for example, Rhizoctonia solani; Rhizopus species, for example, Rhizopus oryzae; Sclerotium species, for example, Sclerotium rolfsii; Septoria species, for example, Septoria nodorum nodorum; Typhula species, for example, Typhula incarnata; seed and soil-borne rot and root blight caused by Verticillium species, for example, Verticillium dahliae, as well as diseases of seedlings;

[0509] For example, cancer, galls and witches' broom caused by Nectria species, such as Nectria galligena; For example, Verticillium species, such as Verticillium longisporum; Fusarium species, such as Fusarium oxysporum, causing chestnut blight; For example, deformation of leaves, flowers and fruits caused by Exobasidium species, such as Exobasidium vexans; Taphrina species, such as Taphrina deformans; For example, degenerative diseases in woody plants caused by Esca species, such as Phaeomoniella chlamydospora, Phaeoacremonium aleophilum or Fomitiporia mediterranea; Ganoderma species, such as Ganoderma boninense;

[0510] For example, tuber diseases caused by Rhizoctonia species, such as Rhizoctonia solani; Helminthosporium species, such as Helminthosporium solani; Bacterial pathogens, such as Xanthomonas species, e.g., Xanthomonas campestris pv. oryzae; Pseudomonas species, e.g., Pseudomonas syringae pv. lachrymans; Erwinia species, e.g., Erwinia amylovora; Liberibacter species, e.g., Liberibacter asiaticus; Xyella species, e.g., Xylella fastidiosa; Ralstonia species, e.g., Ralstonia solanacearum; solanacearum; Dickeya spp., for example, Dickeya solani; Clavibacter spp., for example, Clavibacter michiganensis; Diseases caused by Streptomyces spp., for example, Streptomyces scabies.

[0511] Soybean diseases: For example, Alternaria leaf spot (Alternaria spec. atrans tenuissima), anthracnose (Colletotrichum gloeosporoides dematium var. truncatum), brown spot (Septoria glycines), Cercospora leaf spot and blight (Cercospora kikuchii), Choanephora leaf blight (Choanephora infundibulifera trispora) (Syn.), Dactuliophora leaf spot (Dactuliophora glycines), Downy mildew (Peronospora manshurica), Drexlera canker (Drechslera glycini), Leaf ring spot (Cercospora sojina), Leptosphaerulina leaf spot (Leptosphaerulina trifolii), Phyllosticta leaf spot (Phyllosticta sojaecola), Pod and stem blight (Phomopsis sojae), Powdery mildew Microsphaera diffusa (Microsphaera diffusa) diffusa), Pyrenochaeta leaf spot (Pyrenochaeta glycines), Rhizoctonia aerial, leaf cluster and spider blight (Rhizoctonia solani), rust (Phakopsora pachyrhizi, Phakopsora meibomiae), common scab (Sphaceloma glycines), Stemphylium leaf blight (Stemphylium botryosum), sudden death syndrome (Fusarium virguliforme), ring spot (Corynespora cassicola) A fungal disease of the leaves, stems, pods, and seeds caused by Bacillus cassiicola.

[0512] For example, microscopic sclerotinia (Calonectria crotalariae), charcoal rot (Macrophomina phaseolina), scab or wilt, root rot, and pod and neck rot (Fusarium oxysporum, Fusarium orthoceras, Fusarium semitectum, Fusarium equiseti), Mycoleptodiscus root rot (Mycoleptodiscus terrestris), Neocosmospora (Neocosmospora vasinfecta), pod and stem blight (Diaporthe phaseolorum), and rhizome disease (Hyperkeratosis diffusa). phaseolorum), branch dieback (Diaporthe phaseolorum var. caulivora), stem rot (Phytophthora megasperma), leaf drop (Phialophora gregata), Pythium rot (Pythium aphanidermatum, Pythium irregulare, Pythium debaryanum, Pythium myriotylum, Pythium ultimum), Rhizoctonia root rot, stem rot, and damping-off (Rhizoctonia solani) solani), Sclerotinia stem rot (Sclerotinia sclerotiorum), Sclerotinia southern blight (Sclerotinia rolfsii), fungal diseases of the roots and culm base caused by Thielaviopsis root rot (Thielaviopsis basicola).

[0513] mycotoxins In addition, the compounds of formula (I) and compositions comprising same can reduce the mycotoxin content in harvested materials and foodstuffs and feedstuffs produced therefrom, including, but not limited to, those produced by the following fungi: F. acuminatum, F. asiaticum, F. avenaceum, F. crookwellense, F. culmorum, F. graminearum (Gibberella zeae), F. equiseti, F. fujikoroi, F. musarum, F. oxysporum, F. proliferatum, F. Fusarium species such as F. poae, F. pseudograminearum, F. sambucinum, F. scirpi, F. semitectum, F. solani, F. sporotrichoides, F. langsethiae, F. subglutinans, F. tricinctum, F. verticillioides, and others. spec.), and Aspergillus species such as A. flavus, A. parasiticus, A. nomius, A. ochraceus, A. clavatus, A. terreus, A. versicolor, P. verrucosum, P. viridicatum, P. citrinum, P. expansum, P. claviforme, P. roqueforti, P.Deoxynivalenol (DON), nivalenol, 15-Ac-DON, 3-Ac-DON, T2- and HT2-toxins, fumonisin, zearalenone, moniliformin, fusarin, diacetoxyscirpenol (DAS), beauvericin, enniatin, fusaroproliferin, fusarenol, ochratoxin, patulin, ergot alkaloids, and aflatoxins, which can be produced by Penicillium species (P. roqueforti) such as C. purpurea, C. fusiformis, C. paspali, C. africana, and other Claviceps species (Stachybotrys species), and others.

[0514] material protection The compounds of formula (I) and compositions comprising them may also be used in the protection of materials, in particular industrial materials, against attack and degradation by phytopathogenic fungi.

[0515] In addition, the compounds of formula (I) and compositions comprising same may be used as antifouling compositions, either alone or in combination with other active ingredients.

[0516] In this context, industrial materials are understood to mean inanimate materials manufactured for industrial use. For example, industrial materials to be protected from microbial deterioration or decomposition may be adhesives, glues, paper, wallpaper and cardboard, textiles, carpets, leather, wood, fibers and tissues, paints and plastic products, cooling lubricants, and other materials that can be infected or decomposed by microorganisms. Parts of manufacturing plants and buildings that can be damaged by microbial growth, such as cooling water circuits, cooling and heating systems, and ventilation and air-conditioning units, may also be mentioned within the scope of materials to be protected. Industrial materials within the scope of the present invention preferably include adhesives, sizes, paper and cardboard, leather, wood, paints, cooling lubricants, and heat transfer liquids, more preferably wood.

[0517] The compounds of formula (I) and compositions comprising same may prevent harmful effects such as decay, rot, discolouration, bleaching or mould growth.

[0518] In the treatment of wood, the compounds of formula (I) and compositions comprising same may be used against fungal diseases which tend to grow on or within the material.

[0519] Materials refer to all types of wood species and all types of processed wood products for construction purposes, such as solid wood, high-density wood, laminated wood, and veneered plywood. In addition, the compounds of formula (I) and compositions comprising them may be used to protect objects in contact with salt water or freshwater, in particular grain, screens, netting, buildings, mooring equipment, and communication systems, from fouling.

[0520] The compounds of formula (I) and compositions comprising the same may be used to protect stored goods. Stored goods are understood to mean natural substances of plant or animal origin or processed products of natural origin for which long-term protection is desired. Stored goods of plant origin, such as plants or plant parts such as stems, leaves, tubers, seeds, fruits, and grains, may be protected either freshly harvested or after processing by (pre)drying, moistening, pulverizing, grinding, pressing, or roasting. Stored goods also include materials in the form of both raw products, such as building materials, utility poles, and electrical barriers, or finished products, such as furniture. Stored goods of animal origin are, for example, leather, tanned leather, fur, and hair. The compounds of formula (I) and compositions comprising the same may prevent harmful effects such as decay, rot, discoloration, bleaching, or mold growth.

[0521] Microorganisms capable of decomposing or deteriorating industrial materials include, for example, bacteria, fungi, yeasts, algae, and slime organisms. The compounds of formula (I) and compositions comprising them are preferably active against fungi, particularly molds, wood-staining and wood-decomposing fungi (Ascomycetes, Basidiomycetes, Deuteromycetes, and Zygomycetes), as well as slime organisms and algae. Examples include microorganisms from the following genera: Alternaria, such as Alternaria tenuis; Aspergillus, such as Aspergillus niger; Chaetomium, such as Chaetomium globosum; Coniophora, such as Coniophora puetana; Lentinus, such as Lentinus tigrinus; Penicillium, such as Penicillium glaucum; Polyporus, such as Polyporus versicolor; Aureobasidium pullulans. Aureobasidium species such as Aureobasidium pullulans; Sclerophoma species such as Sclerophoma pityophila; Trichoderma species such as Trichoderma viride; Ophiostoma species, Ceratocystis species, Humicola species, Petriella species, Trichurus species, Coriolus species, Gloeophyllum species, and Pleurotus species.Escherichia species such as Poria spp., Serpula spp. and Tyromyces spp., Cladosporium spp., Paecilomyces spp., Mucor spp., and Escherichia coli; Pseudomonas species such as Pseudomonas aeruginosa; Staphylococcus species such as Staphylococcus aureus, Candida spp., and Saccharomyces cerevisiae. Saccharomyces spp., such as Saccharomyces cerevisae.

[0522] Seed treatment The compounds of formula (I) and compositions comprising same may be used to protect seeds from unwanted microorganisms such as plant pathogenic microorganisms, for example, plant pathogenic fungi or plant pathogenic oomycetes. As used herein, the term seed includes dormant seeds, primed seeds, pre-germinated seeds and seeds with emerged roots and leaves.

[0523] Therefore, the present invention also relates to a method for protecting seeds against unwanted microorganisms, which method comprises treating the seeds with a compound or composition of formula (I).

[0524] Seed treatment with the compound or composition of formula (I) not only protects the seeds from plant pathogenic microorganisms, but also protects the germinated seeds, germinated seedlings and plants after germination from the treated seeds.Therefore, the present invention also relates to a method for protecting seeds, germinated seeds and germinated seedlings.

[0525] Seed treatment may be carried out before sowing, at the time of sowing or immediately after sowing.

[0526] When seed treatment is carried out before sowing (for example, so-called on-seed spraying), seed treatment can be carried out as follows: seeds are placed in a mixer together with a desired amount of the compound or composition of formula (I), and the seeds and the compound or composition of formula (I) are mixed until they are uniformly distributed on the seeds.The seeds can then be dried if necessary.

[0527] The present invention also relates to seeds coated with the compounds of formula (I) and compositions comprising same.

[0528] Preferably, seeds are treated in a state that is sufficiently stable so that they are not damaged during the treatment process.Generally, seeds can be treated at any time between harvesting and immediately after sowing.Seeds that are separated from plants and do not have cobs, husks, stalks, coats, hairs or fruit flesh are usually used.For example, it is possible to use seeds that are harvested, washed and dried to a moisture content of less than 15% by weight.Alternatively, it is also possible to use seeds that are dried, for example, treated with water, and then dried again, or seeds that are immediately after priming, or seeds that are stored under priming conditions or pre-germinated seeds, or seeds that are sown on trays, tapes or paper in seedbeds.

[0529] The amount of the compound of formula (I) or the composition comprising the compound to be sprayed on seeds is usually such that the germination of the seeds is not impaired or the resulting plants are not damaged.This must be ensured, especially when the compound of formula (I) exhibits phytotoxicity at a certain application rate.When determining the amount of the compound of formula (I) to be sprayed on seeds, the specific phenotype of the transgenic plants should be taken into consideration in order to achieve optimal seed and germination plant protection with the minimum amount of compound used.

[0530] The compound of formula (I) can be applied directly to seeds, i.e., without other ingredients and without dilution, and compositions comprising it can also be applied to seeds.

[0531] The compound of formula (I) and the composition comprising it are suitable for protecting the seeds of any plant variety.Preferred seeds are those of cereals (wheat, barley, rye, millet, triticale and oats), rapeseed, corn, cotton, soybean, rice, potato, sunflower, kidney bean, coffee, pea, beet (such as sugar beet and fodder beet), peanut, vegetables (tomato, cucumber, onion and lettuce, etc.), turf and ornamental plants.More preferred are the seeds of wheat, soybean, rapeseed, corn and rice.

[0532] The compound of formula (I) and compositions comprising the same may be used to treat transgenic seeds, particularly plant seeds capable of expressing polypeptides or proteins that act against pests, herbicide damage, or abiotic stress, thereby enhancing protective effects. Plant seeds capable of expressing polypeptides or proteins that act against pests, herbicide damage, or abiotic stress may contain at least one heterologous gene that enables the expression of the polypeptide or protein. The heterologous gene in the transgenic seed may originate from a microorganism, for example, Bacillus species, Rhizobium species, Pseudomonas species, Serratia species, Trichoderma species, Clavibacter species, Glomus species, or Gliocladium species. These heterologous genes are preferably derived from Bacillus species. In this case, the gene product is effective against the European corn borer and / or the western corn rootworm. Particularly preferably, the heterologous gene originates from Bacillus thuringiensis.

[0533] Spraying The compounds of formula (I) can be applied as such or in the form of, for example, ready-to-use solutions, emulsifiable concentrates, water- or oil-based suspensions, dusts, wettable powders, pastes, water-soluble concentrates, dusts, soluble granules, granules for general application, suspoemulsion concentrates, natural products impregnated with a compound of formula (I), synthetic products impregnated with a compound of formula (I), fertilizers or microencapsulated in polymeric materials.

[0534] Application is carried out in the usual manner, for example, by irrigation, spraying, misting, broadcast application, dusting, foam application, spreading-on, etc. It is also possible to place the compound of formula (I) by the ultra-low volume method using a drip irrigation system or drench application, to apply the compound of formula (I) between furrows, or to inject the compound of formula (I) into the stem or trunk of the soil. It is also possible to apply the compound of formula (I) by wound seals, painting, or other wound dressings.

[0535] The effective and plant-compatible amount of the compound of formula (I) applied to plants, plant parts, fruits or soil depends on various factors such as the compound / composition used, the target to be treated (plants, plant parts, fruits, seeds or soil), the type of treatment (dusting, spraying, seed dressing), the purpose of the treatment (curing and protecting), the type of microorganism, the growth stage of the microorganism, the sensitivity of the microorganism, the stage of crop growth and the environmental conditions.

[0536] When the compounds of formula (I) are used as fungicides, the application rate can vary within a relatively wide range, depending on the type of application. For the treatment of plant parts such as leaves, the application rate can be in the range of 0.1 to 10,000 g / ha, preferably 10 to 1,000 g / ha, more preferably 50 to 300 g / ha (in the case of application by irrigation or drip irrigation, it is still possible to reduce the application rate, especially when using inert materials such as rock wool or perlite). For the treatment of seeds, the application rate can be in the range of 0.1 to 200 g / 100 kg of seeds, preferably 1 to 150 g / 100 kg of seeds, more preferably 2.5 to 25 g / 100 kg of seeds, even more preferably 2.5 to 12.5 g / 100 kg of seeds. For the treatment of soil, the application rate can be in the range of 0.1 to 10,000 g / ha, preferably 1 to 5,000 g / ha.

[0537] These application rates are merely examples and are not intended to limit the scope of the invention.

[0538] Aspects of the present teachings can be further understood in light of the following examples, which should not be construed in any way as limiting the scope of the present teachings. [Example]

[0539] Generality Measurement of LogP value The LogP values ​​provided herein were determined according to EEC Directive 79 / 831 Annex V.A8 by HPLC (High Performance Liquid Chromatography) on a reversed phase column using the following method: [a] Measure the LogP value by LC-UV measurement in the acidic range using 0.1% formic acid aqueous solution and acetonitrile as the eluent (linear gradient from 10% acetonitrile to 95% acetonitrile). [b] Measure the LogP value by LC-UV measurement in the acidic range using 0.001 molar aqueous ammonium acetate solution and acetonitrile as the eluent (linear gradient from 10% acetonitrile to 95% acetonitrile). [c]Measure the LogP value by LC-UV measurement in the acidic range using 0.1% phosphoric acid and acetonitrile as the eluent (linear gradient from 10% acetonitrile to 95% acetonitrile).

[0540] When LogP values ​​greater than 1 are obtained by the same method, all values ​​are taken and distinguished by a "+".

[0541] Calibration was performed using linear alkan-2-ones (3-16 carbon atoms) with known LogP values ​​(LogP values ​​were determined using linear interpolation between successive alkanones and retention times). λmax values ​​were determined using the UV spectral and chromatographic signal peaks from 200 nm to 400 nm.

[0542] 1H-NMR data The H-NMR of selected examples provided herein is presented in the form of a list of H-NMR peaks. For each signal peak, the δ value (ppm) and signal intensity in parentheses are listed. A semicolon is used as a separator between δ value-signal intensity pairs.

[0543] Thus, an example peak list has the following format: δ1(Intensity 1); δ2(Intensity 2);·····;δ i (strength i );····;δ n (strength n ) Sharp signal intensities correlate with signal height (cm) in printed examples of NMR spectra. Broad signals may indicate several peaks or central portions of the signal and their relative intensities compared to the most intense signal in the spectrum.

[0544] For the calibration of chemical shifts of 1H spectra, we use the chemical shifts of tetramethylsilane and / or, especially for spectra measured in DMSO, the solvent used. Thus, in the NMR peak list, tetramethylsilane peaks may, but are not necessarily, shown.

[0545] The 1H-NMR peak list is similar to a standard 1H-NMR print and therefore usually includes all peaks listed in standard NMR interpretation.

[0546] In addition, they can show the standard 1H-NMR print signals of the solvent, the stereoisomers of the target compound which is also the object of the present invention, and / or the peaks of impurities.

[0547] To show compound signals in the δ range of the solvent and / or water, the usual peaks of the solvent, e.g., the DMSO peak and the water peak in DMSO-D6, are shown in our H-NMR peak list and usually have high intensities on average.

[0548] The peaks of stereoisomers and / or impurities of the target compound typically have, on average, lower intensities than the peaks of the target compound (eg, purity >90%).

[0549] Such stereoisomers and / or impurities may be normal for a particular manufacturing method, and therefore these peaks may aid in recognizing the reproducibility of our manufacturing method through a "by-product fingerprint."

[0550] The expert calculates the peaks of the target compounds using known methods (MestreC, ACD-simulation, and also experimentally evaluated expectations) and can use additional intensity filters as needed to separate the peaks of the target compounds, which will be similar to the relevant peak picking in standard 1H-NMR interpretation.

[0551] A more detailed description of NMR data, including peak lists, can be found in the publication "Citation of NMR Peaklist Data within Patent Applications" of the Research Disclosure Database Number 564025.

[0552] The following examples illustrate, but are not limited to, the preparation and biological activity of compounds of formula (I) according to the invention.

[0553] Synthesis of Compounds of Formula (I) and Intermediates Preparation Example 1: Preparation of methyl N-[6-chloro-3-[3-(trifluoromethyl)phenoxy]pyridazine-4-carbonyl]-N-[2-(2,4-dimethylphenyl)-2,2-difluoro-ethyl]carbamate (compound I.335) To a solution of 6-chloro-N-[2-(2,4-dimethylphenyl)-2,2-difluoro-ethyl]-3-[3-(trifluoromethyl)phenoxy]pyridazine-4-carboxamide (100 mg, 0.206 mmol) and potassium tert-butoxide (34 mg, 0.309 mmol) in THF (3 mL) was added methyl chloroformate (0.024 mL, 0.309 mmol). The reaction mixture was stirred at room temperature for 3 hours, then diluted with water and extracted with ethyl acetate (2 × 50 mL). The organic extract was washed with brine, dried over magnesium sulfate, filtered, and concentrated under reduced pressure. The...

Claims

1. Compounds of formula (I): 【Chemistry 1】 [In the formula, T is O or S; n is 0 or 1; m is 0 or 1; With the proviso that when n is 1, then m is 1; R 1 is hydrogen, hydroxyl, cyano, C 1 ~C 6 -Alkyl, C 1 ~C 6 -Alkoxy, C 1 ~C 6 -Alkoxy-C 1 ~C 6 -Alkyl, -C(=O)R a1 , -C(=O)(OR a1 ), -S(=O)R a1 , -S(=O) 2 R a1 , -C(=O)N(R a2 ) 2 and S(=O) 2 N (R a2 ) 2 R a1 is C 1 ~C 6 -Alkyl, C 1 ~C 6 -Haloalkyl, C 3 ~C 8 -cycloalkyl, and C 2 ~C 6 -alkenyl, R a2 is hydrogen, C 1 ~C 6 -Alkyl, C 1 ~C 6 -Haloalkyl, C 3 ~C 8 -Cycloalkyl and C 2 ~C 6 - selected from the group consisting of alkenyl; R 2 and R 3 is hydrogen, halogen, cyano, hydroxyl, carboxyl, C 1 ~C 6 -Alkyl, C 1 ~C 6 -Haloalkyl, C 1 ~C 6 -Alkoxy, C 1 ~C 6 -alkoxycarbonyl and C 3 ~C 8 -cycloalkyl or R 2 and R 3 together with the carbon atom to which they are attached, 3 ~C 8 - forming a cycloalkyl or non-aromatic 3- to 7-membered monocyclic heterocycle; R 4 and R 5 is hydrogen, halogen, cyano, hydroxyl, carboxyl, C 1 ~C 6 -Alkyl, C 1 ~C 6 -Haloalkyl, C 1 ~C 6 -Alkoxy, C 1 ~C 6 -alkoxycarbonyl and C 3 ~C 8 -cycloalkyl or R 4 and R 5 together with the carbon atom to which they are attached, 3 ~C 8 - forming a cycloalkyl or non-aromatic 3- to 7-membered monocyclic heterocycle; or R 2 and R 4 together with the carbon atom to which they are attached, 3 ~C 8 -cycloalkyl or a non-aromatic 3- to 7-membered monocyclic heterocycle; R 3 and R 5 is independently hydrogen or halogen; or R 2 and R 4 form a covalent bond, and R 3 and R 5 are independently hydrogen or C 1 ~C 6 - alkyl; R 6 is non-aromatic C 3 ~C 12 -Carbon ring, aromatic C 6 -C 14 -Carbocycle, non-aromatic 3- to 14-membered heterocycle, aromatic 5- to 14-membered heterocycle, non-aromatic C 3 ~C 12 -Carbocyclyloxy, aromatic C 6 -C 14 -carbocyclyloxy, aromatic 5- to 14-membered heterocyclyloxy, non-aromatic 3- to 14-membered heterocyclyloxy, non-aromatic C 3 ~C 12 - C substituted by a carbocycle 1 ~C 3 -Alkoxy, aromatic C 6 -C 14 - C substituted by a carbocycle 1 ~C 3 -alkoxy, C substituted by a non-aromatic 3- to 14-membered heterocycle 1 ~C 3 - C substituted by alkoxy, aromatic 5- to 14-membered heterocycle 1 ~C 3 -Alkoxy, non-aromatic C 3 ~C 12 - C substituted by a carbocycle 1 ~C 3 -Haloalkoxy, aromatic C 6 -C 14 - C substituted by a carbocycle 1 ~C 3 -haloalkoxy, C substituted by a non-aromatic 3- to 14-membered heterocycle 1 ~C 3 -C substituted with haloalkoxy and aromatic 5- to 14-membered heterocycle 1 ~C 3 -haloalkoxy; 6 Substituent or R 6 The cyclic portion of the substituent may be one or more R 6S and optionally substituted by R 6S is halogen, cyano, isocyano, nitro, hydroxyl, mercapto, pentafluorosulfanyl, oxo, methylidene, halomethylidene, C 1 ~C 6 -Alkyl, C 1 ~C 6 -Haloalkyl, C 1 ~C 6 -Alkoxy, C 1 ~C 6 -Haloalkoxy, C 2 ~C 6 -Alkenyl, C 2 ~C 6 -haloalkenyl, C 2 ~C 6 -Alkynyl, C 2 ~C 6 -haloalkynyl, C 2 ~C 6 -Alkenyloxy, C 2 ~C 6 -haloalkenyloxy, C 1 ~C 6 -Alkyl sulfanyl, C 1 ~C 6 -Haloalkylsulfanyl, C 3 ~C 8 -Cycloalkylsulfanyl, C 1 ~C 6 -Alkyl sulfinyl, C 1 ~C 6 -Haloalkylsulfinyl, C 3 ~C 8 -Cycloalkylsulfinyl, C 1 ~C 6 -Alkylsulfonyl, C 1 ~C 6 -Haloalkylsulfonyl, C 3 ~C 8 -Cycloalkylsulfonyl, C 3 ~C 8 -Cycloalkyl, C 3 ~C 8 -cycloalkyloxy, C 3 ~C 8 -Cycloalkenyl, aromatic C 6 -C 14 -Carbocycle, aromatic 5- or 6-membered monocyclic heterocycle, non-aromatic 3- to 7-membered monocyclic heterocycle, -N(R c ) 2 , -C(=O)R d , -C(=O)(OR d ), -C(=O)N(R d ) 2 , -S(=O) 2 N (R d ) 2 , —O—Si(C 1 ~C 6 -alkyl) 3 and -Si(C 1 ~C 6 -alkyl) 3 or two R 6S Substituents, together with the carbon atom to which they are attached, are C 3 ~C 8 -may form a cycloalkyl, R c is hydrogen, C 1 ~C 6 -Alkyl and C 3 ~C 8 -cycloalkyl; R d is hydrogen, C 1 ~C 6 -Alkyl and C 1 ~C 6 -haloalkyl; aliphatic R 6S , R c and R d The substituents are cyano, hydroxyl, C 1 ~C 6 -Alkoxy, C 1 ~C 6 -haloalkoxy, -O-Si(C 1 ~C 6 -alkyl) 3 , -Si(C 1 ~C 6 -alkyl) 3 , C 3 ~C 8 -Cycloalkyl, C 3 ~C 8 -optionally substituted by one or more substituents independently selected from the group consisting of halocycloalkyl and non-aromatic 3- to 7-membered monocyclic heterocycle; cyclic R 6S Substituent or R 6S The cyclic moiety of the substituent and the cyclic R c The substituents are halogen, cyano, nitro, hydroxyl, formyl, carboxyl, oxo, methylidene, halomethylidene, C 1 ~C 6 -Alkyl, C 1 ~C 6 -Haloalkyl, C 1 ~C 6 -Alkoxy, C 1 ~C 6 -Haloalkoxy, C 1 ~C 6 -alkoxycarbonyl, C 1 ~C 6 -haloalkoxycarbonyl, C 2 ~C 6 -Alkenyl, C 3 ~C 8 -Cycloalkyl and C 3 ~C 8 -halocycloalkyl; and / or cyclic R 6S Substituent or R 6S The cyclic portions of the substituents, together with the carbon atoms to which they are attached, are C 3 ~C 8 - optionally substituted by two substituents forming a cycloalkyl; R 7 is hydrogen, halogen, cyano, isocyano, hydroxyl, mercapto, nitro, amino, formyl, C 1 ~C 6 -Alkyl, C 1 ~C 6 -Haloalkyl, C 1 ~C 6 -hydroxyalkyl, C 1 ~C 6 -Alkylcarbonyl, C 1 ~C 6 -Haloalkylcarbonyl, C 1 ~C 6 -Alkoxy, C 1 ~C 6 -Haloalkoxy, C 2 ~C 6 -Alkenyl, C 2 ~C 6 -haloalkenyl, C 2 ~C 6 -Alkynyl, C 2 ~C 6 -haloalkynyl, C 2 ~C 6 -Alkenyloxy, C 2 ~C 6 -haloalkenyloxy, C 2 ~C 6 -alkynyloxy, C 2 ~C 6 -haloalkynyloxy, C 1 ~C 6 -Alkyl sulfanyl, C 1 ~C 6 -Haloalkylsulfanyl, C 3 ~C 8 -Cycloalkylsulfanyl, C 1 ~C 6 -Alkyl sulfinyl, C 1 ~C 6 -Haloalkylsulfinyl, C 3 ~C 8 -Cycloalkylsulfinyl, C 1 ~C 6 -Alkylsulfonyl, C 1 ~C 6 -Haloalkylsulfonyl, C 3 ~C 8 -Cycloalkylsulfonyl, C 3 ~C 8 -Cycloalkyl, C 3 ~C 6 -Cycloalkenyl, aromatic C 6 ~C 14 -Carbocycle, aromatic 5- or 6-membered monocyclic heterocycle, non-aromatic 3- to 7-membered monocyclic heterocycle, C 3 ~C 8 -Cycloalkyloxy, aromatic C 6 -C 14 -carbocyclyloxy, aromatic 5- or 6-membered monocyclic heterocyclyloxy, non-aromatic 3- to 7-membered monocyclic heterocyclyloxy, -O-Si(C 1 ~C 6 -alkyl) 3 , -Si(C 1 ~C 6 -alkyl) 3 , -N(R e ) 2 , -C(=NR f ) R f , -NR g C(=O)R g , -C(=O)(OR g ), -C(=O)N(R g ) 2 , -S(=O) 2 N (R g ) 2 and -S(=O)(=NR g ) R g is selected from the group consisting of R e is hydrogen, C 1 ~C 6 -Alkyl, C 1 ~C 6 -Haloalkyl, C 1 ~C 6 -Alkoxy, C 2 ~C 6 -Alkenyl, C 2 ~C 6 -haloalkenyl, C 2 ~C 6 -Alkynyl, C 2 ~C 6 -haloalkynyl, C 3 ~C 8 -Cycloalkyl, C 3 ~C 8 -Halocycloalkyl, aromatic C 6 ~C 14 - independently selected from the group consisting of carbocycle, aromatic 5- or 6-membered monocyclic heterocycle and non-aromatic 3- to 7-membered monocyclic heterocycle; R f is hydroxyl, amino, cyano, C 1 ~C 6 -Alkyl, C 1 ~C 6 -Haloalkyl, C 1 ~C 6 -Alkoxy, C 1 ~C 6 -Alkylamino and di(C 1 ~C 6 -alkyl)amino; R g is hydrogen, C 1 ~C 6 -Alkyl, C 1 ~C 6 -Haloalkyl and C 3 ~C 8 -cycloalkyl; aliphatic R 7 , R e , R f and R g The substituents may be one or more R 7Sa may be substituted by a substituent, cyclic R 7 Substituent or R 7 The cyclic portion of the substituent, cyclic R e and cyclic R g The substituents may be one or more R 7Sc may be substituted by a substituent, R 7Sa is cyano, hydroxyl, carboxyl, C 1 ~C 6 -Alkoxy, C 1 ~C 6 -Haloalkoxy, C 3 ~C 8 -Cycloalkyl, C 3 ~C 8 -Halocycloalkyl, C 1 ~C 6 -alkoxycarbonyl, -O-Si(C 1 ~C 6 -alkyl) 3 , -Si(C 1 ~C 6 -alkyl) 3 , aromatic C 6 ~C 14 - selected from the group consisting of carbocycles and non-aromatic 3- to 7-membered monocyclic heterocycles; R 7Sc is halogen, cyano, nitro, hydroxyl, formyl, oxo, methylidene, halomethylidene, C 1 ~C 6 -Alkyl, C 1 ~C 6 -Haloalkyl, C 1 ~C 6 -Alkoxy, C 1 ~C 6 -Haloalkoxy, C 2 ~C 6 -Alkenyl, C 3 ~C 8 -Cycloalkyl, C 3 ~C 8 -halocycloalkyl, -O-Si(C 1 ~C 6 -alkyl) 3 and non-aromatic 3- to 7-membered monocyclic heterocycles, or two R 7Sc Substituents, together with the carbon atom to which they are attached, are C 3 ~C 8 - forms a cycloalkyl; R 8 is hydrogen, halogen, cyano, isocyano, amino, nitro, hydroxyl, mercapto, carboxyl, C 1 ~C 6 -alkoxycarbonyl, C 1 ~C 6 -Alkyl, C 1 ~C 6 -Haloalkyl, C 1 ~C 6 -hydroxyalkyl, C 1 ~C 6 -Alkoxy, C 1 ~C 6 -Haloalkoxy, C 2 ~C 6 -Alkenyl, C 2 ~C 6 -haloalkenyl, C 2 ~C 6 -Alkynyl, C 2 ~C 6 -haloalkynyl, C 2 ~C 6 -Alkenyloxy, C 2 ~C 6 -haloalkenyloxy, C 2 ~C 6 -alkynyloxy, C 2 ~C 6 -haloalkynyloxy, C 1 ~C 6 -Alkyl sulfanyl, C 1 ~C 6 -Haloalkylsulfanyl, C 1 ~C 6 -Alkyl sulfinyl, C 1 ~C 6 -Haloalkylsulfinyl, C 1 ~C 6 -Alkylsulfonyl, C 1 ~C 6 -Haloalkylsulfonyl, C 3 ~C 8 -Cycloalkyl, C 3 ~C 6 -Cycloalkenyl, aromatic C 6 ~C 14 -Carbocycle, non-aromatic 3- to 14-membered heterocycle, aromatic 5- to 14-membered heterocycle, C 3 ~C 8 -Cycloalkyloxy, aromatic C 6 ~C 14 -carbocyclyloxy, non-aromatic 3- to 14-membered heterocyclyloxy, aromatic 5- to 14-membered heterocyclyloxy, -O-Si(C 1 ~C 6 -alkyl) 3 , -Si(C 1 ~C 6 -alkyl) 3 , -N(R h ) 2 , -SR i , -S(=O)R i and -S(=O) 2 R i is selected from the group consisting of R h is hydrogen, C 1 ~C 6 -Alkyl, C 1 ~C 6 -Haloalkyl, C 1 ~C 6 -Alkoxy, C 2 ~C 6 -Alkenyl, C 2 ~C 6 -haloalkenyl, C 2 ~C 6 -Alkynyl, C 2 ~C 6 -haloalkynyl, C 3 ~C 8 -Cycloalkyl, C 3 ~C 8 -Halocycloalkyl, aromatic C 6 ~C 14 - independently selected from the group consisting of carbocycle, aromatic 5- to 14-membered heterocycle and non-aromatic 3- to 7-membered monocyclic heterocycle; R i is C 2 ~C 6 -Alkenyl, C 2 ~C 6 -haloalkenyl, C 2 ~C 6 -Alkynyl, C 2 ~C 6 -haloalkynyl, C 3 ~C 8 -Cycloalkyl, C 3 ~C 8 -Halocycloalkyl, aromatic C 6 ~C 14 - selected from the group consisting of carbocycles, aromatic 5- to 14-membered heterocycles and non-aromatic 3- to 7-membered monocyclic heterocycles; aliphatic R 8 , R h and R i The substituents may be one or more R 8Sa may be substituted by a substituent, cyclic R 8 Substituent or R 8 The cyclic portion of the substituent, cyclic R h and cyclic R i The substituents may be one or more R 8Sc may be substituted by a substituent, R 8Sa is cyano, amino, nitro, hydroxyl, formyl, carboxyl, C 1 ~C 6 -Alkoxy, C 1 ~C 6 -Haloalkoxy, C 1 ~C 6 -Alkoxy-C 1 ~C 6 -Alkoxy, C 1 ~C 6 -alkoxycarbonyl, C 1 ~C 6 -haloalkoxycarbonyl, C 1 ~C 6 -Alkylcarbonyl, C 1 ~C 6 -Haloalkylcarbonyl, C 3 ~C 8 -Cycloalkyl, C 3 ~C 8 -Halocycloalkyl, C 1 ~C 6 -Alkyl sulfanyl, C 1 ~C 6 -Haloalkylsulfanyl, C 1 ~C 6 -Alkyl sulfinyl, C 1 ~C 6 -Haloalkylsulfinyl, C 1 ~C 6 -Alkylsulfonyl, C 1 ~C 6 -haloalkylsulfonyl, -O-Si(C 1 ~C 6 -alkyl) 3 , -Si(C 1 ~C 6 -alkyl) 3 , a non-aromatic 3- to 7-membered monocyclic heterocycle and -N(R a’ ) 2 R a’ is hydrogen, formyl, C 1 ~C 6 -Alkyl, C 1 ~C 6 -Haloalkyl, C 3 ~C 8 -Cycloalkyl and C 1 ~C 6 -alkylcarbonyl, wherein the non-aromatic 3- to 7-membered monocyclic heterocycle R 8Sa is one or more C, which may be the same or different 1 ~C 6 - optionally substituted by alkyl substituents, R 8Sc is halogen, cyano, amino, nitro, hydroxyl, formyl, carboxyl, oxo, methylidene, halomethylidene, C 1 ~C 6 -Alkyl, C 1 ~C 6 -Haloalkyl, C 1 ~C 6 -Alkoxy, C 1 ~C 6 -Haloalkoxy, C 1 ~C 6 -alkoxycarbonyl, C 1 ~C 6 -haloalkoxycarbonyl, C 2 ~C 6 -Alkenyl, C 1 ~C 6 -Alkyl sulfanyl, C 1 ~C 6 -Alkyl sulfinyl, C 1 ~C 6 -Alkylsulfonyl, C 3 ~C 8 -Cycloalkyl, C 3 ~C 8 -halocycloalkyl, -O-Si(C 1 ~C 6 -alkyl) 3 and one or more C, which may be the same or different. 1 ~C 6 - a non-aromatic 3- to 7-membered monocyclic heterocycle optionally substituted by an alkyl substituent, or two R 8Sc Substituents, together with the carbon atom to which they are attached, are C 3 ~C 8 - cycloalkyl or non-aromatic 3- to 7-membered monocyclic heterocycles, said non-aromatic 3- to 7-membered monocyclic heterocycles being the same or different, and 1 ~C 6 - optionally substituted with alkyl substituents; Q is an aromatic C 6 ~C 14 -Carbon ring, C 3 ~C 8 - a non-aromatic C comprising an aryl fused to a cycloalkyl 7 ~C 12 Bicyclic system, C 3 ~C 8 - a non-aromatic C comprising an aryl fused to a cycloalkenyl 7 ~C 12 Bicyclic systems, non-aromatic 6- to 14-membered bicyclic heterocycles comprising 4- to 6-membered monocyclic non-aromatic heterocycles fused with aryls, monocyclic C 3 ~C 8 - a non-aromatic 6- to 14-membered bicyclic heterocycle comprising a 5- or 6-membered monocyclic heteroaryl fused with a cycloalkyl, an aromatic 5- or 6-membered monocyclic heterocycle, an aromatic 9- or 10-membered bicyclic heterocycle comprising an aromatic 5- or 6-membered monocyclic heterocycle fused with an aryl, and a 9- or 10-membered aromatic bicyclic heterocycle comprising two fused aromatic 5- or 6-membered monocyclic heterocycles, each of said cyclic groups being selected from the group consisting of one or more Q, which may be the same or different. S may be substituted by a substituent, Q S is halogen, cyano, isocyano, nitro, hydroxyl, mercapto, formyl, carboxyl, C 1 ~C 6 -Alkyl, C 1 ~C 6 -Haloalkyl, C 1 ~C 6 -Alkylcarbonyl, C 1 ~C 6 -Haloalkylcarbonyl, C 1 ~C 6 -Alkoxy, C 1 ~C 6 -Haloalkoxy, C 1 ~C 6 -Alkoxy-C 1 ~C 6 -Alkyl, C 1 ~C 6 -alkoxycarbonyl, C 1 ~C 6 -haloalkoxycarbonyl, C 2 ~C 6 -Alkenyl, C 2 ~C 6 -haloalkenyl, C 2 ~C 6 -Alkynyl, C 2 ~C 6 -haloalkynyl, C 2 ~C 6 -Alkenyloxy, C 2 ~C 6 -haloalkenyloxy, C 1 ~C 6 -Alkyl sulfanyl, C 1 ~C 6 -Haloalkylsulfanyl, C 1 ~C 6 -Alkyl sulfinyl, C 1 ~C 6 -Haloalkylsulfinyl, C 1 ~C 6 -Alkylsulfonyl, C 1 ~C 6 -Haloalkylsulfonyl, C 3 ~C 8 -Cycloalkyl, C 3 ~C 8 -cycloalkyloxy, C 3 ~C 6 -cycloalkenyl, non-aromatic 3- to 7-membered monocyclic heterocycle, aromatic 5- to 14-membered heterocycle, -O-Si(C 1 ~C 6 -alkyl) 3 , -Si(C 1 ~C 6 -alkyl) 3 , -OC(=O)R j , -NR j C(=O)R j , -C(=O)N(R j ) 2 , -C(=S)R j , -C(=S)N(R j ) 2 , -C(=NR j ) R j and -C(=NOR j ) R j and -N(R k ) 2 is selected from the group consisting of R j is hydrogen, C 1 ~C 6 -Alkyl, C 1 ~C 6 -Haloalkyl and C 1 ~C 6 - alkoxy, R k is hydrogen, hydroxyl, C 1 ~C 6 -Alkyl, C 1 ~C 6 -Haloalkyl, C 1 ~C 6 -Alkoxy, C 2 ~C 6 -Alkenyl, C 2 ~C 6 -haloalkenyl and C 3 ~C 8 -cycloalkyl; Aliphatic Q S , R j and R k The substituents are cyano, amino, nitro, hydroxyl, C 1 ~C 6 -Alkoxy, C 1 ~C 6 -Haloalkoxy, C 1 ~C 6 -alkoxycarbonyl, C 1 ~C 6 -haloalkoxycarbonyl, C 3 ~C 8 -Cycloalkyl, C 3 ~C 8 -halocycloalkyl, -Si(C 1 ~C 6 -alkyl) 3 and non-aromatic 3- to 7-membered monocyclic heterocycles, cyclic Q S Substituent or Q S The cyclic moiety of the substituent and the cyclic R k The substituents are halogen, cyano, amino, nitro, hydroxyl, formyl, carboxyl, oxo, methylidene, halomethylidene, C 1 ~C 6 -Alkyl, C 1 ~C 6 -Haloalkyl, C 1 ~C 6 -Alkoxy, C 1 ~C 6 -Haloalkoxy, C 1 ~C 6 -alkoxycarbonyl, C 1 ~C 6 -haloalkoxycarbonyl, C 3 ~C 8 -Cycloalkyl, C 3 ~C 8 -Halocycloalkyl, C 2 ~C 6 - one or more R independently selected from the group consisting of alkenyl and non-aromatic 3- to 7-membered monocyclic heterocycle Qs may be substituted by a substituent, and the cyclic group R Qs Substituents, together with the carbon atom to which they are attached, are C 3 ~C 8 - optionally substituted by two substituents forming a cycloalkyl; However, the compound of formula (I) (a) 3-(1H-benzotriazol-1-yloxy)-N-(4-tert-butylphenyl)-6-chloropyridazine-4-carboxamide (CAS Registry Number [561297-99-2]); (f) 3-(1H-benzotriazol-1-yloxy)-6-chloro-N-(cyclohexylmethyl)pyridazine-4-carboxamide (CAS Registry Number [1202404-84-9] is not included). or a salt, N-oxide or solvate thereof.

2. Q is selected from the group consisting of phenyl, naphthyl, bicyclo[4.2.0]octa-1(6),2,4-trienyl, benzodioxolyl, 2,3-dihydrobenzofuranyl, pyridinyl, thienyl, and indolyl, wherein the phenyl, naphthyl, bicyclo[4.2.0]octa-1(6),2,4-trienyl, benzodioxolyl, 2,3-dihydrobenzofuranyl, pyridinyl, thienyl, and indolyl are the same or different. S 2. The compound of formula (I) according to claim 1, which may be substituted by a substituent.

3. Q S is halogen, cyano, nitro, hydroxyl, C 1 ~C 6 -Alkyl, C 1 ~C 6 -Haloalkyl, C 1 ~C 6 -Alkylcarbonyl, C 1 ~C 6 -Alkoxy, C 1 ~C 6 -Haloalkoxy, C 1 ~C 6 -Alkoxy-C 1 ~C 6 -Alkyl, C 2 ~C 6 -Alkenyl, C 2 ~C 6 -Alkynyl, C 1 ~C 6 -Alkyl sulfanyl, C 1 ~C 6 -Haloalkylsulfanyl, C 3 ~C 8 -cycloalkyl, non-aromatic 3- to 7-membered monocyclic heterocycle and -N(R k ) 2 R k 3. A compound of formula (I) according to claim 1 or 2, wherein is hydrogen.

4. R 6 is aromatic C 6 ~C 14 - Carbocyclic, non-aromatic polycyclic C 7 ~C 12 -Carbocycle, non-aromatic polycyclic 6- to 14-membered heterocycle, aromatic 5- to 14-membered heterocycle, aromatic C 6 ~C 14 -Carbocyclyloxy, aromatic C 6 ~C 14 - C substituted by a carbocycle 1 ~C 3 -Alkoxy and aromatic C 6 ~C 14 - C substituted by a carbocycle 1 ~C 3 -haloalkoxy; 6 Substituent or R 6 The cyclic moieties of the substituents are one or more R 6S The compound of formula (I) according to any one of claims 1 to 3, which may be substituted by a substituent.

5. R 6 is phenyl, indanyl, 1,2,3,4-tetrahydronaphthalenyl, spiro[cyclopropane-1,2'-indan]-1-yl, naphthyl, 2,3-dihydrobenzofuranyl, indolinyl, 1,3-benzodioxolyl, chromanyl, isochromanyl, thiochromanyl, 2,3-dihydro-1,4-benzodioxinyl, 5,6,7,8-tetrahydroquinolinyl, 4,5,6,7-tetrahydrobenzothiophenyl, furanyl, thienyl, pyridinyl, pyrimidinyl, indolyl, benzofuranyl, benzoxazolyl, quinolinyl, isoquinolinyl, imidazo[1,2-a]pyridinyl, phenoxy, benzyloxy, and -OCF 2 -phenyl, and the cyclic R 6 Substituent or R 6 The cyclic moieties of the substituents are one or more R 6S The compound of formula (I) according to any one of claims 1 to 4, which may be substituted by a substituent.

6. R 6S is halogen, cyano, C 1 ~C 6 -Alkyl, C 1 ~C 6 -Haloalkyl, C 1 ~C 6 -Alkoxy, C 1 ~C 6 -Haloalkoxy, C 2 ~C 6 -Alkenyl, C 2 ~C 6 -Alkynyl, C 1 ~C 6 -Haloalkylsulfanyl, C 3 ~C 8 -Cycloalkyl, aromatic C 6 ~C 14 - selected from the group consisting of carbocycles, aromatic 5- or 6-membered monocyclic heterocycles and non-aromatic 3- to 7-membered monocyclic heterocycles, and the cyclic group R 6S The substituents are halogen, C 1 ~C 6 -Alkyl, C 1 ~C 6 -Haloalkyl and C 1 ~C 6 -alkoxycarbonyl. - alkoxycarbonyl.

7. R 1 is hydrogen, hydroxyl, cyano, C 1 ~C 6 -Alkyl, C 1 ~C 6 -Alkoxy, C 1 ~C 6 -Alkoxy-C 1 ~C 6 -Alkyl and -C(=O)(OR a1 ) selected from the group consisting of R a1 is C 1 ~C 6 -Alkyl or C 2 ~C 6 A compound of formula (I) according to any one of claims 1 to 6, wherein - alkenyl.

8. R 7 is hydrogen, halogen, cyano, C 1 ~C 6 -Alkyl, C 1 ~C 6 -Haloalkyl, C 1 ~C 6 -hydroxyalkyl, C 1 ~C 6 -Alkylcarbonyl, C 1 ~C 6 -Alkoxy, C 2 ~C 6 -Alkenyl, C 2 ~C 6 -Alkynyl, C 1 ~C 6 -Alkyl sulfanyl, C 1 ~C 6 -Alkyl sulfinyl, C 3 ~C 8 -cycloalkyl, aromatic 5- or 6-membered monocyclic heterocycle, non-aromatic 3- to 7-membered monocyclic heterocycle, -N(R e ) 2 , -C(=NR f ) R f and -C(=O)N(R g ) 2 R e , R f and R g A compound of formula (I) according to any one of claims 1 to 7, wherein

9. R 8 is hydrogen, halogen, hydroxyl, C 1 ~C 6 -Alkyl, C 1 ~C 6 -Haloalkyl, C 1 ~C 6 -Alkoxy, C 2 ~C 6 -Alkenyl, C 2 ~C 6 -Alkenyloxy, C 2 ~C 6 -haloalkenyloxy, C 1 ~C 6 -Alkyl sulfanyl, C 1 ~C 6 -Haloalkylsulfanyl, C 1 ~C 6 -Alkyl sulfinyl, C 1 ~C 6 -Alkylsulfonyl, C 3 ~C 8 -Cycloalkyl, aromatic C 6 ~C 14 -Carbocycle, non-aromatic 3- to 14-membered heterocycle, aromatic 5- to 14-membered heterocycle, C 3 ~C 8 -cycloalkyloxy, non-aromatic 3- to 14-membered heterocyclyloxy and -N(R h ) 2 R h A compound of formula (I) according to any one of claims 1 to 8, wherein

10. A composition comprising at least one compound of formula (I) according to any one of claims 1 to 9 and at least one agriculturally suitable adjuvant.

11. A method for controlling phytopathogenic fungi, said method comprising the step of applying at least one compound of formula (I) according to any one of claims 1 to 9 or a composition according to claim 10 to plants, plant parts, seeds, fruits or the soil in which said plants grow.

12. Formula (I): 【Chemistry 2】 [In the formula, R 1 is hydrogen, hydroxyl, cyano, C 1 ~C 6 -Alkyl, C 1 ~C 6 -alkoxy, -C(=O)R a1 , -C(=O)(OR a1 ), -S(=O)R a1 , -S(=O) 2 R a1 , -C(=O)N(R a2 ) 2 and S(=O) 2 N (R a2 ) 2 T is O and R a1 , R a2 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , n, m and Q are as defined in claim 1. A method for preparing a compound of the formula: Formula (1): 【Chemistry 3】 [In the formula, U 1 is hydroxyl, halogen or C 1 ~C 6 -alkoxy, R 7 , R 8 and Q is as defined in claim 1. and Formula (2): 【Chemistry 4】 [In the formula, R 1 is hydrogen, hydroxyl, cyano, C 1 ~C 6 -Alkyl, C 1 ~C 6 -alkoxy, -C(=O)R a1 , -C(=O)(OR a1 ), -S(=O)R a1 , -S(=O) 2 R a1 , -C(=O)N(R a2 ) 2 and S(=O) 2 N (R a2 ) 2 and R a1 , R a2 , R 2 , R 3 , R 4 , R 5 , R 6 , n and m are as defined in claim 1. and The method comprises the step of reacting

13. Formula (I): 【Chemistry 5】 [In the formula, R 1 is hydrogen, hydroxyl, C 1 ~C 6 -Alkyl or C 1 ~C 6 -alkoxy, T is O, and R 8 is hydrogen or C 1 ~C 6 -alkyl, R 7 is hydrogen, halogen, hydroxyl, mercapto, C 1 ~C 6 -Alkyl, C 1 ~C 6 -Haloalkyl, C 1 ~C 6 -Alkoxy, C 1 ~C 6 -Haloalkoxy, C 2 ~C 6 -Alkenyloxy, C 2 ~C 6 -haloalkenyloxy, C 2 ~C 6 -alkynyloxy, C 2 ~C 6 -haloalkynyloxy, C 1 ~C 6 -Alkyl sulfanyl, C 1 ~C 6 -Haloalkylsulfanyl, C 3 ~C 8 -Cycloalkylsulfanyl, C 3 ~C 8 -Cycloalkyl, C 3 ~C 6 -cycloalkenyl, C 3 ~C 8 -Cycloalkyloxy, aromatic C 6 ~C 14 -carbocyclyloxy, aromatic 5- or 6-membered monocyclic heterocyclyloxy, non-aromatic 3- to 7-membered monocyclic heterocyclyloxy and -N(R e ) 2 R e is as defined in claim 1, R 2 , R 3 , R 4 , R 5 , R 6 , n, m and Q are as defined in claim 1. A method for preparing a compound of the formula: Formula (3): 【Chemistry 6】 [Wherein G is a halogen and R 1 is hydrogen, hydroxyl, C 1 ~C 6 -Alkyl or C 1 ~C 6 -alkoxy, R 8 is hydrogen or C 1 ~C 6 -alkyl, R 7 is hydrogen, halogen, hydroxyl, mercapto, C 1 ~C 6 -Alkyl, C 1 ~C 6 -Haloalkyl, C 1 ~C 6 -Alkoxy, C 1 ~C 6 -Haloalkoxy, C 2 ~C 6 -Alkenyloxy, C 2 ~C 6 -haloalkenyloxy, C 2 ~C 6 -alkynyloxy, C 2 ~C 6 -haloalkynyloxy, C 1 ~C 6 -Alkyl sulfanyl, C 1 ~C 6 -Haloalkylsulfanyl, C 3 ~C 8 -Cycloalkylsulfanyl, C 3 ~C 8 -Cycloalkyl, C 3 ~C 6 -cycloalkenyl, C 3 ~C 8 -Cycloalkyloxy, aromatic C 6 ~C 14 -carbocyclyloxy, aromatic 5- or 6-membered monocyclic heterocyclyloxy, non-aromatic 3- to 7-membered monocyclic heterocyclyloxy and -N(R e ) 2 R e is as defined in claim 1, R 2 , R 3 , R 4 , R 5 , R 6 , n and m are as defined in claim 1 , Formula (4): 【Chemistry 7】 wherein Q is as defined in claim 1. and in the presence of a base.

14. Compound of formula (1): 【Chemistry 8】 [In the formula, Q is as defined in claim 1; U 1 is hydroxyl, halogen or C 1 ~C 6 -alkoxy; R 7 , R 8 is as defined in claim 1 and at the same time is hydrogen, C 1 ~C 6 -Alkyl, and aromatic C 6 ~C 14 - not carbocyclic; However, the compound of formula (1) is 【Table 1】 No,].

15. Compound of formula (3): 【Chemistry 9】 [In the formula, G is a halogen; n=1 and m=1; R 1 is hydrogen; R 2 , R 3 is hydrogen; R 4 and R 5 is hydrogen or fluorine; R 6 is as defined in claim 4; R 7 is hydrogen, halogen, hydroxyl, mercapto, C 1 ~C 6 -Alkyl, C 1 ~C 6 -Haloalkyl, C 1 ~C 6 -Alkoxy, C 1 ~C 6 -Haloalkoxy, C 2 ~C 6 -Alkenyloxy, C 2 ~C 6 -haloalkenyloxy, C 2 ~C 6 -alkynyloxy, C 2 ~C 6 -haloalkynyloxy, C 1 ~C 6 -Alkyl sulfanyl, C 1 ~C 6 -Haloalkylsulfanyl, C 3 ~C 8 -Cycloalkyl, C 3 ~C 6 -cycloalkenyl, C 3 ~C 8 -Cycloalkyloxy, aromatic C 6 ~C 14 -carbocyclyloxy, aromatic 5- or 6-membered monocyclic heterocyclyloxy, non-aromatic 3- to 7-membered monocyclic heterocyclyloxy and -N(R e ) 2 R e is as defined in claim 1, R 7 and R e may be substituted as defined in claim 1; R 8 is hydrogen or C 1 ~C 6 - alkyl; However, the compound of formula (3) is 【Table 2】 【change】 【change】 【change】 No,].

Citation Information

Patent Citations

  • 2,4-diaminopyrimidine derivatives

    JP1999511749A

  • 3-phenoxy-4-pyridazinol derivative and herbicide composition containing the same

    JP2004002263A

  • Substituted aryl-amine derivatives and methods of use

    JP2008507539A

  • novel microbicide

    JP2009537469A

  • Composition and light-emitting element using the composition

    JP2010031249A

Cited By

  • Triazine and pyrimidine (thio)amide compounds as fungicidal compounds.

    JP2023525349A

  • Azabicyclic (thio)amides as fungicidal compounds.

    JP2023529294A